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ABSTRACT 
Resistant starch (RS) is a complex carbohydrate that reaches the large intestine and is 
fermented by the colonic microflora. Two types of novel starches were processed: (1) 
stearic-acid complexed high-amylose cornstarch (SAC) which contains high resistance 
and (2) Guat from an inbred corn line with a high resistant starch content and ARXGuat 
from a hybrid of two corn lines AR (digestible starch) and Guat (resistant starch). The 
inhibition by SAC on colorectal carcinogenesis was compared with high amylose starch 
(HA) and normal corn starch (CS), and the study for the same purpose on Guat and 
ARXGuat starches was compared with AR starch. In all of the studies, starch diets were 
fed to Azoxymethane (AOM) - induced Fisher 344 rats for 8 weeks with 50-55% of the 
diet replaced with RS. The cooking method of water-boiling was applied to both studies. 
A bread-baked method was also applied to the SAC study for the comparison of the 
cooking methods. In the SAC study, the amount and concentration of Short Chain Fatty 
Acids (SCFAs) were assessed. Global gene expression was also studied in the colon 
mucosa of rats fed different diets or injected with AOM/saline by Affymatrix Microarray. 
Target genes differentially expressed after AOM treatment, or by the feeding of SAC 
were selected and identified by semi-quantitative real-time polymerase chain reaction 
analysis (semi-qRT-PCR). In our studies, SAC cooked by either the water-boiling or 
bread-baking method markedly reduced the Aberrant Crypt Foci (ACF) and Mucin 
Depleted Foci (MDF) numbers, and an enhanced ACF multiplicity was observed 
compared with cooked HA or CS within their cooking groups. Aberrand crypt foci 
numbers were dramatically decreased in the rats fed starches cooked by the bread-baking 
method compared with that in rats fed starch prepared by the water-boiling method. 
vi 
 
Increased cecal weights and decreased cecal content pH, as well as increased total SCFAs 
or individual SCFA (butyrate, acetate) amounts were obtained by the same comparison. 
Microarray screening identified 3368 induced and 3060 repressed genes by AOM 
treatment and 544 induced and 859 repressed genes by SAC treatment, among which 
seven genes were confirmed by semi-qRT-PCR. In the Guat and ARXGuat study, Guat 
was found to cause a slight but significant increase in the ACF multiplicity, but no 
significant differences were found in total number of ACF, MDF or AC in rats fed either 
Guat or ARXGuat, relative to those fed AR. Collectively, the studies suggested the 
inhibitory effect of novel RS SAC on colonic preneoplastic lesions after the starches were 
cooked. It also revealed that the rats fed starch diets prepared by bread-baked cooking 
method had decreased preneoplastic lesion numbers compared with those fed water-
boiled starch diets.  
 
 
 
 
 
  
CHAPTER 1: GENERAL INTRODUCTION 
Introduction 
 
Resistant starch is a starch escaping digestion in the small intestine and fermenting in 
large intestine (Englyst et al., 1992). It serves as a potential source of fermentable 
substrate to produce short chain fatty acids by gut microflora (Scheppach et al., 1995). It 
also decreases cecal and fecal pH (Phillips et al., 1995) and increased their body weights 
(Gibson et al., 1996). Resistant starch has been reported to provide health benefits to 
humans and protect against diseases such as obesity, diabetes, chronic inflammatory 
bowel diseases, and cancers in cell culture systems and animal models (Higgins et al., 
2011; Brennan, 2005; Jacobasch et al., 1999; Le Leu et al., 2009). On average, intake of 
high fiber diet is poor in Western societies. Resistant starch, however, can be a good 
alternative for dietary fiber since it is well tolerated and can be added up to 6 times the 
average daily intake in the normal Western diet (Van Munster et al., 1994). 
In recent years, more and more studies have accumulated suggesting the benefit of 
RS on chronic inflammatory bowel diseases and colon cancer. Intestinal microflora, 
comprising several hundred species and forming a large ecosystem in its host, was 
revealed to play an essential role in the resistance to these diseases. Carbohydrates are the 
main substrate for the microflora. Resistant starch, an indigestible form of carbohydrate, 
is fermented by gut microflora and forms SCFA, hydrogen, methane and other products 
(Cummings et al., 1997). Butyrate is considered the most effective inhibitor of colorectal 
cancer (CRC) among the 3 main components of SCFA (butyrate, acetate, and propionate) 
and plays an important role in inhibiting proliferation and activating apoptosis of colon 
epithelial cells based on studies in colon cancer cell lines  (Velazquez et al., 1996). 
Butyrate stimulates the expression of tumor suppressor proteins APC and E-cadherin, and 
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inhibits the accumulation of beta-catenin in the nucleus and thus deactivates oncogenes 
(Velazquez et al., 1997). 
Resistant starch has been found in a wide range of natural plants. Four types of RS 
have been described including physically inaccessible starch, naturally highly resistant 
starch to α-amylase digestion, retrograded resistant starch, or chemically modified starch, 
respectively. Chemical modification is an effective way to increase the resistance of 
starch granules to enzyme hydrolysis. One of the most popular modification methods is to 
conduct esterification of starch using anhydride, propylene oxide, or octenyl succinic 
anhydride (Chung et al., 2008). In our study, SAC is a production of linear molecules of 
amylose combined with stearic acid forming a single helical complex. This complex has 
an increased resistance to amylase hydrolysis presumably because the structure of the 
complex prevents it from fitting the enzyme binding site and being hydrolyzed (Hasjim, 
2009).  
Another kind of manmade RS came from natural plant breeding programs, in which a 
new RS line was bred from parent lines and inherits high resistant traits from them. Some 
of these RS have been put into the market, such as BarleyMax, a hybrid variety of barley, 
and Hi-maize resistant starch, highly resistant maize starch isolated from a special hybrid 
of high amylose starch. In our study, one maize line that was originally from Guatemala 
and one from Argentina were inbred as Guat and AR, respectively, and they were then 
crossed to make the ARXGuat hybrid. The resistance of the starches and the potential 
benefits of these starches in the rat large bowel were tested in our study.  
It was the first time that the starches were cooked and evaluated for their effect on 
colorectal carcinogenesis. Cooking is a gelatinization process for starches. A fully 
gelatinized process requires sufficient amounts of water and appropriate temperature. In 
our study, neither the water-boiled method nor the bread-baked method provided full 
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gelatinization to the starches. The less gelatinized the RS is, the higher resistant starch 
content it gains (Donavan et al., 1979). Thus the resistant starch contents of SAC were 
different after the starch was cooked by the two different cooking methods (32.7 + 0.8% 
in bread-baked SAC diet and 27.2 + 0.1% in water-boiled SAC diet, respectively). 
The studies in this thesis examined the inhibitory effect of cooked RS from 2 starch 
modification methods, SAC or cornline breeding (Guat and ARXGuat), in the colon of 
azoxymethane-induced Fisher 344 rats by observing the occurrence of aberrant crypt foci 
and mucin depleted foci. Both lesions are widely considered as carcinogen-induced 
preneoplastic lesions and are highly correlated to the risk of colon cancer incidence in 
humans (Corpet and Tache, 2002). Also, mucin-depleted foci were reported as a better 
pre-cancerous predictor than aberrant crypt foci (Femia et al., 2004; Pretlow et al., 1990). 
A global gene screening was also conducted in the studies of water-boiled SAC 
compared to CS in our rat model. Microarrays provided powerful analysis of a large 
number of different mRNAs and identified genes and gene families whose expression 
levels were changed by diet in previous studies (Kato et al., 2004; Park et al., 2008). 
Microarrays were also applied to CRC patients as an assessment of gene alteration 
(Galamb et al., 2005; Croner et al., 2005). These previous studies provided references for 
our studies as that AOM treatment in rats were mimicking CRC incidence in human, and 
we also hoped to find target genes associated with diet treatment using similar microarray 
techniques.  
Lowered cecal pH and increased cecal weights were observed in rats fed cooked 
SAC and HA compared with rats fed CS. The same trend was also observed in rats fed 
cooked Guat compared with those fed AR. These cecal changes are related to the 
accumulation of SCFA that comes from the fermentation of RS. In this process, gut 
microflora might play an important role as they use RS as a substrate to produce SCFA, 
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which impacts the incidence of CRC by modulating the proliferation, apoptosis and 
differentiation of epithelial cells (Siavoshian et al., 2000; Gibson et al., 1992; Diez-
Gonzalez et al., 1999). Resistant starch, in turn, can modify the gut microbial population 
after it is fed to animals, which may affect the ability of gut microflora on colonic 
fermentation (Silvi et al., 1999). 
 The purpose of the studies included in this dissertation is to assess the inhibitory 
effect of some RS on colonic preneoplastic lesions. These RS include the complex of 
high-amylose starch and stearic acid SAC, and RS from traditional breeding Guat and 
ARXGuat. The hypothesis of the studies is that our RS will reduce the risk of colon 
preneoplastic lesions through changes in gene expression levels and changes in gut 
microbial metabolism. 
 
Dissertation Organization 
 
This dissertation examines the inhibitory effect of cooked RS (SAC, Guat, and 
ARXGuat) against colorectal preneoplastic lesions in an azoxymethane-induced rat model 
using ACF and MDF as biomarkers for CRC. The studies suggested that cooked SAC 
was efficient as an inhibitor of preneoplastic lesions. The enhanced fermentation in the 
large bowel and increased SCFA amount were also revealed and presumably related to 
this inhibitory effect of colon lesion incidence by the function of gut microflora. Global 
gene expression was screened for the effect of AOM treatment and diet treatment 
respectively. Genes or signaling pathways that related to carcinogenesis were mostly up-
regulated in AOM-induced colon samples, and the common genes which showed 
differential expressions in both AOM treatment and diet treatment were mostly down-
regulated in SAC treated colon samples compared with the controls, indicating SAC 
efficiently activated the cancer suppression process and inactivated functions of 
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oncogenes genetically.  In the study of cooked Guat and ARXGuat starches in the same 
animal model, no inhibitive effect was seen compared to digestible control starch (AR). 
In the first paper, “Inhibition of Azoxymethane-induced Preneoplastic Lesions in the 
Rat Colon by a Cooked Stearic Acid Complexed High-amylose Cornstarch”, the 
hypothesis that water-boiled SAC would be effective in inhibiting colon preneoplastic 
lesions in AOM-induced F344 rats and that high moisture cooking would be important on 
the suppression of colon carcinogenesis by this SAC was tested. The study confirmed that 
water-boiled SAC markedly reduced MDF numbers compared with the water-boiled HA 
or CS. Increased cecum weight, decreased cecal pH, and increased amount of cecal total 
SCFA, or fecal butyrate and propionate were also observed in rats fed water-boiled SAC. 
This indicated that an enhanced fermentation and SCFA accumulation by gut microflora 
may play an important role in this process of preneoplastic suppression. It was also 
observed that uncooked SAC did not show reduction in ACF or MDF occurrence 
compared with CS. In this study, Dr. Jay-Lin Jane and Dr. Jovin Hasjim in the 
Department of Food Science and Human Nutrition in Iowa State University modified the 
high-amylose VII resistant starch to SAC and analyzed the resistant starch content of the 
starches or diets. Dr. Suzanne Hendrich and Dr. Li Li from the same department analyzed 
the SCFA amount and concentration in cecum and feces of Fisher 344 rats after they were 
treated and sacrificed. I set up the animal model and analyzed the efficiency of SCA on 
colonic preneoplastic lesion suppression in both cooked and uncooked method.  I wrote 
the manuscript for this collective work, and the paper was published in Journal of 
Agricultural and Food Chemistry. 
The second paper was titled “Inhibition of Azoxymethane-induced Preneoplastic 
Lesions in the Rat Colon by a Stearic Acid Complexed High-amylose Cornstarch using 
Different Cooking Methods and Assessing the Potential Gene Targets”. This study tested 
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the hypothesis that SAC could prevent the incidence of preneoplastic lesions in the colon 
of AOM-treated Fisher 344 rats when this SAC was cooked in either of the two methods, 
water-boiled or bread-baked and the intake of SCA would trigger some expression 
changes at the genetic level.  This study revealed that SAC cooked by both methods 
profoundly reduced the incidence of total ACF, large ACF and MDF compared with HA 
or CS in each respective cooking method. Moreover, rats fed bread-baked SAC showed 
dramatically fewer preneoplastic lesions than rats fed water-boiled SAC. Increased cecal 
contents and decreased cecal pH, as well as increased total SCFA and butyrate, acetate 
and propionate were observed in the cooked SAC group by either cooking method. 
Overexpression of Genes such as HSPD1, HSPH1, MCM6, RAC1, CD55, and TFRC 
were tested in rats after AOM induction, and the same genes were down-regulated after 
water-boiled SAC diet was fed.  In this study, Dr. Suzanne Hendrich and Dr. Li Li 
collected data for the SCFA analysis. I modified the HA into SAC, tested its effect on 
carcinogenesis in the AOM-induced Fisher 344 rats, collected endpoints and did the 
analysis. Dr. Jiqing Peng from ISU GeneChip Facility conducted the Microarray. Dr. 
Man-Yu Yum and Tieming Ji of the Statistics Department of ISU helped me with the 
analysis of microarray data. I also wrote the manuscript. 
The third manuscript, “A Study on the Effect of water-boiled Guat209 and ARXGuat 
a hybrid of Guat209 and AR16035 corn starches on Azoxymethane-induced Preneoplastic 
Lesions in the Rat Colon”, assumed that Guat, a resistant starch, would inhibit colon 
preneoplastic lesions compared with a digestible starch AR in AOM-treated F344 rats 
after the starches were water-boiled. And the hybrid of these two corn lines, ARXGuat, 
would inherit the high resistant feature of Guat and also show an inhibitory effect on pre-
cancerous lesions after water-boiling. However, this study showed no lesion suppression 
from either water-boiled Guat or ARXGuat, although enhanced cecal weights and 
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reduced cecal pH were observed.  For this study, Dr. Linda Pollak selected the corn lines. 
Dr. Marvin Paul Scott and Susan Duvick conducted the breeding work of the corn lines. I 
was responsible for the data collection from the rat model, data analysis and manuscript 
writing.  
The research papers follow the general introduction and literature review. A general 
conclusion is provided at the end of the dissertation.  
 
Literature Review 
 
Colon Cancer (CRC) 
CRC is one of the leading causes of cancer death worldwide. CRC was estimated to 
be the third most common cancer in both men and women, and is more common in 
developed countries. In the USA alone, an estimated 102,900 cases of colon and 39,670 
cases of rectal cancer were predicted to occur in 2010, among which 51370 deaths were 
expected, accounting for 9% of all cancer deaths (American Cancer Society, 2010). In 
Europe, 413,000 people were diagnosed with colorectal cancer and among them 207,000 
died in 2006.  It has been the highest incidence cancer and the second-most deadly after 
lung cancer (Europacolon, 2011). The highest incidence rates of CRC occur in North 
America, Western Europe and Japan, while the lowest rates occur in Africa, Asia and 
Central America. The rates have been increasing largely in economically developing 
countries (Jemal, 2011).  Some research showed that colorectal cancer incidence rates for 
both males and females primarily increased in the economically transitioning countries 
including Eastern European countries, most parts of Asia, and select countries of South 
America based on the data from 1983-87 to 1998-2002 (Center et al., 2009). 
Colorectal cancer, also known as bowel cancer, is the cancer caused by uncontrolled 
cell growth in the colon or rectum of the gastrointestinal tract (American Cancer Society, 
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2010). Colorectal cancers start in the lining of the bowel, most are benign as colorectal 
polyps or adenoma, but some develop into cancer over time (Falterman et al., 1974). 
Colorectal cancers can be adenocarcinomas, lymphomas or squamous cell carcinomas. 
The latter two are not as common and not as well characterized (Beart, 1990; Juturi et al., 
1999). In our studies, we focused on pre-neoplastic lesions that originate in the colorectal 
epithelium.  Epidemiologic studies have revealed a number of risk factors for colorectal 
cancer including age, family history of CRC or inflammatory bowel disease, smoking, 
alcohol consumption, obesity, and diet (Giovannucci, 2002; Wu et al., 1987).   
Colorectal cancer can occur from familial (hereditary) genetics or as a sporadic 
genetic insult following an environment impact. Most colorectal cancers occur as 
sporadic cases. Most hereditary colorectal cancers are Familial Adenomatous Polyposis 
(FAP) and Hereditary Nonpolyposis Colorectal Cancer (HNPCC).  About 20% of 
colorectal cancers occurred from familial, 5% of the incidence came from genetic 
syndromes such as (FAP and HNPCC, and around 75% occurred sporadically (Fearon 
and Vogelstein, 1990; Hendon et al., 2005).  Familial Adenomatous Polyposis is an 
autosomal dominant syndrome characterized by multiple adenomatous polyps. Familial 
Adenomatous Polyposis may occur in the gastric, duodenal, jejunoileal, and colorectal 
areas. Patients with FAP usually have CRC within 8–10 years. Some genes on 
chromosome 5q21 are associated with FAP and are likely to contribute to colorectal 
tumorigenesis, including adenomatous polyposis coli tumor-suppressor gene (APC) and 
mitotic checkpoint proteins complex gene (MCC). The MCC gene was considered to 
cause FAP by somatic mutation in sporadic colorectal carcinomas. The APC gene is 
involved in cellular processes for the development of CRC (Kinder et al., 1991; Joslyn et 
al., 1991).  Hereditary Nonpolyposis Colorectal Cancer is an autosomal dominant 
condition with an increased risk of developing colorectal cancer at an earlier age than 
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sporadic colorectal cancer. Individuals with HNPCC have about an 80% lifetime risk for 
CRC. Two-thirds of these cancers occur in the proximal colon (Rodney et al., 2001).  
Carcinogenesis in the colon epithelium is a multistep process including different 
epithelial cell growth events in each step and commonly considered as an “adenoma-
carcinoma” model, followed by malignant transformation (Kinzler and Vogelstein, 1996). 
In this model, accumulation of multiple genes, rather than their sequence, determines 
tumorigenesis.  Two kinds of genetic alterations happen in the process:  for the inherited 
syndromes such as APC and HNPCC, germline mutations are inherited, and for sporadic 
cancers, somatic mutations occur in a stepwise mannar (Fearon and Vogelstein, 1990). 
Mutations in the APC gene, a tumor suppressor gene that occurs in both inherited and 
sporadic tumors, usually appear in the early stage of tumorigenesis.  The mutation of APC 
leads to the loss of APC function as part of a protein complex targeting β-catenin for its 
degradation and thus activates β-catenin/Tcf-4 acts for proliferation in intestinal crypt 
epithelial cells (Bright-Thomas and Hargest, 2003).  Among the genes that change in the 
process of tumorigenesis, K-ras and p53 are also key genes. The mutation of k-ras gene 
follows APC mutation, found in 50% of sporadic colorectal cancers. Ras oncogene 
mutation switches on the transmission of extracellular growth signals to the nucleus 
(Smith et al., 2002).  The p53 suppressor gene is the most commonly mutated gene in 
human cancer occurring in the late development of CRC since the mutation of p53 gene 
could be identified in up to 75% CRCs but rarely found in adenomas and aberrant crypt 
foci (Manne et al., 1997).  
 
Diet and Life Style 
Environmental factors play a major role in the development of colorectal cancer. Diet 
and lifestyle are two of the main environmental factors that affect the occurrence of CRC. 
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One study reported data from a population-based study conducted in northern California, 
Utah, and Minnesota in 1991-1995. In this study, the lifestyle patterns for both men and 
women were divided by dietary variables, body size, medication, supplementation, 
alcohol, and physical activity. Previous studies suggested that consuming a Western style 
diet (high in meat, refined grains and sugar, and low in vegetables and fiber) and physical 
inactivity were most related to the high incidence rate of CRC. High levels of physical 
activity, consuming high levels of calcium and folate, keeping energy balance and 
maintaining an appropriate body weight were also reported to reduce the incidence of 
CRC (Slattery, 2000). Migrant studies of populations moving from areas with different 
colorectal cancer incidence also help the research on the environment impact on CRC.  It 
was reported that CRC was sharply increased in Korean-Americans compared with 
Koreans in both genders (Lee et al., 2007). 
Dietary fiber was widely accepted as a protective factor for CRC. But the concept 
became controversial as research accumulated.  In a pooled study of 13 prospective 
cohort studies for 6 to 20 years of follow-up across studies, dietary fiber intake was 
inversely associated with the risk of colorectal cancer in age-adjusted analyses. However, 
high dietary fiber intake was not associated with a reduced risk of colorectal cancer after 
accounting for other dietary risk factors (Park et al., 2005). A 16-year-follow-up study in 
women aged from 34 to 59 years old with no history of cancer, inflammatory bowel 
disease, or familial polyposis revealed no association between the intake of dietary fiber 
and the risk of colorectal cancer (Fuchs et al., 1999). As studies were conducted, it was 
realized that the fiber type might be important for its association with colorectal cancer 
inhibition. A prospective study in men from 1986 to 1994 indicated a modest reduced risk 
of distal colon adenoma with increasing intake of fiber from fruit but not cereals or 
vegetables. Soluble fiber appeared to be inversely associated with distal colon adenoma, 
10
  
but insoluble fiber did not have this association. No consistent relation was found 
between fiber and rectal adenomas or hyperplastic polyps (Platz et al., 1997). Notably, 
one of the reasons that no association was seen for fiber with CRC might be that human 
fiber intake is generally low. For example, the adequate intake for 45,491 women 50 
years and older was estimated at 21 g/day/woman (Food and Nutrition Board, Institute of 
Medicine, 2002). A study of older women with a mean follow-up time of 8.5 years 
revealed no association between fiber intake and CRC, but the 10th percentile of dietary 
fiber intake was 5.4 g, and the 90th percentile was only 18.2 g, indicating an inadequate 
intake of fiber for a large group of women in that age range (Mai et al., 2003).  
Another common nutritional recommendation over the last 20 years for avoiding 
colorectal cancer was to reduce the intake of dietary fat. A cohort study in men suggested 
that intakes of total fat, saturated fat, and animal fat were not related to risk of CRC. 
However, red meat intake was associated with an elevated risk of CRC. Men who ate 
beef, pork, or lamb as a main dish five or more times per week had a relative higher risk 
compared to men eating these foods less than once per month (Giovannucci, 1994). A 
prospective study in women found that animal fat was positively associated with the risk 
of CRC. In this study, results showed the relative risk of CRC in women who ate beef, 
pork, or lamb as a main dish every day was sharply increased compared with those who 
ate these foods less than once a month. The ratio of the intake of red meat to the intake of 
chicken and fish was also an increased factor for CRC. Processed meats and liver were 
also significantly associated with increased risk. Fish and chicken without skin were 
related to decreased risk. No association for vegetable fat was observed (Willett, 1990). 
Observations also revealed a connection between the increased intake of Folic acid 
supplementation (Benito et al., 1991; Bird, 1995; Giovannucci et al., 1998), calcium and 
Vitamin D (De Stefani et al., 1997; Pritchard et al., 1996; Kampman et al., 1994; Grau et 
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al., 2003), and high consumption of fruits and vegetables (Michels et al., 2000; van 
Duijnhoven et al., 2009) and the decreased occurrence of CRC, yet some of the findings 
were still controversial.   
 
Starch 
Starch is a carbohydrate produced by all green plants.  It is common in the human 
diet, e.g. in staple foods such as potatoes, wheat, maize (corn), rice, and cassava. Starch 
contains two types of glucans: amylopectin and amylose.  Amylopectin is highly 
branched molecules with a-(1->4) glycosidic-linked short linear chains connected by a-
(1->6) glycosidic linkages.  Amylopectin is packed into a semi-crystalline structure by the 
branch chains. Amylose is comprised of primarily linear molecules with a-(1->4) 
glycosidic linkages; some consist of a few branches.  Amylose presents in an amorphous 
form.  Amylose content is about 15-30% in normal starch, and 50% or more in high 
amylose starch (Nakamura, 2002).  The crystallinity of high-amylose starch is less than 
that of the normal starch due to the greater amount of amylose in high-amylose starch.  
Gelatinization of starch causes an irreversible change of the starch from semi-
crystalline structure to amorphous structure when starch granules are heated to an 
appropriate temperature with a sufficient amount of water.  During the gelatinization 
process, the starch granules swell, and the double helices in the granules dissociates. 
Gelatinization temperature and enthalpy change of gelatinization are two main properties 
of gelatinization, which are impacted by three main factors: structure of the amylopectin, 
amylose content, and phosphate-monoester derivatives of the starches. Amylose presents 
in starch granules in an amorphous form and reduces the crystallinity of the starch 
granules, which causes a reduced enthalpy change of starch gelatinization. Then 
amylopectin presents more in a crytallinity structure. High-amylose cornstarch has a high 
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gelatinization temperature (more than 100◦C) due to its long branch-chains of 
amylopectin since long branch-chains spread more through the crystalline formation and 
stabilizes the crystalline structure compared with short branch chain amylopectin.  
Phosphate-monoester derivatives have negative charges thus providing repulsion forces 
between each other. Consequently, starches with a high proportion of the phosphate-
monoester derivatives on its amylopectin have a low gelatinization temperature (Jane et 
al., 1999). 
Retrogradation happens during the storage of gelatinized starch where gelatinized, 
amorphous starch molecules recrystallize in a double helical structure. Retrogradation of 
the starch is impacted by the amylose content, amylopectin structure, lipid content, 
storage temperature, and moisture content of starch paste. Amylose retrogrades faster 
than amylopectin. The presence of lipids and phospholipids make starch harder to 
retrograde since the lipids restrict the swelling of starch granules and the dispersion of 
starch molecules during cooking, and keeps the starch molecules close enough to resist 
retrogradation. Lipids can also form a complex with amylose, which also helps to resist 
retrogradation (Slade and Levine, 1987; Jane et al., 1999). Phosphate-monoester 
derivatives provide repulsive forces and reduce the retrogradation of starch.  
Enzyme hydrolysis of starch molecules produces glucose as an energy source for 
plant metabolism, as well as for animal and human energy generation. Enzyme hydrolysis 
is slower in starch granules than in gelatinized amorphous starch molecules. Enzyme 
hydrolysis is also slower in large starch granules than in smaller granules. The structure 
of amylopectin, amylose content, lipid content, granular size, and polymorphism are all 
factors to impact susceptibility of the starch granules to enzyme digestion (Tester et al., 
2004).   
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Resistant starch is not absorbed in the small intestine and is thus passed on to the 
larger intestine. Resistant starch is fermented in the large intestine by the gut microflora 
producing short chain fatty acids and other organic acids. Resistant starch can be 
classified into five types according to their structures and their enzyme resistance: RS 
type 1 (RS1) is physically inaccessible starch protected by a protein matrix or cell wall 
material, such as whole grains, legumes, and pasta. RS1 in legume seeds is protected by 
the cell wall, which prevents the starch granules from getting enough water when 
cooking. Thus the starch granules cannot fully swell and be gelatinized and are less 
digestible. RS1 in whole grains or in pasta is surrounded by a protein matrix, which forms 
a barrier for amylase hydrolysis and swelling during cooking.  As a result, the center of 
the starch granules is not fully gelatinized and is less susceptible to amylase hydrolysis 
(O'Dea et al., 1980; Granfeldt et al., 1991). Resistant starch type 2 (RS2) is uncooked 
native semi-crystalline granular starch which displays the B- and some C-type 
polymorphs. Green banana starch, high-amylose cornstarch, and uncooked potato starch 
are all included in this category. RS2 turns from a semi-crystalline structure to a highly 
digestible amorphous structure during heat processing and consequently loses its 
resistance to enzymes during cooking.  RS type 3 (RS3) is retrograded starch from the 
cooked starch. Gelatinized starch molecules retrograde from amorphous to a double 
helices structure during storage. This crystalline structure of RS3 is enzyme resistant. RS3 
has a melting temperature above 120◦C, so most RS3 remains crystalline after heat 
processing. Starches containing a large portion of amylose or long branch-chains of 
amylopectin are easily produced into RS3. On the contrary, starches with short branch 
chains of amylopectin are usually not able to form RS3 because the double helices and 
short branch chains formed are not long enough to produce stable crystals (Sievert and 
Pomeranz, 1990). Resistant starch type 4 (RS4) is chemically modified or cross-linked 
14
  
starch, with decreased water solubility and accessibility of enzymes to hydrolyze the 
starch molecules. The hydrophobic moieties of the starch granules also have fewer 
enzyme binding sites for hydrolysis.  Thus, they are less accessible for enzyme 
hydrolysis.  A newly developed type 5 RS (RS5) consisting of amylose-lipid complex has 
been introduced recently (Hasjim et al., 2010). One hypothesis is that the linear molecules 
of amylose entangle with lipids and form a single helix complex, and the hydrocarbon 
chains of the lipid stay in the center of the helix through hydrophobic interaction with the 
amylose molecules. The amylose-lipid complex exists as amorphous or crystalline 
complex. The amorphous complex has lower dissociation temperature than the crystalline 
complex. Incubating the amorphous complex at temperatures above their dissociation 
temperatures and below the dissociation temperature of the crystalline complex will 
convert amorphous complex into crystalline complex (Biliaderis and Seneviratne, 1990). 
The crystalline complex is more resistant to amylase hydrolysis than the amorphous 
complex (Seneviratne and Biliaderis, 1991).  
The non-digestible feature of resistant starch results in a low glycemic index since 
RS dilutes the digestible carbohydrate in food (Douglass, 1975). Consequently, RS 
improved the insulin sensitivity in humans and possibly prevent or reduce disease 
processes related to metabolic syndrome such as non-insulin-dependent diabetes, 
hypertension, and lipid abnormalities (DeFronzo and Ferrannini, 1991). Resistant starch 
also decreased the incidence of obesity by reducing the total energy intake. Since foods 
rich in RS stay in the digestive system longer, they may prevent the hypoglycemia-
induced hunger and promote satiety, thus reduce food intake. On the other hand, since RS 
is not a good source of energy intake, the body has to use fat in adipose tissue to provide 
energy (Raben et al., 1994; Ranhotra et al., 1996). Resistant starch was also reported to 
decrease serum triglyceride and cholesterol concentrations, and reduce the risk of 
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cardiovascular disease (Ranhotra et al., 1996). Hasjim reported that RS5 reduced 
postprandial plasma glucose and insulin levels in humans. Twenty male human-subjects 
were fed bread made from 60% (dry basis) RS5 or white bread. Subjects fed RS5 had 
their postprandial plasma glucose and insulin levels reduced to 55% and 43%, 
respectively, compared with those fed control white bread (100%). The results suggested 
that the RS5 can be used for the intervention of diseases such as diabetes and obesity 
(Hasjim et al., 2010). Other studies showed evidence that resistant starches could lower 
serum plasma cholesterol after they were processed by heat and moisture treatment. One 
study gave 4 diets to six-month-old ovariectomized female Wistar rats 7 days after 
ovariectomization for 21 days: heat-moisture treated high-amylose corn starch; 
gelatinized high-amylose corn starch; and gelatinized normal corn starch. The dietary 
fiber contents were 64.5, 19.3, 2.4, and 0.1% measured by AOAC 991.43. The study 
showed that total plasma cholesterol concentrations decreased with increasing dietary 
fiber content, and hypocholesterolemic effect of HACS in ovariectomized rats appeared 
to be more effective with starch treated with heat-moisture (Liu et al., 2007).   
Resistant starch has been observed to prevent colon preneoplastic lesions or CRC in 
recent years. In a short term animal study, male Wistar weanling rats were given 2 AOM 
injections, and RS was fed to rats 3 weeks after the first AOM injection by low-RS 
composition (7.6 g/kg body weight), middle-RS composition (15.2 g/kg body weight) or 
high-RS composition (22.8 g/kg body weight). Normal cornstarch was used as control.  
Rats were killed 13 weeks after initial injection of AOM. Incidence of ACF, number of 
Aberrant Crypts (AC), and the crypt multiplicity showed significant decreases in RS 
treated animals compared with controls, and there was a reverse accordance of ACF 
incidence, AC, and crypt multiplicity with the percentage of RS in the diet (Liu et al., 
2008). A long term animal study also proved that feeding dietary RS (high amylose 
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cornstarch, HA) protected against AOM-induced colon carcinogenesis. Male Sprague-
Dawley rats were provided 10% HA, 20% HA or control cornstarch diets. After eating 
their experimental diets for 4 weeks, the rats were injected AOM twice and then 
maintained on their dietary regimen until 25 weeks after second AOM injection. Both 
doses of HA significantly decreased the incidence and multiplicity of adenocarcinomas in 
the colon compared with the control group (Le Leu et al., 2007).  In a human study, 
patients with recently removed colonic adenoma(s) were fed native amylomaize starch 
(RS) or maltodextrin (control) for 4 weeks. Bile acid concentration and secondary bile aid 
decreased sharply in humans fed RS relative to control. Secondary bile acids are 
promoters of colon carcinogenesis in laboratory animals (Valhouny et al., 1984). 
Epidemiologic studies also showed a positive correlation between fecal bile acid 
concentration and CRC risk (Hill, 1991). The results from this experiment thus might 
correlate RS with a reduced risk of CRC (Grubben et al., 2001).  
Although no study, to our knowledge, has showed the impact of starch properties and 
structures on different cooking methods, previous studies have shown that the heat-
moisture treatment (HMT) of starches can impact the molecular structures and the 
properties of starches, which suggests an impact of starch properties and their effects on 
colon carcinogenesis. Heat-moisture treatment is defined as a physical modification that 
involves treatment of starch granules. Three conditions are required for the treatment: 1) 
moisture < 35% moisture w/w, 2) temperature at 84 – 120 ◦C, 3) treatment time at 15 min 
– 16 h. Some studies showed a decreased granular swelling and amylose leaching by 
HMT in legume (Hoover and Vasanthan, 1994) and tuber (Tattiyakul et al., 2006) 
starches. Hoover et al. (Hoover and Manuel, 1996) also reported that HMT decreased the 
swelling factor (amylomaize V > waxy maize > dull waxy maize > normal maize), 
amylose leaching (amylomaize V > normal maize), pasting viscosities (amylomaize V > 
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normal maize), acid hydrolysis (amylomaize V > normal maize > waxy maize > dull 
waxy maize), and enzyme hydrolysis (amylomaize V > normal maize > dull waxy maize 
> waxy maize). Shin et al. (Shin et al., 2005) tested structural characteristics of potato and 
sweet potato RS and suggested that partial acid hydrolysis, autoclaving-cooling, and 
HMT are good methods for increasing the RS content of these starches. These studies 
also suggested that the reduction in granular swelling and amylose leaching on HMT 
were due to an association of less branched starch chains during HMT. The association of 
the starch chains occurred within the amorphous and crystalline regions of the granules, 
involving the interaction between amylose-amylose and/or amylopectin-amylopectin 
chains. Heat-moisture treatment was also reported to decrease the enzyme hydrolysis of 
some resistant starches under certain treatment conditions. Kweon et al. (Kweon et al., 
2000) reported a decrease in the digestibility of normal and Hylon V (57% amylose) 
maize starches after an HMT treatment (110 ◦C/16 h in the moisture range 15 - 21%).  At 
18% moisture, digestibility decreased by about 20, 32, 7, and 14%, respectively in 
normal, waxy, Hylon V, and Hylon VII (71% amylose) starches. Notably, starch 
digestibility increased when HMT condition changed. Starch digestibility increased on 
HMT (110 ◦C/16 h) at moisture contents in the range 24 - 27% in normal and Hylon V 
starches, and at 27% moisture in waxy and Hylon VII starches. 
Studies also showed that HMT can increase resistant starch content. One study 
compared the effect of RS formation in normal and high amylose (ae VII) maize starches 
on HMT (30% moisture at 100- 140 ◦C, 80 min.) and ae-VII maize starch increases the 
amount of boiling-stable RS of 13, 25, and 34% at 100, 120, and 140 ◦C respectively by 
the AOAC method (Brumovsky et al., 2001). Another study reported that Hylon V maize 
starch (∼50% amylose) increased resistant starch by 19% and decreased slow digestible 
starch and rapidly digestible starch levels by 12% and 6%, respectively, compared to raw 
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Hylon V maize starch on HMT (45% moisture, 110 ◦C, 4 h) and phosphorylation (sodium 
trimetaphosphate/ sodium tripolyphosphate) (Sang and Seib, 2006). 
In our studies described in this dissertation, starches used for comparison came from 
two different sources. In the first two studies, a high-amylose starch and stearic acid 
complex (SAC) was processed as a RS5. HA and a normal corn starch were used as 
positive and negative controls to compare the resistant and preneoplastic lesion inhibitive 
features with SAC. In the third study, traditional breeding of corn lines was conducted. 
AR 16035 (AR) and Guat 209 (Guat) were inbreds from the Latin American exotic 
cornlines. AR 16035 (AR) and Guat 209 (Guat) were then crossed to get the new corn 
line ARXGuat, with the hope that ARXGuat would inherit the high-yielding property of 
AR and high RS property of Guat. Starches in both experiments were cooked, which was 
a gelatinization process. Resistant starch contents were increased in the RS diets since 
they were not fully gelatinized mainly due to the higher gelatinization temperatures than 
the temperatures provided by the cooking methods. The starches were fed to rats as fresh 
as possible, and they were not stored in refridgerator to avoid retrogradation and its 
impact on the resistant starch contents of the RS. 
 
Animal Model 
Animal models are essential tools to study the mechanisms underlying the initiation 
and progression of CRC. Naturally mutant or genetically modified animals, such as 
APC
min/+
 mice, are used to mimic and study hereditary CRC, whereas chemically induced 
rodent CRC models are broadly developed to mimic non-hereditary tumorigenesis.  
Azoxymethane (AOM), an organotrophic colon carcinogen, does not interact with 
DNA directly but is activated by cytochrome P450 and then follows a hydroxylation step. 
Further metabolism by colonic microflora produces methyldiazonium (Sohn et al., 2001; 
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Fiala et al., 1977).  It initiates cancer by inducing mutagenic lesions in target cells by the 
alkylation of DNA at the O6 position of guanine. Azoxymethane is a downstream 
metabolite of dimethylhydrazine (DMH), and showed a higher potency and enhanced 
stability than DMH, thus AOM is now more frequently used than DMH, but both are used 
for many studies (Moriya et al., 1982; Rosenberg and Liu, 1995). 
Azoxymethane is predominantly used as an agent for tumor initiation, but some 
reports its usage for tumor promotion (Bissahoyo et al., 2005). Azoxymethane treatment 
is mostly performed in rats, but studies have been performed with AOM in mice. 
Azoxymethane rodent models for CRC are widely used to study sporadic (nonfamilial) 
forms of colorectal cancer, similar to those in sporadic forms of the human CRC (Moser 
et al., 1990; Papanikolaou et al., 1998). Azoxymethane-induced tumors also resemble 
human CRC at the molecular level. Azoxymethane-induced tumors display aberrant 
expression of APC (Maltzman et al., 1997), which causes elevated β-catenin signaling 
and transcription of candidate target genes such as cyclin D1 and c-myc (Takahashi et al., 
2000). Azoxymethane rodent models also showed a mutation of Ras, but p53 allelic loss 
was rarely seen (Okamoto et al., 1993).  On the other hand, the tumor initiation induced 
by DMH does not appear to involve APC or p53 mutations (Moen et al., 1996). 
Repetitive administration of AOM produces tumors in the distal colon of rodents, and 
AOM-induced carcinogenesis is organ-specific (Shamsuddin and Trump, 1981; Druckery, 
1972; Papanikolaou et al., 1998, Delker et al., 1999).   
Azoxymethane is one of the most successful carcinogens used in the induction of 
CRC in rodent models. Meta-analysis revealed that the use of AOM-induced rodent 
models of carcinogenesis predicted chemopreventive efficacy in humans better than other 
models (Corpet and Pierre, 2005). It also has the advantage of low cost, simple 
application, and high potency and reproducibility. Markedly, although AOM has many 
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advantages, the tumors induced by AOM rarely show the feature of mucosal invasiveness 
and metastasis, which are common in human CRC (Boivin et al., 2003; Nambiar et al., 
2003; Shamsuddin, 1984). 
Repeated intraperitoneal injections of AOM to rodents are highly efficient in the 
induction of colon tumors in rodents.  The susceptibility of different rodent strains to 
AOM, intestinal microflora, and the AOM preparation method also impact the induction 
of CRC by AOM. In rat studies, a standard protocol for F344 rats is treating animal with 
no more than two injections of 15 mg AOM per kg body weight (Kawamori et al., 1999). 
Dextran sodium sulfate (DSS), a pro-inflammatory reagent, induces rodent models 
for colitis-associated tumor development, especially that by chronic colitis in ulcerative 
colitis or Crohn’s disease (Okayasu et al., 1990). DSS is usually applied together with 
AOM. A two-stage colon tumor model may use a single injection of AOM and a single 
cycle of DSS for 20 weeks to mimic colitis-driven tumor development (Tanaka et al., 
2003; Suzuki et al., 2006).  One of the disadvantages of DSS is that the model, either with 
or without carcinogen, needs a long period or repeated administration of DSS to induce 
colitis and colitis-related CRC, and the occurrence and multiplicity of the tumors are 
relatively low (Okayasu et al., 2002). 
Another rodent model to develop tumors uses 2-Amino-1-methyl-6-phenylimidazo [4, 
5-b] pyridine (PhIP). Aberrant crypt foci (Takahashi et al., 1991), putative preneoplastic 
lesions of the colon (Bird, 1987), and CRCs (Ito et al., 1991; Hasegawa et al., 1993) have 
been reported to be induced by PhIP in F344 male rats. Mutations and suppressed 
expression of Apc gene was frequently observed in PhIP-induced colon tumors (Kakiuchi 
et al., 1999; Ubagai et al., 2002), resembling the process in human CRC case (Kinzler and 
Vogelstein, 1996; Polakis, 2000). 
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Some animals widely used in the testing of CRC occurrence by environment factors 
are Fisher 344, Sprague-Dawley or Wistar rats. Usually male rodents of 5-6 week old, 
180- 200 g in weight are ideal. Two injections of AOM at 15mg/kg body weight are 
popularly conducted. 
 
Preneoplasctic lesions 
Aberrand Crypt Foci (ACF) 
Aberrand Crypt Foci have been identified as putative precancerous lesions of the 
colon. Aberrand crypt foci were first described by Bird in methylene blue –stained 
colonic mucosa from rodents treated with AOM in 1987 (Bird, 1987).  ACF are featured 
as: (1) having altered luminal openings; (2) exhibiting thickened epithelia; and (3) being 
larger than adjacent normal crypts (Bird et al., 1989).  ACF can be divided into 3 
categories histologically: nondysplasia, dysplasia, and a mixed type of both hyperplasia 
and dysplasia. Nondysplasia can be further divided into 2 subtypes: ACF with normal 
mucosa and ACF with hyperplasia. Aberrand crypt foci with normal mucosa lack 
significant modifications of the epithelium lining the crypts; they have enlarged crypts (at 
least 1.5 times larger than normal) with only slightly enlarged and elongated nuclei, but 
no mucin depletion. Crypt cells with positive staining of PCNA and Ki-67 remain at the 
lower part of the crypts. Hyperplasia has larger or longer crypts than normal crypts, 
sometimes showing apical branching. The luminal opening is serrated and slightly 
elevated from the surrounding normal mucosa, with partial mucin depletion, but without 
dysplasia.  Nuclei are enlarged or sometimes crowded without stratification. Cells with 
positive staining of PCNA and Ki-67 remain at the lower and middle parts of the crypts. 
Dysplasia is also called microadenoma.  Crypts of dysplasia have enlarged, elongated and 
sometimes stratified and depolarized nuclei. The number of goblet cells is decreased 
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obviously and mucin is depleted. The major site of PCNA and Ki-67 positive staining is 
extended to the upper part of the crypts. Dysplastic ACF occurs commonly in FAP 
patients, but not in sporadic patients. Sporadic ACF patients have less frequent APC 
mutations then FAP patients, and more frequent methylation. The third type is a mixed 
type of hyperplasia and dysplasia.  
Aberrand crypt foci were first reported in both experimental animals and human as a 
potential biomarker of human colorectal cancer (Roncucci et al., 1991; Pretlow et al., 
1991; Tudek et al., 1989; McLellan, 1988). Aberrand crypt foci were considered to play 
an important role in the adenoma-carcinoma sequence in epidemiologic studies 
supporting ACF as a biomarker for colorectal carcinoma. Genetic abnormalities were also 
described in ACF (Gupta et al., 2007). Another review summarized publications of ACF 
incidence as well as ACF numbers or size, with subject characteristics, such as age or 
family history of CRC. The review concluded that ACF can be used as an intermediate 
endpoint due to the relationship of ACF to the known risk factors for CRC (Stevens et al., 
2007).   
Using ACF in a rodent model as a biomarker is possible in a short term of 
experimental period of 8 weeks. Aberrand crypt foci are specific to colon carcinogenesis, 
and are induced by colon specific carcinogens in a dose dependent manner, and size and 
crypt multiplicity increase with time as the disease develops (Bird, 1995).  Several factors 
play a critical role in the incidence of ACF and tumors, including: carcinogen dosage, 
rodent strain, administration method, and the intervention time at the carcinogenic state, 
etc.  For example, the frequency of carcinogen injection affects the number and growth 
features of ACF. Testing the ACF number and other features of rats injected with AOM 
once a week for 1, 2 or 4 weeks showed that the rats injected 4 times or twice had a 
similar number of ACF at week 6 after the last AOM injection. At week 18, rats with 4 
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AOM injections induced a significantly higher number of ACF with advanced growth 
features than those had 2 AOM injections. 
The ACF incidence in rodents is strongly associated with tumor occurrence. In one 
study, male Sprague-Dawley rats were fed diets with cholic acid (CHA), a colonic tumor 
promoter (Magnuson et al., 1993). In this study, crypt multiplicity, rather than the number 
of ACF at early time points was considered a good predictor of tumor incidence. The 
increased crypt multiplicity in rats fed CHA suggested that the growth of a small number 
of ACF caused an increased number of tumors compared to a control AIN76 diet. In 
another study, the incidence of ACF at an early time period was compared with the 
incidence of tumors later in F344 rats treated with AOM and CRC chemopreventive agent, 
sodium phytate. The results showed that the development of larger ACF (with four or 
more crypts) was predictive of the tumor incidence (Pretlow et al., 1992).   
Aberrand crypt foci appear within two weeks after carcinogen injection, and each 
ACF evolve from one altered crypt.  As time progresses, a single crypt expands by crypt 
branching or multiplicity and develops into more than one crypt (Bird, 1998). Aberrand 
crypt foci in colons are in a dynamic state. Some may remodel or regress or even get 
eliminated; others may progress forward to the next stage. Thus the number of ACF may 
vary with time (Cheng and Lai, 2003).  One study explained how ACF grow in different 
stages of carcinogenesis. Sprague-Dawley rats were injected with a single dosage of 1,2-
dimethylhydrazine-HCL at varying time points ranging from 2 to 57 weeks.  Two weeks 
after the second injection, a large number of primal ACF (1-3 crypts/foci) were observed 
in the rat colons. From post-carcinogen injection at week 6, an increasing number of 
intermediate (4-6 crypts/foci) or advanced (>6 crypts/foci) ACF and a decreased 
incidence of primal lesions were observed.  Beyond 24 weeks post-carcinogen injection, 
which can be included in the progression stage, the incidence of advanced ACF reached a 
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peak and occurrence of microadenomas, adenomas, and adenocarcinomas were observed 
(McLellan et al., 1991). 
The time of carcinogen administration is vital in determining the yield of the 
preneoplastic lesions. An agent can be a tumor inhibitor or promoter depending on the 
time point it is fed to the animals relative to the carcinogen administration. When a 
compound is added to the diet at the first AOM injection, the experiment is directed at the 
effect to prevent the incidence and growth of ACF at the initiation and post-initiation 
stage by the compound. If the compound is fed at a later time point, e.g. 4-8 weeks after 
first AOM injection, the emphasis is the impact on ACF at the post-initiation and 
promotion stages (Bird and Good, 2000).  Cholic acid (CHA), a primary bile acid, was 
generally expected as a colon carcinogenesis promoter, but one study showed how 
different feeding time points before or after carcinogen treatment affected the result of the 
colon carcinogenesis (Baijal et al., 1998). In this study, Male Sprague-Dawley rats were 
injected twice, 1 week apart, with AOM. Following the first AOM injection, animals 
were randomly assigned to two groups and fed control AIN-93G diet (CON) or control 
diet containing 0.2% CHA (CHA). Three weeks after the first injection, the animals were 
randomly assigned to CON or CHA diets within each present diet group, thus four 
treatments were formed: CON-CON, CON-CHA, CHA-CHA, and CHA-CON. After 3, 
12, and 20 weeks following the first carcinogen injection, the rats were killed and the 
number and crypt multiplicity of ACF were counted, and tumors were evaluated at week 
20. Numbers of medium (4-6 crypts/focus) and large (> or = 7 crypts/focus) ACF and 
average crypt multiplicity were significantly higher in CHA-CHA and CHA-CON 
compared with CON-CON and CON-CHA. CHA-CHA had the highest tumor incidence 
followed by CHA-CON, and tumor multiplicity and number of tumors per rat in CHA-
CON were similar to CHA-CHA. CON-CHA produced a tumor outcome similar to CON-
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CON, it did not enhance colonic tumor incidence comparing to the other two groups.  
These results suggested that transient exposure to CHA (CHA-CON) was sufficient to 
induce an increased ACF and tumor yield, yet a delayed intervention with CHA (CON-
CHA) did not enhance colonic tumor incidence. It could be concluded that CHA was 
effective in enhancing colon carcinogenesis during early phases and ineffective in post-
initiation phases. In our studies, rats were injected with AOM twice with one week 
between injections. Resistant starch diets were fed 3 days after the second AOM 
injection, which fell into the promotion stage of tumorigenesis.  
Distribution of ACF could be in the proximal, mid and distal section of the colon in 
AOM-injected Fisher 344 rats.  In a previous study, F344 rats were treated with 2 doses 
of azoxymethane (15 mg/kg body weight, s.c.) one week apart, and sacrificed 6, 12, 20, 
30 and 36 weeks after the first carcinogen injection. Control groups of untreated rats were 
sacrificed at the same time points. The number of ACF per area, their multiplicity 
(number of crypts per focus), ACF frequency and multiplicity according to each colonic 
site, histology of ACF and macroscopic lesions were recorded and compared between 
AOM-injected and control groups. In the AOM-injected group, higher ACF incidence 
happened in the mid colon than in the distal colon and rectum, and they were rare in the 
proximal colon and cecum. On the other hand, adenomas and well-differentiated 
adenocarcinomas were found in the distal colon. All proximal neoplasms were signet ring 
cell carcinomas, suggesting signet ring cell carcinomas had a different pathway of growth 
than ACF. It also indicated that ACF distribution was not correlated to adenoma and 
adenocarcinoma distribution (Ghirardi et al., 1999).   
All of our studies utilized AOM induced Fisher 344 rats as our animal model. 
Azoxymethane was administrated before the feeding of RS to the rats, so that the 
prevention of preneoplastic lesions in the promotion stage could be assessed. The rats 
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were fed RS or relative controls for 8 weeks, and then euthanized for the endpoint test. 
Preneoplastic lesions were collected and counted in the distal region of the rat colon.  
During the formation of ACF, or when cells turn from ACF to adenomas, a lot of 
genes are changed in their expressions. Some of the key genes are listed below.  
β-catenin, a transcriptional activator, has an important role in epithelial tumorigenesis. 
β-catenin belongs to the β-catenin-Tcf oncogenic pathway. Overexpression of β-catenin 
protein was reported in both humans and rats (Takahashi et al., 1998; Morin et al., 1997). 
In ACF with hyperplasia, β-catenin was found at the cell membrane, same as in normal 
colon epithelium. In ACF with dysplasia, as well as in adenoma and carcinoma, β-catenin 
was localized less in the membrane and more in the nuclei and cytoplasm (Hao et al., 
2001). 
There was no difference between hyperplastic ACF and normal mucosa when 
comparing microsatellite instabilities and mutations of APC, H-ras, k-ras, p53, DCC, and 
DNA repair genes hMLH1, hMSH2 (Sedivy et al., 2000).  But hyperplastic ACF had 
frequent K-ras mutations (Otori et al., 1995), chromosome 1p loss (Chan et al., 2002), and 
CpG island Methylation (Chan et al., 2002). Of these gene alterations, K-ras mutation 
was one of the major events in ACF formation (Stopera et al., 1992). The mutation rate of 
K-ras in ACF was similar to that of small adenomas, and was higher in occurrence than in 
CRC (Stopera et al., 2000).  
COX and c-myc, two oncogenes, were also found to have an increased mRNA or 
protein expression in carcinogen induced rats (Furukawa et al., 2002).  The expression of 
the oncogenes cfos, ras, bcl-2 and p53 were abnormal in ACF (Otori et al., 1999). The 
APC gene is considered a “gatekeeper gene”, maintaining the stability of the colon 
epithelium.  A decreased mRNA expression of APC was observed in ACF both in human 
and in carcinogen treated rats (Furukawa et al., 2002), but the mutation rates of APC in 
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ACF was lower or undetectable compared to those in adenomas and carcinomas, 
suggesting that an APC mutation was not present during the initiation stage of ACF 
(Yuan et al., 2001). If a ras gene mutation occurred first, ACF would be nondysplasia; if 
an APC mutation occurred first, ACF would be dysplasia, and a K-ras mutation and other 
gene mutations would follow (Takayama et al., 2001). Accordingly, in sporadic colorectal 
carcinogenesis, K-ras mutations mainly occurred during the formation of ACF. APC 
mutation occurred when ACF turned into adenomas. In FAP, somatic mutations of APC 
occurred first during ACF formation, followed by K-ras mutations ((Jen et al., 1994). 
The mismatch repair (MMR) system is a DNA repair process. Inactivation of MMR 
can result in instability of the whole genome and an increased rate of spontaneous 
mutations of other vital genes to carcinogenesis. MMR was also found to be involved in 
cell-cycle regulation, and p53-dependent apoptotic response to a variety of DNA damages 
(Zhang et al., 1999). Germline mutations of MMR, especially hMSH2 and hMLH1, 
increase the incidence of HNPCC (Peltomaki et al., 2001).   
CpG island methylation, an epigenetic alteration, and microsatellite instability (MSI), 
a genetic phenotype alteration, also play important roles in the development of ACF. 
Silencing of genes mediated by CpG island methylation may inactive the gene, and 
further cause the incidence of ACF or CRC. For example, hMLH1 gene promoter was 
aberrantly methylated in sporadic CRC (Veigl et al., 1998). MSI could occur either in 
dysplastic or hyperplastic ACF from HNPCC patients. MSI was also seen in some 
sporadic ACF.  In HNPCC patients, carcinomas with high levels of MSI were a hallmark 
(Augenlicht et al., 1996). 
Mucin Depleted Foci (MDF) 
MDF, another preneoplastic biomarker in rat colon carcinogenesis, feature absent or 
scarce mucous production. It is a focal lesion formed by crypts with a lumen, which is 
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often distorted when compared with normal surrounding crypts (Caderni et al., 2003). 
Elevation of the lesion above the surface of the colon, and multiplicity of the foci are also 
frequent features of MDF. MDF can be identified using Alcian blue, which stains acid 
mucin in blue. If stained by alcian blue-neutral red, the epithelial layer of the mucosa is 
shown as a reddish background stained by neutral red, and the acid mucin was stained by 
alcian blue as blue spots.  MDF are viewed as a reddish background surrounded by 
normal shaped and sized blue spots. MDF can also be stained by high-iron diamine 
Alcian blue. MDF occur at a lower incidence than ACF in rats when the same dosage of 
carcinogen was administered, but MDF are more dysplastic than common ACF. In a 
study comparing the relationship among ACF, MDF and BCAC in male F344 rats given 
DMH, MDF were suggested to have more potential in predicting CRC than ACF, and 
MDF with more than 4 crypts were shown to overexpress β-catenin (Yoshimi et al., 
2004).  
MDF were suggested as a subgroup of ACF and may predict tumor outcome better 
than ACF. Male F344 rats were first fed synbiotics, an intestinal cancer reducer, or 
control diet for 10 days. Rats were then injected AOM twice, 1 week apart. Aberrand 
crypt foci or MDF were collected 15 weeks after the first AOM injection and tumors were 
detected 31 weeks after first AOM injection. MDF appeared 7 weeks after AOM 
treatment. The number and multiplicity of MDF at 15 weeks after first AOM injection 
were correlated with carcinogenesis. On the contrary, ACF number was not correlated 
with tumor outcome (Caderni et al., 2003).  
Beta-catenin-accumulated crypts (BCAC) 
BCAC are pre-malignant lesions of CRC, featured as dysplastic crypts with 
overexpress of β-catenin. BCAC are frequently accompanied by Paneth cells. The number 
of the crypts/lesion and histological abnormality of BCAC were found to significantly 
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increase with time, with higher cell proliferative activity than in ACF. The most common 
β-catenin gene mutation in BCAC is the same as that detected in colon tumors, suggesting 
that BCAC are the pre-malignant lesion and that these mutations play gatekeeper roles in 
the development of colon tumors. BCAC, as well as colon tumors, have β-catenin gene 
mutations more frequently than typical ACF in both cytoplasm and nuclei, indicating the 
potential of BCAC to progress into malignant lesions. β-catenin mutations were detected 
in both well differentiated and poorly differentiated adenocarcinomas. The above results 
indicated that activation of β-catenin signaling pathway is not only important in the 
initiating stage, but also in the promotion stage of colorectal carcinogenesis (Yamada et 
al., 2003). Among the early lesions, ACF showed more frequent K-ras mutations than 
BCAC, indicating that K-ras mutations are closely associated with the formation of 
typical ACF.  
Chemopreventive agents or tumor promoters have been applied to alter the 
development of BCAC.  Peucedanum japonicum, an herb in the Ryukyu Islands, was 
reported to inhibit BCAC in AOM-injected male F344 rats (Morioka et al., 2004). 
Azoxymethane-treated F344 rats were fed CHA (0.5%) diet during the post-initiation 
phase significantly reduced the total number, multiplicity and size of ACF, as well as the 
number of large ACF (>4 aberrant crypts/focus). CHA significantly enhanced the 
multiplicity, size and the number of large BCAC (> 6 crypts/lesion), but not the incidence 
of BCAC when compared with the control diet group (Hirose et al., 2003).  
In summary, ACF and its subset MDF are among the most widely used precancerous 
biomarkers that predict the incidence of sporadic CRC. BCAC, putative preneoplastic 
lesions independent from ACF, have recently been suggested as intermediate biomarkers 
for colon carcinogenesis. All these preneoplastic lesions can be induced by AOM 
treatment. ACF and MDF can be easily observed using an optical microscope after dye 
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staining, while BCAC have to be detected by immunohistochemistry. Some studies also 
showed that ACF were more sensitive than BCAC in assessing the impact of continuous 
feeding of certain diets (Hirose et al., 2003).  ACF/MDF detection thus might be a 
simpler, more sensitive way to predict colon carcinogenesis, but a combination of the two 
methods could be considered a more reliable prediction and thus both of these lesions 
were assessed in our studies. 
 
Short Chain Fatty Acids (SCFA) 
Among SCFAs, acetate is the most abundant in fecal and cecal samples, followed by 
propionate and butyrate. Other organic acids, such as lactate and succinate, are also found 
in SCFA, but in much smaller amounts (Hoverstad and Bjorneklett, 1984; Takahashi et 
al., 1993).  
Consequences of fermentation in the large bowel include the increase of cecal or 
fecal weight, reduced transit time, and increased cecal pH, which have possible 
implications for protection against large bowel cancer. First, an increased fecal weight 
was observed mainly due to the increase in bacterial cell mass (Stephen and Cummings, 
1980). Resistant starch and other fermentable fibers are only partially fermented, so their 
residual polysaccharides absorb water and add to the fecal weight (McBurney et al., 
1985). Consequently, a reduced transit time is observed, and the contents of the large 
bowel lumen are diluted, which would reduce the time putative carcinogens are in contact 
with the large bowel mucosa (Burkitt, 1969). Short Chain fatty acids are relatively weak 
acids and raising SCFA concentrations through fermentation decreases digesta pH. When 
high-amylose starch, wheat bran, or oat bran was fed, pH values decreased significantly 
since these are fermentative substrates (Noakes et al., 1996; Lampe et al., 1993; Kashtan 
et al., 1992). Short Chain fatty acids concentration may be the most important impact 
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factor for the decrease of pH. One report revealed that there was a negative relationship 
between fecal SCFA and pH (Segal et al., 1995). The lowered pH values may prevent the 
pathogenic bacteria from rapid growth. In a swine study, the increased content of SCFA 
was reported to be related to the lowered numbers of potential pathogens such as 
Salmonella (Prohaszka et al., 1990).  
Studies were reported that the consumption of RS can increase SCFA in rat cecum 
and colon. Rats fed 350 g raw potato starch/kg have a higher concentration of SCFA in 
the cecum, compared with rats fed digestible wheat starch (Younes et al., 1996). Feeding 
rats with raw pea also resulted in an increased butyrate proportion while the proportion of 
acetate, isobutyrate, isovalerate and valerate decreased compared with rats fed maize 
starch (Goodlad and Mathers, 1990).  
Resistant starch or dietary fibers were reported to protect against colorectal cancers. 
A significantly increased concentration of acetate and propionate in intestinal contents 
was observed in rats treated AOM and fed high amylose maize starch. A decrease in the 
number of ACF was also observed in the same group of rats. When clostridium 
butyricum, an anaerobic prokaryote that utilizes HA and produces butyrate and acetate, 
was fed to rats together with HA, a more significant increase of acetate and propionate 
concentration, as well as a decrease in ACF was found (Nakanishi et al., 2003). Rats with 
tumors induced by dimethylhydrazine were fed different fibers and assessed the number 
and size of tumors. Significantly fewer tumors were observed in the rats fed wheat bran 
compared with those fed guar or oat bran. The concentration of fecal butyrate strongly 
and negatively correlated with tumors (Weaver et al., 1988).  
Short Chain fatty acids were found to have paradoxical effects on the proliferation of 
colon epithelial cells. Short Chain fatty acids stimulate proliferation in normal colonic 
epithelium, while butyrate and propionate reduce proliferation of cancer cells.  An in vitro 
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study used biopsy specimens obtained from normal individuals at routine colonoscopy. 
Tissues were incubated with sodium salts of SCFAs and cell proliferation was found to 
rise significantly in all incubations (Scheppach et al., 1992). The effect of SCFA on cell 
proliferation was also reported to be dose-respond. Luminal and serosal n-butyric acid (0, 
0.1, 1, or 10 mmol/L, adjusted to neutral pH) were assessed on the epithelial cell 
proliferation of pig colonic mucosa in organ culture.  Crypt cell production rate was used 
as the measurement of proliferative activity. With 0 or 0.1 mmol/L serosal n-butyric acid, 
luminal n-butyric acid increased crypt cell production rate at 1 mmol/L, and decreased 
crypt cell production rate at 10 mmol/L when compared to the controls with 0 mmol/L 
luminal n-butyric acid. With 1 or 10 mmol/L serosal n-butyric acid, luminal n-butyric 
acid depressed organ culture taking crypt cell production rate dose-dependently. This 
experiment indicated that n-butyric acid stimulated colonic epithelial cell proliferation at 
low concentration and inhibited it at high concentration (Inagaki and Sakata, 2005). 
Of all the SCFAs, butyrate is considered to mostly relate to CRC inhibition. Butyrate 
is well recognized as an anti-proliferative agent, differentiation-inducing agent, and 
apoptosis-inducing agent. Butyrate works as an anti-proliferative agent through inhibiting 
DNA synthesis and cell growth via inhibition of histone deacetylase, while other SCFA 
are much less active in this respect (Kruh, 1982). The effect is reversible when butyrate is 
removed from culture media. Butyrate enhanced repair and survival of human 
adenocarcinoma cell lines which were suffered from ultra violet radiation damage. The 
mechanism was revealed as the histone acetylation which allows the enzymatic 
accessibility of chromatin in permeabilised cells (Smith, 1986).  As a differentiation-
inducing agent, SCFA reduced cloning efficiency and induces the activity of membrane 
glycoproteins such as alkaline phosphatase, a commonly used marker of differentiation, 
and altered the subcellular distribution pattern of the disaccharidases in some human 
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colorectal cancer cell lines (Chung et al. 1985). Other SCFAs did not show such an effect 
compared with butyrate (Whitehead et al. 1986). Butyrate did not show this effect in all 
cell lines, though. In one line derived from familial adenomatous polyposis, butyrate was 
reported to increase malignancy (Berry and Paraskeva, 1988). Apoptosis is considered a 
final stage of colonic epithelial cell differentiation pathways. Studies have accumulated in 
epithelial cell culture models proving the active effect of butyrate in cell apoptosis. For 
example, butyrate was detected and associated with apoptosis in cell lines derived from 
colonic adenomas and carcinomas (Hague et al., 1993).  Butyrate also induced typical 
apoptotic morphology of condensed chromatin and an associated DNA fragmentation 
pattern when it was added in culture medium of unattached cells (Wylie et al., 1980).  
Propionate and acetate were also found to induce apoptosis in colon tumor cell lines, such 
as AA/C1 and RG/C2, but both propionate and acetate induced apoptosis in a less level 
compared with butyrate (Hague et al., 1995) 
 
Gut microflora, SCFA and CRC 
There is a large population of bacteria in rodent and human cecum and colon. Many 
species of bacteria live in the mammalian large intestine, with up to 10
11
 - 10
12
 cells/g of 
luminal contents (Simon and Gorbach, 1984). About 60% of fecal solids are also bacteria, 
with anaerobic bacterial far outnumbering aerobic bacteria (Salminen. et al., 1998). In 
human feces, more than 50 genera and 400 species of bacteria have been identified, most 
of which are anaerobes, such as bacteroides, bifidobacteria, eubacteria, streptococci, and 
lactobacilli (Gibson and Roberfroid, 1995; hill, 1995). A number of bacteria can secrete 
hydrolases which the human host cannot secrete to hydrolyze carbohydrate. Of all the 
bacteria living in the colonic lumen, some can infer important health benefits to the host, 
and others can be pathogens in certain circumstances. For example, some genera of 
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microflora are related to the incidence of CRC in different directions. Bacteria of the 
bacteroides and clostridium genera were reported to increase the incidence of CRC in 
animals, whereas other genera such as lactobacillus and bifidobacteria prevent colonic 
tumorigenesis (Horie et al., 1999; Singh et al., 1997; Pool-Zobel et al., 1996).  One major 
metabolic function of gut microflora is to ferment non-digestible dietary residues by 
various enzymes and biochemical pathways provided by these gut microflora, and 
produce energy and nutrients for both themselves and the host. Non-digestible 
carbohydrates, such as resistant starch, are used as fermentable substrate to generate 
SCFA as metabolic endpoint, and the fermentation differs in the different part of large 
intestine. In the cecum and right colon, fermentation is very intense, resulting in high 
SCFA amount, acidic pH, and rapid growth of bacterial. In the left colon, SCFA are at a 
lower concentration, the pH is close to neutral and bacterial populations are close to 
static. On the other hand, a higher incidence of polyps was observed in the distal colon, 
which might relate to the lower SCFA concentration in this region (Govers et al., 1999). 
In particular, butyrate is the major energy source for the colonic mucosa and has been 
implicated in the protection of CRC. As evidence, butyrate inhibits cell proliferation and 
stimulates cell differentiation in human neoplastic epithelial cell lines (Siavoshian et al., 
2000), and reversely express phenotypic markers of differentiation in neoplastic cells or 
normal epithelial cells (Gibson et al., 1992).  In addition, apoptoses may be increased in 
neoplastic cells and inhibited in normal epithelial cells by adding butyrate (Diez-
Gonzalez et al., 1999).  Butyrate was also observed to modify gene expression by being 
involved in chromatin hyperacetylation and DNA methylation in the colon (Csordas, 
1996; Pool-Zobel et al., 1996), but how gene expression alterations by butyrate are related 
to CRC is not known yet. Studies have been accumulated to explore the link between 
SCFA, protection impact against CRC and RS. It has been presumed that RS may affect 
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the colonic fermentation and further inhibit CRC by modifying the gut microbial 
population. A study on human flora-associated rats showed increased colon butyrate and 
increased numbers of gut microflora that produce SCFA, such as lactobacilli and 
bifidobacteria in rats fed a retrograded high amylose starch compared to sucrose-fed rats 
(Silvi et al., 1999). 
In our studies assessing the inhibitive effect of cooked SAC on carcinogenesis, cecal 
and fecal SCFA amount and concentrations were tested from fresh cecum content and 
feces of rats after 8-week feeding of SAC or the controls.  The cecal weight change and 
pH alteration were also assessed as a reflection of RS fermentation in the large bowel. 
These results could be linked with the incidence of ACF/MDF in the rat colon as an 
indirect proof of gut microflora to utilize RS and impact carcinogenesis.  
In our studies, we assumed that a reduced preneoplasia, either ACF or MDF, 
occurred when the cooked resistant starch diets were fed to the rats. The cooked resstant 
starch diets were fermentated by gut microbes and produced SCFA. The inhibitive effect 
of the cooked resistant starch diets might come from the impact of both the metabolism of 
SCFA and the changed gut microbial population.   
 
Genetics of colorectal cancer 
CRC is a genetic disease. The initial genetic alteration of a cell starts aberrant 
proliferation, followed by the accumulation of more mutations. Thus some subclones 
developing enhanced growth properties transform to malignant and invasive cancers. This 
process is mainly a result of mutational activation of oncogenes and mutational 
inactivation of tumor suppressor genes. Alteration of stability genes, such as 
Microsatellite instability (MSI) and mismatch repair (MMR) are also important events 
responsible for tumorigenesis. 
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Genetic alterations in oncogenes 
One important oncogene alteration is ras mutation.  Ras gene mutation was usually a 
point mutation and was found in approximately 50% of colorectal carcinomas and 
adenomas which are greater than 1 cm in size, but they were found in less than 10% of 
the adenomas with size smaller than 1 cm (Vogelstein et al., 1988), indicating that ras 
gene mutations may be responsible in the later adenoma progression, rather than the 
initiating event in most tumors (Pretlow et al., 1993). Mutated ras protein is active in 
pathways such as RAF/MAPK, JUN and PI3K (Downward et al., 2003). 
Oncogene alteration was also seen as gene amplification and rearrangement, 
including the amplification of meu, c-myc, and c-myb, as well as the rearrangement of trk 
gene. c-myc is highly expressed in most colorectal carcinomas, and it was frequently 
revealed in the distal colon (Steward et al., 1986).  
Tumor suppressor genes 
The mutation of tumor suppressor genes mainly occurs as an event of loss of specific 
chromosomal regions. The mutation of p53 gene occurs with the allelic loss of 
chromosome 17p in colorectal tumors. P53 protein regulates DNA repair during 
replication and induces apoptosis. Wild-type p53 gene, identified as a tumor suppressor, 
inhibits colorectal tumor growth. p53 mutations occur mostly from the transition from 
adenoma to cancer, and have been identified in 40-50% sporadic colorectal cancers 
(Baker et al., 1989).  
Another common allelic loss in colorectal tumor occurs in chromosome 18q, leading 
to the gene mutation of DCC and SMAD4/2.  DCC gene functions in cell adhesion. 
Reduction of its expression in colorectal epithelial cells may alter adhesion of normal 
cell-cell and cell-extracellular matrix interaction (Hoffman and Edelman, 1983). 
Inactivation of SMAD4 is associated with cancer progression through TGF-β/SMAD 
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signaling pathway. SMAD4 gene expression was found in 16-25% colorectal cancer 
cases, and SMAD2 gene mutation was found in 6% of the cases (Thiagalingam et al., 
1996; Eppert et al., 1996). 
APC gene mutation is critical in the early development of colorectal cancer. Loss of 
function mutations in APC or activating mutations of β-catenin result in the stabilization 
and accumulation of β-catenin in the nucleas, activating the transcription factor T-cell 
factor (Tcf-4), and further activating the β-catenin/Tcf-4 pathway which switch the cells 
from differentiation to proliferation in the intestinal crypt epithelial cells (Van de 
Wetering et al., 2002). 
MSI and MMR 
MSI are characterized by expansions or contractions in the number of tandem repeats 
of simple DNA sequences. MSI are euploid tumors without allelic losses (Ionov et al., 
1993). MMR genes are responsible for correcting the ubiquitous nucleotide base mispairs 
and small insertions or deletions that occur during DNA replication (Papadopoulos et al., 
1995). Frequent mutations of MSI includes the TGB β -RII, BAX, TCF4, Caspase 5, 
HIF1 α, BRAF and PI3KCA (Popat et al., 2005). In human CRC, MMR enzymes, 
including hMSH2, hMLH1, hPMS1, hPMS2, and hMSH6, have since been shown to be 
responsible for MSI (Bronner et al., 1994; Nicolaides et al., 1994). MMR related genes 
include hMSH2 (human mutS homolog 2), hMLH1 (human mutL homolog 1), hPMS1 
and hPMS2 (human postmeiotic segregation 1 and 2), hMSH6 (human mutS homolog 6), 
and hMLH3, a mismatch repair gene that interacts with MLH1 (Papadopoulos et al., 
1995). 
A well-known colon model for tumorigenesis was proposed as an adenoma-
carcinoma sequence. In this model, transition from normal epithelium to adenoma and 
carcinoma is associated with acquired molecular events, including the mutation and 
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alteration of the genetic events described above. The accumulation of germline or somatic 
mutations, rather than their sequence with respect to one another, determines the 
biological behavior of the tumor. At least four to five gene mutations occur in the 
malignant tumor, while fewer are required for benign tumors. In some tumor suppressor 
genes, the mutation of one allele may be sufficient for an altered cellular phonotype, so 
these tumor suppressor genes might not be recessive at the cellular level (Fearon and 
Vogelstein, 1990). 
 
Overall Summary 
In our studies, the RS were obtained by different methods that were assumed to 
improve their resistance in the gastrointestinal tract. Our goal was to determine the health 
benefits of these RS to humans after they were cooked. Specifically, we would like to 
know the ability of these cooked RS on the reduction or prevention of colon cancer. To 
reach this goal, we first evaluated the inhibitory effects of the RS with known resistance 
on colorectal preneoplastic lesions in an AOM-induced F344 rat model for a short term of 
8 weeks. We also measured the SCFA amount and concentrations, as well as cecal 
fermentation, as indirect evidence of altered gut microbial metabolism by the 
fermentation of the RS. Global gene screening was applied to colon samples from AOM-
treated rats fed RS diet or CS diet, or the CS diet-fed rats treated with AOM or saline, 
respectively, by microarray assessment to discover differially expressed genes after RS 
diet treatment or AOM treatment, respectively. Several potential target genes that were 
differentially expressed during the treatment of SAC on AOM-induced rats were assessed 
by RT-qPCR as preliminary studies to explore the molecular genetic mechanism of the 
carcinogenesis inhibition by cooked RS. These differentially expressed genes were 
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selected for RT-qPCR because they were previously shown to correlate with colon cancer 
occurrence, thus having potential to explain how the modulation of the genes by cooked 
RS may have impacted the incidence of CRC. Further, some of theses genes were of 
particular interest since they showed totally opposite directions of expression by AOM 
treatment and cooked RS diet treatment respectively, indicating their potential to reverse 
the progress of AOM induced CRC after cooked RS diets were fed. 
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Abstract  
 
We evaluated a novel stearic-acid-complexed-high-amylose-cornstarch (SAC) for the 
prevention of preneoplastic lesions in the colon of azoxymethane (AOM)-treated 
Fisher344 rats fed resistant starches at 50-55% of the diet for 8 weeks. Uncooked-SAC (r-
SAC) diet was compared with raw-normal-cornstarch-diet (r-CS) or raw-high-amylose-
cornstarch-diet (r-HA), and water-boiled-CS (w-CS) was compared with w-HA and w-
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SAC, respectively. w-SAC markedly reduced MDF numbers compared with w-HA or w-
CS. r-HA significantly decreased ACF numbers compared with r-CS or r-SAC. Increased 
cecum weight and decreased cecum pH were observed in SAC or HA groups. The highest 
amounts of total or individual SCFAs in cecum, and butyrate or propionate in feces were 
observed in the AOM-treated w-SAC group. This study revealed the effectiveness of a 
novel resistant starch on inhibiting colonic preneoplastic lesions and the importance of 
high moisture cooking on the suppression of colon carcinogenesis by this resistant starch. 
 
 
Introduction 
 
    Colorectal cancer (CRC) is one of the most prevalent cancers in western countries and 
is rapidly increasing in developing countries. In the United States, CRC is the third most 
common cancer in both men and women. In 2009, CRC accounted for almost 9% of all 
cancer deaths (1). It has been commonly believed that dietary factors play an important 
role in preventing or enhancing colon cancer development. Previous studies showed 
evidence that the intake of dietary sucrose or highly digestible starches would increase the 
development of aberrant crypt foci (ACF) in rodents and was associated with colon 
cancer in humans (2-5). Other studies showed evidence of an inhibitory effect on colonic 
preneoplastic lesions or colon cancer development in rodents fed raw cornstarch or potato 
starch compared with rapidly digestible starches (6-8). The impact of resistant starch 
intake on colon cancer, however, remains controversial because some studies did not find 
protective effects of these carbohydrates against colon carcinogenesis (9-11).  The 
differences could be related to issues in the method used for the diet preparation, such as 
whether the starch was cooked prior to addition to the diet. 
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    Resistant starch (RS) is a portion of dietary starch, which is not digested and absorbed 
in the small intestine of healthy individuals. Resistant starch was classified into four 
classes: Type 1 RS, physically inaccessible starch, such as coarsely ground whole grains 
and legumes; type 2 RS, crystalline (uncooked) starch granules with the B- or some C-
type crystalline structure, such as raw potato, banana, and high-amylose maize starch; 
type 3 RS, retrograded amylose, which can be found in cooked and chilled potatoes; and 
type 4 RS, chemically modified starch.  A newly developed type 5 RS consisting of 
amylose-lipid complex has been introduced recently (13), and the effects of this starch on 
colon cancer prevention were not previously reported. 
    RS cannot be digested in the small intestine, and it enters the large intestine where it is 
fermented by the anaerobic microflora to produce short-chain fatty acids (SCFAs). Thus, 
RS can increase cecal and large intestinal contents, alter microbial populations and 
increase large intestinal SCFAs (14, 15). These physiological properties produced by RS 
have been proposed to prevent against colorectal cancer development (15).  
    There is a large and diverse bacterial population in the human cecum and colon. The 
number of bacteria can reach 10
10
 to 10
11
 cfu/g wet wt (16). More than 400 species of 
bacteria were identified in human feces, comprising about 50% of the dry weight of feces. 
Gut bacteria can hydrolyze resistant starch that is not digested in the small intestines and 
makes it into the cecum and colon and these bacteria can then ferment this starch to 
SCFAs. Of the three SCFAs (butyrate, acetate, and propionate), butyrate has been 
extensively studied and is considered to be the most potent for protection against colon 
carcinogenesis (15-17).   
    The research reported here aimed to test the hypothesis that amylose-lipid complex 
(RS5) could inhibit preneoplastic lesions (colon-cancer precursors) in the colon of rats 
treated with a chemical carcinogen. In this study, we investigated the inhibitory effect of a 
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stearic acid-complexed high-amylose maize starch (SAC) on preneoplastic lesions, i.e., 
aberrant crypt foci (ACF) and mucin depleted foci (MDF), in the rat colon induced by 
injection of azoxymethane (AOM).  AOM is a genotoxic agent frequently used in rodent 
animal models to induce colon carcinogenesis. It is a metabolite of 1,2-dimethylhydrazine 
(DMH), but it can offer better potency and stability than DMH (18, 19). Because starchy 
food in human diet is generally consumed after cooking, diets prepared with cooked 
starch will be more meaningful for application in human colon cancer prevention. 
Meanwhile, the preparation of SAC involved heating, so the cooking of all the starches 
made for a more precise comparison between SAC and other starches. In addition, to 
understand the effect of cooking on the inhibitory effects of different starches, we 
prepared the diets with and without water boiling the starch.  Impacts of various starches 
on SCFAs and cecal fermentation (cecum pH and weight) were assessed, which provides 
information on changes in the colon of rats eating different starches that might relate to 
colon cancer formation and growth.   
 
Materials and Methods 
    Diets. Three starches were evaluated: CS (Cargill Gel™ 03420; Cargill Inc., 
Minneapolis, MN), HA (AmyloGel 03003; Cargill Inc., Minneapolis, MN), and SAC 
(processed using HA in the Department of Food Science and Human Nutrition, Iowa 
State University) (13). CS and HA were used as negative and positive controls, 
respectively.  
    Two successive experiments were conducted using diets formulated based on the 
standard diet recommended by the American Society for Nutritional Sciences for mature 
rats (AIN-93M) (20) (Table 1). In the two experiments, the 3 starches were prepared by 
61
  
different methods. In the first experiment, the raw starch was added at 50% by dry weight 
into each diet group. In the second experiment, the starches were cooked by boiling in 
water and the cooked starch was added into each diet at 55%. The 5% cellulose in the 
AIN-93M was removed in the second experiment to allow for a higher dietary content of 
the starches under investigation. To make water-boiled starch, the starches were mixed 
with water gradually during cooking and the starch-water mixture was slowly stirred 
throughout the process until a paste was formed. The paste was then cooled for 20 
minutes to room temperature. The water-boiled starch pastes were then mixed with the 
powder containing the rest of AIN-93M diet ingredients and made into diets. Diets were 
prepared every two days and immediately fed fresh to the rats. Three samples of each diet 
were collected and tested for their resistant starch content on day 0. The resistant content 
of the diets in the raw starch diet experiment were measured by the Megazyme/AOAC 
method 2002.02 (21), and the resistant content of the diets in the cooked diet experiment 
were assessed by AOAC method 991.43 (22). Water content of these samples was 
determined by drying the diet in an oven at 105
o
C for 3 hours. The water content was 
calculated on a dry-weight basis.  
    Animals and Housing. Five-week-old male Fischer 344 (F344) rats were obtained 
from Charles River laboratory (Wilmington, MA). Fifty-four F344 rats were obtained for 
the raw starch diet experiment and forty-five F344 rats were obtained for the water-boiled 
diet experiment. The animals were housed individually in stainless-steel, wire-mesh 
cages. A stainless-steel wire floor was placed on the bottom of each cage to prevent the 
rats from eating their own feces. During the study the temperature was maintained at 
22+1
o
C and relative humidity at 60%+5%, and fluorescent lights were on from 6 AM to 6 
PM. Diet and water were provided ad libitum. The animal studies were performed in 
compliance with the guidelines of The Institutional Animal Care and Use Committee. 
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    Carcinogen Treatment. Azoxymethane was purchased from Midwest Research 
Institute (Kansas City, MO) and F344 rats were injected at seven weeks of age. In the raw 
starch diet experiment, AOM was injected at the dosage of 15 mg AOM/Kg rat body 
weight. In the water-boiled starch diet experiment, AOM was injected at the dosage of 20 
mg AOM/Kg rat body weight. In both experiments, the rats were dosed by intraperitoneal 
injection and the AOM injection dosages for each experiment were decided by dosage 
studies that assessed the yield of lesions. The dosage of AOM used in each experiment 
was the highest dose that yielded most lesions and did not show toxicity in the rats. 
    Cecal Weight and pH. Five-week-old F344 rats were fed with control cornstarch diet 
(r-CS or w-CS for the respective experiments) for 2 weeks. Then 2 AOM or saline 
injections were administered to the rats one week apart. During the injection period and 
three days after the second injection, the rats were fed with r-CS or w-CS for the raw and 
water-boiled starch experiments, respectively. Then the rats were divided randomly into 3 
diet groups with 18 rats in each diet group (10 AOM-injected rats and 8 saline-injected 
rats) for the raw starch diet experiment or 15 rats (10 AOM-injected rats and 5 saline-
injected rats) in each diet group for the water-boiled starch experiment. Two rats died in 
the water-boiled starch experiment (one in the saline injected w-HA group and one in the 
AOM injected w-HA group). The 3 starch diets were fed to the diet groups respectively 
for 8 weeks. Body weight was measured weekly. Fresh food was provided every two days 
in a pre-weighed amount. The food remaining at the end of the 2 day feeding period was 
weighed and food disappearance was calculated. The rats were then killed by decapitation 
and cecum was collected, weighed as cecal weight with contents, and cut open. The cecal 
contents were scraped off from the cecal wall, and the pH and weight of the cecal 
contents were measured. Then the cecum tissue was rinsed in phosphate buffered saline, 
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quickly dried with a paper towel and weighed in the water-boiled starch experiment. The 
liver was removed and weighed.  
    Aberrant Crypt Foci and Mucin Depleted Foci. The rinsed colons were cut open 
longitudinally, laid flat, and flushed with saline. The distal 75mm were trimmed and fixed 
in 10% formalin for 24 hours before they were made into specimens. Colons were stained 
with 1% alcian blue in acetic acid (pH 2.5), then counterstained with 1% neutral red to 
view ACF and MDF. Aberrand crypt foci were defined as crypts that: (i) have altered 
luminal openings; (ii) exhibit thickened epithelia; (iii) are larger than adjacent normal 
crypts. MDF are characterized by the absence or very limited production of mucins. 
Moreover, MDF are focal lesions (i.e., there is a clear distinction between normal 
surrounding crypts and the MDF). MDF could also frequently be observed with an 
elevation above colon surface and a multiplicity (crypts/foci) >3 (23). 
    Short Chain Fatty Acids. Short Chain fatty acids were measured in the water-boiled 
starch experiment only. Fresh fecal samples were collected two days before rats were 
sacrificed. Cecal and colonic contents were collected during the autopsy at the end of the 
study. All the samples were kept at -50
o
C until analysis. Short Chain fatty acids, 
including acetate, propionate and butyrate, were extracted and analyzed with gas 
chromatography as described (24). Briefly, specimens were homogenized in 10 volumes 
of distilled water and centrifuged at 3000G for 10min; 1mL supernatant was mixed with 
100 µmol 2-ethyl-butyric acid (Sigma-Aldrich, St. Louis, MO) as internal standard. 
Hydrochloric acid was added to protonize SCFAs, followed by diethyl ether (2mL) 
extraction and derivatization with N-(tert-butyldimethylsilyl)-N-methyltrifluoro-
acetamide (Sigma-Aldrich, St. Louis, MO) at 80
o
C for 20 minutes. Short Chain fatty 
acids silyl derivatives (1ul) were injected in a split mode into a Gas Chromatograph 
(Model HP 6890N) (Hewlett-Packard, Roseville, CA) equipped with a flame ionization 
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detector and a SPB5 capillary column (30 m×0.25mm i×d, 1µm film; Supelco, Inc). 
Helium was used as carrier gas. The initial oven temperature was held at 70
o
C for 4 min, 
and was increased at 7
o
C/min to 160
o
C and retained at this temperature for 5 min. The 
injector temp was 200
o
C, and the detector temperature was 220
o
C. A standard SCFAs 
mixture containing acetate, propionate and butyrate (Sigma-Aldrich, St. Louis, MO) was 
used for calculation: acetate: y=16.191x-0.0825 (R
2
=0.9996), propionate: y=9.725x-
0.0132 (R
2
=0.9996), butyrate: y=6.7347x-0.0135 (R
2
=0.9999) respectively. The 
concentration of SCFAs was expressed as mol/g wet weight. Digesta SCFAs pools were 
calculated as the product of concentration (µmol/g) of individual acid, or their sum (total 
SCFAs) and gram of the cecal content weight. 
    Statistical Analysis. Body weight, food disappearance, cecal content pH, cecal weight, 
ACF and MDF number, total amount and concentration of SCFAs were analyzed using 
two-way analysis of variance test and with a t-test post hoc test when statistically 
significant main effects or interactions were observed. All values were reported as mean + 
standard deviation. All statistical analyses were performed using SAS software (SAS 
Institute) and P-value < 0.05 was considered significant. 
 
Results 
    Resistant Content of the Experimental Diets. Resistant content of the three diets 
used in the raw starch experiments were 0.4%, 13.2%, and 12.2% for r-CS, r-HA and r-
SAC, respectively, whereas resistant content rose dramatically from 1.9% to 14.3% and 
25.8% for w-CS, w-HA and w-SAC respectively (Table 2). The proportion of the 
resistant content in each diet was based on the dry diet weight after it was mixed with 
other ingredients. The assessments revealed that the resistant content of w-SAC diet or w-
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HA diet were substantially greater compared with that of w-CS diet. For the raw starch 
diet experiment, the resistant content of r-HA and r-SAC were not different statistically, 
but they were significantly higher than that of r-CS.  The water-boiled cooking process 
significantly increased the differences in resistant content between SAC and control 
starch diets. The Megazyme/AOAC method 2002.02 does not include the process of 
cooking the diets and is proper for assessing resistant content of raw starch diet. AOAC 
method 991.43 contains a boiling step. For the water-boiled diets, the diet preparation 
procedure already contained the water-boiling step, so the AOAC method 991.43 
reflected their resistant content.  
    Body Weight, food Disappearance and Liver Weight. No significant difference was 
seen in the body weight gain or food disappearance over the period of eight weeks in 
either the raw starch diet experiment or the water-boiled diet experiment. A body weight 
gain of 98+12 g was observed with the rats fed the diets in the raw starch diet study 
comparing the end and the beginning body weights and a body weight gain of 101+15 g 
was seen in the rats fed water-boiled starch diet. In the raw starch diet experiment, the 
average daily food disappearance of rats fed raw starch diet was 18.9+1.4 g and 15.4+1.8 
by wet weight and dry weight respectively. In the water-boiled diet experiment, the 
average daily food disappearance of rats was 14.4+1.2 g and 11.3+2.1 by wet weight and 
dry weight respectively. No effects of diet or AOM were observed on liver weight of the 
rats at the end of either experiment. 
Cecum Weight and pH. In both the raw starch diet experiment and the water-boiled 
diet experiment, total cecal weight with contents (in the raw starch diet experiment) and 
cecal content weight /cecal tissue weight (in the water-boiled starch diet experiment) were 
significantly elevated in rats fed SAC and HA (Figure 1A; Figure 2A and 2B).  
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Cecal content pH was significantly decreased in rats fed SAC and HA (P-value < 0.05) 
(Figure 1 B; Figure 2C).      
Aberrant Crypt Foci and Mucin Depleted Foci. In the raw starch diet experiment, 
only ACF numbers were counted because there were too few MDF and ACF were seen 
only in AOM-treated rats. There was a significant decrease in the ACF number in rats fed 
r-HA compared with the rats fed r-CS or r-SAC (P-value < 0.05), but the ACF number in 
rats fed r-SAC did not differ statistically from that of rats fed r-CS diet (Figure 1C).  
    In the water-boiled diet experiment, MDF were only seen in the AOM treated rats and 
a significant reduction was seen in the rats fed w-SAC and w-HA diets. Although there 
was a trend toward a decrease of ACF with rats fed w-SAC and w-HA diets, there was no 
significant difference between these groups (Figure2D and 2E). 
    The numbers of large ACF (crypts/foci >= 4) were also counted and compared. A 
similar trend was observed as in the total ACF numbers. In the raw starch diet 
experiment, 16.8+4.3, 6.9+4.4, and 14.7+8.1 large ACF were observed in rats fed r-CS, r-
HA and r-SAC diets, respectively. A significant decrease was seen in the large ACF 
number in rats fed r-HA diet compared with the rats fed r-CS or r-SAC diet (P-value < 
0.05). In the water-boiled diet experiment, 10.5+8.1, 10.1+6.7, and 7.9+7.6 large ACF 
were counted in rats fed w-CS, w-HA and w-SAC diets, respectively. No significant 
difference was observed between these groups. 
    All the above data were not compared between the raw starch experiment and water-
boiled starch experiment since the two experiments were not conducted at the same time.  
    Short Chain Fatty Acids in the Water-boiled Starch Diet Study. Total amounts of 
pooled acetate, propionate and butyrate in the cecum (µmol) were significantly higher in 
rats fed w-HA and w-SAC compared with rats fed w-CS in both saline and AOM treated 
groups (Table 3). There was no difference in the amount of individual SCFAs in the 
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cecum contents between w-HA and w-SAC diet groups in both saline and AOM 
treatments. However, in rats treated with AOM, total cecum SCFAs was highest in w-
SAC, followed by w-HA and then w-CS.  
In all groups, acetate was the most abundant SCFAs detected in cecum, colon and 
feces. Propionate was the second most abundant SCFAs in cecum contents and feces, and 
least abundant was butyrate. Short Chain fatty acids concentration was highest in cecum, 
followed by colon, and then feces. In general, no difference was observed in the 
individual or total SCFAs concentration in the residue of cecum and colon between 
groups. However, in rats treated with AOM, fecal propionate and butyrate concentrations 
were significantly increased in rats fed w-HA or w-SAC compared with rats fed w-CS. 
Whereas, in animals treated with saline, w-HA significantly increased fecal butyrate 
concentration compared with w-CS and w-SAC groups.  
 
Discussion 
    Type 1, 2 and 3 resistant starches are widely present in foods such as navy beans, raw 
banana, and cooked-and-chilled potato. In this study, a type 5 resistant starch was 
prepared by complexing a high amylose cornstarch with stearic acid. w-SAC inhibited 
MDF after being fed to Fisher 344 rats for 8 weeks compared with w-CS or w-HA. The r-
SAC did not inhibit these lesions when fed to rats in comparison to diets containing r-HA 
or r-CS. To our knowledge, the inhibition of colon carcinogenesis has not been previously 
attempted using water-boiled normal starch compared with similarly cooked high 
amylose or processed high amylose cornstarches. SAC also increased cecum weigh and 
decreased cecum pH after feeding rats compared with all CS groups and some HA 
groups. These changes are expected to be due to an enhanced ability of SAC to avoid 
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hydrolysis in the small intestine and thus increase the fermentation in the large intestine 
(10, 13, 22, 25, 26). 
    An inhibition of MDF preneoplastic lesions by w-SAC at the promotion stage in male 
Fisher 344 rats was observed, compared with rats fed w-CS or w-HA. In this study, the 
ACF number tended to decrease in parallel with the effects seen on MDF, although the 
decrease was not statistically significant. In the raw starch diet experiment, the average 
ACF number decreased significantly in the rats fed r-HA, but the same trend was not seen 
in the rats fed r-SAC in comparison with the r-CS. The large ACF multiplicity (crypts >= 
4) has been suggested to be a better predictor of tumor incidence since large ACFs have 
much greater potential to progress into cancer (27). In our study the numbers of large 
ACF in different diet groups reflected the same trend as was observed with the total ACF 
numbers. These results indicated that after boiling the starches, an inhibitory effect of w-
SAC on colon carcinogenicity was shown compared with w-HA or w-CS diet; yet 
compared with the r-HA or r-CS diets, the r-SAC did not inhibit the colon pre-neoplasia. 
Comparing the resistant content of the diets in the raw starch diet experiment and the 
water-boiled starch diet experiment, we observed that the water-boiling process resulted 
in a dramatic difference in the resistant content of w-CS, w-HA and w-SAC diet. Yet in 
the raw starch diet experiment, the resistant content of r-HA and r-SAC were not 
different. Considering the fact that r-SAC was a heat-treated product of r-HA, comparison 
of either resistant content or protective effects of colon carcinogenesis between the 
cooked starches was more appropriate than the comparisons between uncooked starches. 
For CS or HA, heating was expected to cause the starch granule to swell and amylose to 
leach out from the granule. But for SAC, we hypothesize that the lipid and amylose 
formed a complex which prevented the amylose from leaching and starch granules from 
swelling. Thus resistant content of CS or HA decreased significantly compared with that 
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of SAC after boiling in water. Such a feature of SAC to keep an intact granule could 
result in the improved digestive enzyme-resistance. The impact of cooking on starch is 
important because humans generally consume cooked cornstarch.  
    ACF have been defined as a putative biomarker for colon cancer, yet recent literature 
suggested that MDF could be a more sensitive predictor of colon cancer than ACF. Bird 
(1987) reported ACF as a biomarker for colon cancer in 1987 (28). Femia et al. (2004) 
demonstrated that the number of MDF, its multiplicity and the number of large MDF 
(crypts > 12) were significantly enhanced by cholic acid, a promoter of colon 
carcinogenesis
 
or decreased by piroxicam, a colon cancer-inhibiting drug (29). Research 
by Pretlow et al. (1990) also supported MDF as an effective cancer predictor in a study in 
F344 rats treated with AOM and phytate (30). 
    Previous studies showed controversial results on the impact of dietary resistant starch 
on colon carcinogenesis. Bauer-Marinovic et al. (2006) showed that hydrothermally 
treated Novelose 330, a commercially developed RS3 prevented colon tumors in 1,2-
dimethylhydrazine-treated Sprague-Dawley rats when incorporated into diet (31). In this 
study, the rats were fed with Novelose 330 or raw control starch diet throughout the 
study. After 1 week of diet feeding, the rats were injected DMH at 1-week intervals for 20 
weeks. Young et al. (1996) observed increased epithelial proliferation, ACF density and 
colorectal tumor formation in Sprague-Dawley rats fed diets containing raw potato starch 
(RS2), and an addition of raw wheat bran to this resistant starch diet suppressed 
tumorigenesis (11). These rats were fed the diets for 31 weeks throughout the initiation 
and after the initiation (treatment with 1,2-DMH injection) stages. Conversely, Thorup et 
al. (1995) found a lowered number of ACF in Wistar rats fed raw potato starch diet 
compared with rats fed sucrose, raw cornstarch or a basic semi-synthetic diet (8). In this 
study, the carbohydrate in the basic diet contained 90% starch (45% cornstarch and 45% 
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potato starch) and 10% sucrose/dextrin. All other diets used the respective test starches to 
replace the carbohydrate. Rats were injected with AOM once a week for 2 weeks. Then 
they were assigned to their respective diets.  
    SCFAs are thought to play an important role in the process of inhibiting colon 
carcinogenesis since SCFAs stimulates cell proliferation and induces apoptosis, which in 
turn impacts carcinogenesis. Short Chain fatty acids, including acetic, propionic, and 
butyric acids can be major end products of microbial fermentation of some dietary 
polysaccharides including resistant starch after they escape absorption in the small 
intestine and are then digested in the large intestine. It was reported that resistant starch 
feeding increased cecal and colonic SCFAs concentrations. Kleessen et al. (1997) 
reported a stimulation of bifidobacteria, lactobacilli, and a higher SCFAs concentration in 
male Wistar rats by a retrograded potato starch (32). Sakamoto et al. (1996) showed an 
increased butyrate concentration in colonic content and in feces after the Sprague-Dawley 
rats were fed 3% resistant starch (10). In the water-boiled starch diet study, we did not 
observe difference in fecal or colonic SCFAs concentration between groups, but a 
significantly increased cecal SCFAs amount in rats fed w-SAC and w-HA diet was 
observed. It was suggested that total SCFAs excretion might also be relevant to the ability 
of resistant starch to reduce colon cancer risk, considering higher cecal content weight 
and thus SCFAs amounts available for colonocytes (17). Differences in total SCFAs 
amount between w-SAC and w-HA might be related to their efficacy in decreasing ACF 
occurrence (Table 3). Other end points altered by the gut bacteria fermentation are an 
increased cecal weight and decreased cecal pH (16, 33). The results of an elevated cecal 
weight and decreased pH in cecal content by SAC and a change in SCFA content in our 
study indicated a microflora fermentation function stimulated by the processed resistant 
starch, which in turn shows a potential to suppress colon carcinogenesis. 
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    Butyrate is an important SCFA because it is reported to reduce proliferation of 
colorectal cancer cells and stimulates proliferation in normal colorectal epithelial cells as 
observed in in vitro studies (34, 35). Meanwhile, butyrate can induce apoptosis of 
colorectal epithelial cells and increase the differentiation and cell migration in colon 
cancer cells (36, 37). In human colonic mucosa, butyrate was found to cause an increased 
transcriptional regulation of several pathways such as citric acid cycle (TCA-cycle), fatty 
acid metabolism, electron transport, TNF-alpha signaling and oxidative stress pathways 
(38). In some in vitro studies, butyrate was applied to the SW620 colon carcinoma cell 
line or HT29 colonic adenocarcinoma cell line and microarray analysis demonstrated that 
some genes that regulate apoptosis, DNA synthesis, repair and recombination were up 
regulated, while numerous oncogenes, cell cycle regulators and transcription factors were 
down regulated (38-40).   
    Increased fecal butyrate and propionate concentration by w-HA and w-SAC feeding 
was observed in our study, suggesting that distal SCFAs concentration might be 
associated with decreased ACF occurrence by w-SAC or w-HA. Colon cancer risk is 
higher in the distal colon compared with the proximal colon, and studies showed that 
AOM induced 63% more tumor in the distal colon than proximal colon (41). Considering 
the physiological significance of SCFAs, especially propionate and butyrate, in 
maintaining colon health and inducing hyper-proliferative cell apoptosis, increased 
SCFAs in distal colon may have important implications in the prevention of colon cancer 
(15). Studies have shown that apoptotic index measured 6h after an acute dose of AOM 
(10mg/kg) in distal crypts was significantly correlated with fecal SCFAs concentration 
but not with cecal SCFAs in Sprague-Dawley rats fed Hi-Maize starch or non-starch 
polysaccharides (wheat bran and cellulose) for 4 weeks (42). 
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The reduction of colorectal pH has been studied as a marker for the inhibition of 
carcinogenicity. Cecal pH may be related to cecal fermentation and a high production of 
SCFAs. Decreased fecal pH has been associated epidemiologically with lower colon 
cancer risk by studying different ethnic populations in urban and rural South Africa (43). 
An acidic cecal environment inhibits growth of pathogenic bacteria (44) and may also 
decrease secondary bile acid levels, which were suggested as promoters for colon 
carcinogenesis (45). In our study, cecum pH was significantly decreased by SAC or HA, 
but SCFAs concentration (µmol/g wet wt) was not appreciably affected. It is possible that 
other organic acids might contribute to the decreased cecal pH observed. Kishida et al. 
reported that although cecal pH was decreased from 7.1 in gelatinized normal cornstarch 
to 5.4 by 21 days of high amylose cornstarch feeding in Wistar rats, no difference was 
observed in total cecal SCFAs concentration between the two groups (46). On the other 
hand, succinic acid was significantly correlated with decreased cecal pH (r
 
= -0.978, P-
value < 0.05) in their study with more than 4-fold increase in rats fed high amylose 
starch.  But some studies have suggested that a very low pH might increase the risk of 
carcinogenesis because very low pH may stimulate epithelial cell proliferation, which in 
turn could enhance the chemically initiated carcinogenesis (40, 47). 
An elevated cecal tissue and content weight was found in rats fed diets containing w-
SAC and w-HA compared with those fed w-CS, and the same trend was observed in total 
cecal weight rats fed r-SAC and r-HA compared with those fed r-CS. The increase in the 
cecal weigh is likely related to the increase in fermentation in the cecum and the 
production of SCFA by gut microflora in animals fed resistant starches. The cecum is the 
main fermentation site in rodents, where the increased digesta by resistant starch and the 
increase in microbes would produce SCFA.  It has been reported that SCFA reduced 
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smooth muscle contractibility and fluid output which would help support the 
accumulation of gut contents in the cecum (48). 
    In the raw starch experiment, 5% cellulose was included in all diets. In the water-boiled 
experiment, 5% cellulose was removed from the ingredients and its proportion was made 
up by the starch under study. The removal was made based on our desire to optimize the 
amount of experimental starch and on reports suggesting the suppression of colonic 
carcinogenesis by cellulose. For example, cellulose diets and non-fiber diets were fed to 
AOM-treated (5mg/kg body weight) Sprague-Dawley rats for 50 weeks and cellulose 
diets were reported to significantly lower the induction rate of tumor in rats compared 
with non-fiber diets (49).  
    In conclusion, our results showed that a water-boiled cooking method on SAC 
significantly enhanced its ability to inhibit MDF, a preneoplastic lesion that is used as 
biomarkers for colon tumor in comparison with w-CS or w-HA. Incorporating w-SAC in 
the diet inhibited preneoplastic lesions at the promotion stage in male Fisher 344 rats, 
compared with the rats fed w-CS and w-HA cooked by the same method. The F344 rats 
fed w-SAC developed significantly fewer MDF in the water-boiled starch diet study and 
had a trend toward decreasing ACF number.  It is notable that a similar SAC used in a 
human study caused a lower circulating glucose and insulin response than the same load 
of wheat starch following a single meal in humans (13). To our knowledge, this is the first 
time the inhibition of preneoplastic colonic lesions was demonstrated in rats fed cooked 
starch. Boiling the starches in water is a common process in cooking and human diets 
contain cooked starch. It will be important to assess other promising cooking methods and 
the impact of cooking on other starches in future research.   
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Abbreviations 
ACF, Aberrant Crypt Foci 
AOM, Azoxymethane 
CRC, Colorectal cancer 
CS, Control cornstarch diet 
HA, High amylose cornstarch diet 
MDF, Mucin Depleted Foci 
r-CS, Raw control cornstarch diet 
r-HA, Raw high amylose cornstarch diet 
RS, Resistant starch 
r-SAC, Raw stearic acid complexed high-amylose cornstarch diet 
SAC, Stearic acid complexed high-amylose cornstarch diet 
SCFAs, Short chain fatty acids 
w-CS, Water-boiled control cornstarch diet 
w-HA, Water-boiled high amylose cornstarch diet 
w-SAC, Water-boiled stearic acid complexed high-amylose cornstarch diet. 
 
Safety 
Azoxymethane is a potent carcinogen to induce colon cancer in rats and mice. It might 
cause harm to human if swallowed, inhaled or absorbed trhough skin.  
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Figure Captions 
Figure 1.  Endpoints collected after rats fed raw starch diets were killed (9 weeks after 
the first AOM injection):  (A) Cecal weight (with content) (g). (B) cecal content pH; C. 
average ACF number. 
The ACF were measured in the distal 75mm of the colon. 
ACF were only seen in AOM-treated rats. Values are means +SD. 
a,b,c.
 bars with different 
letters in each panel are significantly different P-value < 0.05.
 
 
Figure 2.  Endpoints collected after rats fed water-boiled starch diets were killed (9 
weeks after the first AOM injection): (A) Cecal tissue weight (g). (B) Cecal content 
weight (g). (C) cecal content pH. (D) average ACF number. (E) average MDF number. 
The ACF and MDF were measured in the distal 75mm of the colon. 
ACF were only seen in AOM-treated rats. Values are means +SD. 
a,b,c.
 bars with different 
letters in each panel are significantly different P-value < 0.05. 
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Tables 
Table 1: Diet Ingredients for the Raw Starch Diet Experiment and the Water-boiled 
Starch Diet Experiment
1. 
 
 
Diet Ingredient 
Raw 
Starch 
Diet (%) 
Water-
Boiled 
Starch Diet 
(%) 
starch 50.0 55.0 
casein 20.0 20.0 
Dextrose 15.0 15.0 
cellulose (insoluble 
fiber) 
5.0 0.0 
mineral mix (AIN-93) 3.5 3.5 
choline 0.2 0.2 
methionine 0.3 0.3 
vitamin mix (AIN-93) 1.0 1.0 
corn oil 5.0 5.0 
 
1.
Starches were purchased from Cargill Inc., Minneapolis, MN and 
used as obtained or processed and/or cooked as described in the 
text.  All non-starch diet ingredients in both experiments were 
purchased from Harland Teklad (Madison, WI) or Sigma-Aldrich 
(St. Louis, MO). 
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Table 2: Resistant Starch Contents of the Three Diets Prepared by Two Methods (% dry 
feed basis) 
 
Starch group 
Resistant Starch 
Content of Diets in 
Raw Starch 
Experiment (%) 
Resistant Starch 
Content of Diets in 
Water-boiled 
Starch Experiment 
(%) 
Control normal cornstarch 
diet 
0.4+0.6
b
 1.9+1.5
c
 
High amylose cornstarch diet 13.2+0.8
a
 14.3+3.0
b
 
Stearic acid complexed high-
amylose cornstarch diet 
12.2+0.7
a
 25.8+5.0
a
 
 
 
Data are expressed as mean+SD. Resistant Starch Content of diets in raw starch 
experiment was measured by Megazyme/AOAC method 2002.02, and Resistant Starch 
Content of diets in the water-boiled experiment was measured by AOAC method 991.43.  
a,b,c
 indicates values in each column with different letters are significantly different at P-
value < 0.05. 
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Table 3: Effect of Experimental Starch Diets on Cecal, Colonic and Fecal SCFA 
Concentrations in Fisher344 Rats Fed the Diets in the Raw Starch Diet Experiment. 
group Saline, w-CS Saline, w-HA Saline, w-SAC AOM, w-CS AOM, w-HA AOM, w-SAC 
Cecum (µmol) 
Total SCFA* 131.6 ± 28.9 c 653.2 ± 78.8 ab 643.9 ± 158.1 ab 177.2 ± 67.0 c 569.7 ±217.6 b 890.5 ± 260.9 a 
Acetate 85.8 ± 23.8 b 417.5 ± 63.4 a 342.4 ± 116.4 a 118.3 ± 47.1 b 371.0 ± 160.5 a 544.9 ± 179.2 a 
Propionate 29.1 ± 5.6 b 165.9 ± 88.1 a 188.9 ± 47.1 a 37.0 ± 13.4 b 138.1 ± 52.6 a 217.4 ± 113.1 a 
n-Butyrate 16.6 ± 4.2 b 69.7 ± 37.8 a 112.6 ± 69.7 a 21.9 ± 7.7b 60.6 ± 21.9 a 128.2 ± 55.9 a 
Cecum (µmol/g wet wt)      
Total SCFA 41.1 ± 12.6 49.0 ± 6.5 34.2 ± 6.3 61.5 ± 23.3 43.1 ± 16.1 55.8 ± 14.0 
Acetate 26.8 ± 9.3 ab 31.5 ± 6.5 ab 18.2 ± 5.5 b 41.1 ± 16.6 a 28.2 ± 12.5 ab 34.5 ± 10.0 ab 
Propionate 9.1 ± 2.7 11.8 ± 4.4 10.0 ± 1.8 12.9 ± 4.9 10.3 ± 3.2 13.6 ± 7.3 
n-Butyrate 5.2 ± 1.8 5.8 ± 4.0 6.0 ± 3.5 7.5 ± 2.2 4.6 ± 1.5 7.8 ± 2.7 
Colon (µmol/g wet wt) 
Total SCFA 22.4 ± 6.6 ab 30.2 ± 8.0 ab 20.2 ± 5.5 ab 29.3 ± 13.8 ab 17.6 ± 6.8 b 30.9 ± 10.9 a 
Acetate 16.4 ± 4.0 21.0 ± 4.2 11.8 ± 3.7 20.8 ± 8.9 13.6 ± 5.1 21.1 ± 6.8 
Propionate 3.0 ± 1.4 4.9 ± 3.5 4.8 ± 1.4 4.2 ± 2.4 2.7 ± 1.3 5.6 ± 4.2 
n-Butyrate 3.0 ± 1.4 4.3 ± 3.5 3.5 ± 2.9 4.4 ± 2.7 1.3 ± 0.9 4.2 ± 3.1 
Feces (µmol/g wet wt) 
Total SCFA 16.8 ± 6.6 16.2 ± 1.0 13.4 ± 3.5 10.7 ± 3.3 16.1 ± 6.4 16.6 ± 6.0 
Acetate 14.9 ± 5.5 10.3 ± 5.6 7.7 ± 1.6 9.6 ± 2.9 12.7 ± 5.1 11.3 ± 3.9 
Propionate 1.5 ± 1.7 ab 3.6 ± 3.1 a 4.4 ± 1.2 a 0.9 ± 0.4 b 2.4 ± 1.3 a 3.5 ± 1.8 a 
n-Butyrate 0.5 ± 0.6 bc 2.2 ± 2.7 a 1.4 ± 1.4 ab 0.2 ± 0.2 c 1.0 ± 0.5 ab 1.8 ± 1.3 a 
 
Data are expressed as mean+SD.
 
a,b,c
 indicates values in each row with letters and without a common letter differ, P-value < 
0.05. 
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CHAPTER 3: INHIBITION OF AZOXYMETHANE-INDUCED 
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Abstract 
 
We evaluated a novel stearic-acid-complexed-high-amylose-cornstarch (SAC) for 
the prevention of preneoplastic lesions in the colon of azoxymethane (AOM)-treated 
Fisher344 rats fed cooked resistant starches at 55% of the diet for 8 weeks when two 
cooking methods were applied respectively: water-boiling and bread-baking methods. 
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Water-boiled SAC (w-SAC) diet was compared with water-boiled CS (w-CS) or water-
boiled HA (w-HA), and bread-baked CS (b-CS) was compared with bread-baked HA (b-
HA) and bread-baked SAC (b-SAC), respectively. Global gene expression profiles of 
colon mucosa from rats fed different diets in the water-boiled group were determined. 
Either w-SAC or b-SAC markedly reduced ACF and MDF numbers compared with HA 
or CS within their cooking groups. Increased cecal contents and decreased cecal pH were 
observed in SAC or HA groups. The total SCFAs or each individual SCFA (butyrate, 
acetate, and propionate) were observed to increase in certain SAC groups. Differentially 
expressed genes were found for AOM or diet treatment in rats fed w-CS or w-SAC, and 7 
genes (CACYBP, RhoA, MAPK1, TOPBP1, HSPH1, MCM6, HSPD1) were confirmed 
with semi- quantitative real time-PCR. This study revealed that SAC cooked by both 
methods inhibited colonic preneoplastic lesions and identified potential gene targets. 
 
1. Introduction 
Colorectal cancer is one of the leading causes of cancer deaths worldwide. In the 
USA alone, an estimated 102,900 cases of colon and 39,670 cases of rectal cancer were 
predicted to occur in 2010, among which 51370 deaths were expected, accounting for 9% 
of all cancer deaths (American Cancer Society, 2010). Colorectal cancer was estimated to 
be the third most common cancer in both men and women. Diet has been reported as an 
important modifiable factor for control risk of colon cancer (Rogers et al., 1993).  
 
Resistant starch (RS) is the sum of starch and products of starch degradation that 
is not digested and absorbed in the small intestine of healthy individuals. Traditionally, 
RS was classified into four categories: RS1, physically inaccessible starch (e.g. coarsely 
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ground whole grains and legumes); RS2, crystalline (uncooked) starch granules with the 
B- or some C-type crystalline structure (e.g. raw potato, banana, and high-amylose maize 
starch); RS3, retrograded amylose, which can be found in cooked and chilled potatoes; 
and RS4, chemically modified starch. A newly developed type 5 RS consisting of 
amylose-lipid complex has been introduced recently (Hasjim et al., 2010). 
     
RS cannot be digested in the small intestine, and it enters the large intestine where 
it is fermented by the anaerobic microflora to produce short-chain fatty acids (SCFAs). 
Thus, RS can increase cecal and large intestinal contents, alter microbial populations and 
increase large intestinal SCFAs (Sengupta et al., 2006; Scheppach et al., 1995). These 
physiological properties produced by RS have been proposed to prevent colorectal cancer 
development (Scheppach et al., 1995). Of the three main SCFAs (butyrate, acetate, and 
propionate), butyrate has been extensively studied and has been considered to be the most 
potent for protection against colon carcinogenesis (Hijova and Chmelarova, 2007; 
Topping and Clifton, 2001).   
 
Hasjim (Hasjim et al., 2010) reported that SAC, a RS5, reduced postprandial 
plasma-1 glucose and insulin levels in humans. Twenty male human subjects were fed 
bread made from 60% (dry basis) SAC or white bread. Subjects fed SAC had their 
postprandial plasma glucose and insulin levels reduced to 55% and 43%, respectively, 
compared with those fed control white bread (100%). The results suggested that the SAC 
can be used for the intervention of diseases such as diabetes and obesity.  
 
In our previous study, we discovered that water-boiled SAC had a better 
inhibitory impact on colon carcinogenesis in Fisher 344 rats than uncooked forms. This 
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discovery is notable because humans generally consume cooked cornstarch. In this study, 
we explored the impact of different cooking methods on the colorectal carcinogenesis 
further. To our knowledge, this is the first time the influence of different cooking methods 
on the ability of RS to prevent preneoplastic lesions have been reported.  We also 
conducted global gene expression analysis by microarray and identified several potential 
genetic targets using qRT-PCR that may be important in colon cancer prevention by 
water-boiled SAC. 
 
2. Materials and Methods 
2.1. Diets 
Three starches were incorporated into diets and fed to the rats, CS (Cargill Gel™ 
03420; Cargill Inc., Minneapolis, MN) , HA (AmyloGel 03003; Cargill Inc., Minneapolis, 
MN) and SAC (processed from Department of Food Science and Human Nutrition, Iowa 
State University) (Hasjim et al., 2010) as the negative control, positive control, and 
experimental diet, respectively. The diets were formulated based on the standard diet 
recommended by the American Society for Nutritional Sciences report for mature rats 
(AIN-93M), except that 5% cellulose was not included, and starch content was set at 55% 
(Reeves, 1997). All three starches were cooked by two different methods: water-boiled 
method and bread-baked method (Table 1). For the water-boiled diets, the starches were 
mixed with water gradually and cooked on the range top of a stove. The starch-water 
mixture was slowly stirred throughout the cooking process until a paste was formed. The 
paste was then cooled to room temperature and added into the rest of AIN-93M diet 
ingredients. For the bread-baked diets, each starch was mixed with bread flour in the 
proportion of 5:2. First 2.5 g yeast were mixed with 100 g warm water and held for at 
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least 10 min, and then 300 g of starch and bread flour mixture were mixed together. Next, 
2.0 g salt was dissolved with 65 g hot water and 12.5 g shortening, and heated on a 
boiling water bath until melted. The melted shortening, salt solution and yeast were then 
added into the starch-bread flour mixture and mixed slowly for 3.5 min to form dough. 
The dough was put in a greased pan, covered with a moist towel and let rise for 1 hour. 
The dough was then put in a loaf pan and let rise for another hour. The raised dough was 
baked in an oven for 25 minutes at 400
o
F, and then cooled for 1 hour at room 
temperature. The bread was then dried, ground and mixed with other ingredients of the 
modified AIN-93M diet. Diets were prepared and fed to rats every two days. 
 
Notably, a key strategy was to keep the CS, HA and CSA at 55% of the diet and 
thus in the bread-baking diets, the composition of vitamins and minerals were less than 
the standard AIN-93M rat diet (Table 1B). In the bread-baking diet ingredients, the 
vitamin mix was included at 56% of the recommended amount in the AIN-93M diet, and 
mineral mix was contained at 61% of the amount in the AIN-93M diet. L-lysine, DL- 
tryphophan, L-histidine, and DL- threonine were added to the diet since they were needed 
by rats and not sufficiently obtained from the wheat protein and other ingredients of the 
bread-baked diet (Table 1C). Eighteen amino acids from each diet were listed and 
compared, among which 7 are essential amino acids (Table 1C). All of the amino acids in 
the water-boiled diet exceeded the recommended amount for the AIN-93M diet. All of the 
essential amino acids were present in the bread-baked diet, but isoleucine and leucine 
were somewhat low compared with the AIN-93M ingredient (86% and 79% of the 
recommended amount in AIN-93M diet, respectively). There were another 6 amino acids 
from the bread-baking diet that were 55-97% of what was recommended for the AIN-93 
M diet. Comparing the bread-baked diet with water-boiled diet, two amino acids 
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(Glutamic acid and glycine) from the bread-baking diet had higher amounts than that 
contained in the water-boiled diet, and all the other amino acids in the bread-baking diet 
were 38% - 96% of the respective amino acid content in the water-boiled diet. The total 
amount of amino acids were higher in the bread-baked diet than in the AIN-93M 
ingredient (14.83% of bread-baked diet and 14.05% of the AIN-93M diet), but less than 
that of the water-boiled diet (20.07%). Although most of the amino acids were sufficient 
compared with their recommended amount in the AIN-93M ingredient, they were mostly 
less than the respective amount in the water-boiled diet. The reason for the lower amount 
of vitamins, minerals and selected amino acids was that bread flour, wheat gluten, 
shortening, yeast and salt had to be added in addition to the resistant starch or control 
starch to shape and make the bread in the bread-baking process. Thus, with 37.97% the 
above components of the total, the remaining ingredients had to be reduced to keep the 
diets at a composition of 55% corn starch.  
 
2.2. Carcinogen treatment 
AOM was purchased from Midwest Research Institute (Kansas City, MO) and 
diluted by phosphate buffered saline (PBS) to 2mg/ml. AOM solution was injected by 
intraperitoneal injection to 60 rats at seven weeks of age at the dosage of 20 mg AOM/Kg 
rat body weight. The remaining 30 rats were injected with physiological saline (VWR 
International, Inc., Batavia, IL) by the same method, and they served as controls. 
 
2.3. Animals and housing 
Five-week-old male Fischer 344 (F344) rats were obtained from Charles River 
laboratory (Wilmington, MA). Ninety animals were housed individually in a plastic cage 
with stainless-steel, wire-mesh top. A stainless-steel wire floor was placed on the bottom 
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of each cage to prevent the rats from eating their own feces. The rats were housed in an 
animal room at the temperature of 22+1
o
C and relative humidity at 60%+5% with a 12-
hour light cycle. Diet and water were provided ad libitum.  
 
F344 rats were first injected with AOM or saline at 6 weeks of age. They were 
injected with AOM for a second time one week later. From their arrival until 3 days after 
the second injection, the rats were fed with w-CS or b-CS. Then the rats were divided 
randomly into 6 diet groups (w-CS, w-HA, w-SAC, b-CS, b-HA and b-SAC) with 5 
saline-injected rats and 10 AOM-injected rats in each diet group. The rats were fed the 6 
diets respectively for 8 weeks. Body weight was measured weekly and food 
disappearance was calculated every 2 days when freshly prepared diet was provided. The 
rats were then killed by carbon dioxide euthanasia and opened the thoracic cavity and 
abdominal cavity. 
 
2.4. Resistant starch content (RC) and water content (WC) 
Diet samples were collected right after they were made. Water content of these 
samples was determined by Sartorius moisture analyzer MA30 (Bohemia, NY). Resistant 
starch contents were then assessed by AOAC method 991.43 on a dry-weight basis 
(Horwitz, 2003).  
 
2.5. Cecal weight and pH, liver weight 
Cecum was collected from rats and cut open. The cecal content weigh and pH 
were measured. Cecal tissue was rinsed in PBS, quickly blotted with a paper towel and 
weighed. The liver was also removed and weighed.  
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2.6. ACF and MDF 
The rinsed colons were cut open longitudinally, laid flat, and flushed with PBS. 
The distal 75mm of the colon measured from the anus was fixed in 10% formalin for 24 
hours before processing into specimens. Colons were first stained with 1% alcian blue in 
acetic acid (pH 2.5), and then counterstained with 1% neutral red to view total ACF 
number, ACF multiplicity and MDF number. The proximal and distal ACF number, ACF 
multiplicity and MDF number were also counted. ACF was also grouped in to small (1-3 
crypts) or large (>=4 crypts) by size and large ACF numbers were also enumerated. 
 
2.7. SCFA 
Fresh fecal samples were collected two days before rats were sacrificed. Cecal and 
colon contents were collected during the necropsy at the end of the study. All the samples 
were kept at -80
o
C until analysis. 
 
After thawing, cecum, colon or fecal samples were diluted with distilled water at a 
ratio of 1:1, 1:2.5 or 1: 3, respectively. Extraction of SCFA and Gas Chromatography 
analysis were performed by following the methods described (Sayar, 2007) with slight 
modification. Briefly, 500 μL supernatant collected after centrifuging the homogenous 
slurry at 3,000 g for 10 min, was added to 250 μL concentrated hydrochloric acid 
containing 50 μL 2-ethyl-butyric acid (0.1 M) (Sigma-Aldrich, St. Louis, MO) as internal 
standard. After 2 × 1 mL diethyl ether extraction, 200 μL upper ether phase was silylated 
with 20 μL N-(tert-butyldimethylsilyl)-N-methyltrifluoro-acetamide (Sigma-Aldrich, St. 
Louis, MO) at 80 
o
C for 20 min. SCFA derivatives were stored at room temperature for 
24 h in the dark before Gas Chromatography analysis. 
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SCFA silylated derivatives were analyzed by a Gas Chromatography equipped 
(HP 6890N) with a flame ionization detector using a SPB5 30 m × 0.25 mm i.d. × 1 μm 
capillary column (Supelco, Inc). A split mode was used and the Gas Chromatography 
conditions were as follows: injection volume (1 μL), initial temperature at 70 oC for 5 min 
raised to 160 
o
C at 7
 o
C /min and final temperature at 160 
o
C for 4 min, injector 
temperature (200 
o
C), and detector temperature (220 
o
C). Quantifications of SCFA were 
based on the standard curves established using internal standard 2-ethyl-butyric acid. All 
standards and samples were analyzed in replicates. SCFA data was presented as mean 
values ± standard deviation. The concentration of SCFA was expressed as µmol/g wet 
weight. Cecal SCFA amounts were calculated as the product of the concentration 
(µmol/g) of individual acids, or the pooled SCFA amount.  
 
2.8 RNA Processing and Microarray 
Colon samples were collected for Microarray studies from 3 rat experiments 
(experiment 1, 2 and 3). All of these rats were treated exactly the same way as in the 
preneoplastic lesion study. Colon mucosa was scraped from the surface of colon tissue 
and collected immediately in liquid nitrogen after rats were killed and used for RNA 
extraction later. Total RNA was isolated from rat colon mucosa using Trizol (Invitrogen, 
Carlsbad, CA). In one microarray analysis study, colon mucosa samples came from 2 rat 
experiments (experiment 1 and 2). Twenty total RNA samples were isolated from distal 
rat colon mucosa (the colon section from anus to 75mm above anus) in either AOM w-
SAC rat group or AOM w-CS rat group to compare the effects on gene expression levels 
caused by the two diets fed to AOM treated rats with 10 samples in each group (6 from 
the distal section of rat colons in one experiment, 4 as replicates from the other 
experiment). In a second comparison of the gene expression difference impacted by AOM 
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treatment, nineteen RNA samples were isolated from either the distal (anus to 75mm 
above anus) or the adjacent rat colon mucosa (the next 75mm from the distal section) in 
the rats fed w-CS and treated either AOM or saline from 2 experiments (experiment 1 and 
3). In this comparison, ten samples were collected from the rats fed w-CS and injected 
AOM (6 samples from distal colons of one experiment and 4 samples from the adjacent 
colons of the other experiment), and 9 samples were collected from the rats fed the same 
diet and injected with saline (6 samples from distal colons of one experiment and 3 
samples from the adjacent colons of the other experiment). A further purification was 
conducted with RNeasy Protect Mini Kit (QIAGEN, Valencia, CA), and RNase-Free 
DNase (QIAGEN) was performed to remove contaminating DNA. Integrity, quality, and 
quantity of isolated RNAs were confirmed with RNA 6000 Nano LabChip kit with 
Agilent 2100 Bioanalyzer (Agilent Biotechnologies, Palo Alto, CA).   
 
These RNA samples were then applied to an Affymetrix oligonucleotide 
microarray using GeneChip Rat Genome 230 2.0 (Affymetrix, Santa Clara, CA) for gene 
expression analyses, and each replicate was analyzed on an individual GeneChip. The 
labeling of RNA was conducted with the GeneChip 3' IVT Express Kit and control 
reagent package according to manufacturer’s instructions (Affymetrix, Santa Clara, CA), 
and the process was performed by a GeneChip fluidics station 450 and a GeneChip 
Scanner 3000 7G (Affymetrix, Santa Clara, CA). All techniques for the GeneChip array 
were carried out according to the manufacturer’s instructions by the Microarray Facility 
at Iowa State University. Samples from AOM w-CS group and saline w-CS group were 
compared for the effects AOM conducted on the gene expressions. Samples from AOM 
w-SAC and AOM w-CS rats were analyzed for the effects of SAC diet on the gene 
expression level. 
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2.9 Semi-quantitative real time-PCR 
DNA-free RNA was reverse-transcribed using the iScript cDNA synthesis kit 
(BioRad, Hercules, CA). Four genes were chosen to verify the AOM effects on gene 
expressions, and 5 genes were selected for the diet effects. These genes were chosen for 
quantitative real-time PCR analysis (qRT-PCR) based on their significant differential 
expression in treatments False Discovery Rate (FDR) less than 0.05 and Fold Change 
(FC) more than 1.2 either up-regulated or down-regulated, and their relevance to 
biological pathways of interest. GAPDH was used as control. The primers used to 
confirm differentially expressed genes were designed using the software PrimerQuest 
(Integrated DNA Technologies, Inc., Coralville, IA) and synthesized by Integrated DNA 
Technologies, Inc. A MyiQ thermal cycler using the SYBR green supermix kit was used 
for the qRT-PCR procedure according to the manufacturer’s instructions (BioRad, 
Hercules, CA). Conditions for the qRT-PCR were: 95 °C for 3 min, and 40 cycles of 95 
°C for 15 s, annealing temperature of the primer for 30 s, and 72 °C for 30 s, followed by 
95 °C for 1 min, and 55 °C for 1 min. The following genes were selected for qRT-PCR to 
confirm microarray results: MAPK1, CACYBP, RhoA, and APC were selected for the 
expression levels in AOM injected rats in comparison with saline injected rats in the w-
CS diet groups. TOPBP1 was tested for its gene expression in AOM-injected rats fed w-
SAC in comparison with AOM-injected rats fed w-CS. The expression of HSPH1, 
MCM6, and HSPD1 were assessed both in AOM-injected rats fed w-SAC compared with 
those fed w-CS, and in AOM-injected rats compared with saline injected rats which were 
fed w-CS. The primer sequences and annealing temperatures were presented in Table 2.    
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2.10 Statistical Analysis 
Two-way AVONA was performed through GLM Procedure in SAS for cecal 
weight, pH, preneoplastic lesions, and SCFA (SAS Institute, 2010). One-sided t-test was 
then applied to test the directions of the differences between groups. All values were 
reported as mean + standard deviation, and P-value < 0.05 was considered significant.  
 
The microarray experiment was designed as a balanced incomplete block design 
with replications as fixed blocks and injection levels (AOM, saline) and diet levels (CS, 
SAC) as the factors and analyzed for the differences of gene expression. An unbalanced 
incomplete block design was carried out to the samples testing the gene expression 
changes caused by AOM treatment. The normalized log signal intensities were fitted to 
the linear model. The moderated t-test (Smyth et al., 2004) and q-value procedure (Storey 
and Tibshirani, 2003) were employed to control FDR at 0.05 level for AOM treatment 
analysis and Diet treatment analysis. FC was also taken into consideration in prioritizing 
genes for further study. Within genes of FDR < 0.05 for the analyses of the either 
treatment, an up-regulated or down-regulated 1.2-fold change or more were considered 
biologically significant (Strath et al., 2009; Jickling et al., 2010). 
 
DAVID 6.7 was used to identify pathways with significant differentially 
expressed genes. Gene ontology functional classifications based on the differentially 
expressed genes were also obtained. The rat Affymetrix background was applied when 
conducting the above procedures (Huang et al., 2009a, 2009b). Cluster and TreeView 
programs (Eisen et al., 1998) were used to develop heat map with genes that had FDR < 
0.01 and FC > 1.5 both in the direction of up-regulation and down-regulation. 
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3. Results 
3.1. Resistant starch content (RC) and water content (WC) of the experimental diets 
Resistant starch contents of the water-boiled and bread-baked diets are shown in 
Table 3. Resistant starch content decreased in the order of SAC, HA and CS within each 
cooking method (bread-baked or water-boiled). Water content of all 6 diets was 49-60%. 
Only w-CS had significantly higher water content compared with all the other diets 
(Table 3). 
 
3.2. Body weight, food disappearance and liver weight 
No significant difference was seen in the body weight gain or food disappearance 
over the period of eleven weeks. Rats fed the water-boiled starches and bread-baked 
starches gained 187 + 14 and 187 + 17 g body weight respectively over the 11 weeks 
feeding time. Average daily food disappearances of rats in water-boiled and bread-baked 
groups were 16.6 + 1.8 and 15.8 + 2.1 g in dry weight, respectively. Liver weight 
collected from rats fed the water-boiled and bread-baked starches were 8.9 + 0.5 and 8.9 
+ 0.8 g, respectively. No effects of diet or AOM were observed on liver weight of the rats 
at final sacrifice. 
 
3.3. Cecum Weight and pH 
In the rats fed both the water-boiled starches and the bread-baked starches, cecal 
content weight and cecal tissue weight were significantly higher in rats fed SAC and HA 
compared with that in rats fed CS. Cecal contents pH was significantly lower in rats fed 
SAC and HA (P-value < 0.05) than in the CS groups (Fig. 1).  
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3.4. ACF and MDF 
Total ACF number, ACF multiplicity, and Total MDF number were assessed in 
the distal 75mm of colon tissue in both water-boiled and bread-baked diet groups. Both 
lesions were seen in AOM-treated rats only (Fig. 2). 
 
In the water-boiled groups, ACF number decreased significantly in rats fed w-
SAC compared with the rats fed w-CS or w-HA (P-value < 0.05). In the bread-baked 
group, ACF number assessed in rats fed b-SAC was also dramatically lower than that of 
rats fed b-CS or b-HA diet. Comparing the two cooking methods, ACF number was 
significantly lower in the rats fed the bread-baked starches (29 + 12, 29 + 7, and 17 + 7 
ACF for b-CS, b-HA, and b-SAC, respectively) then in the rats fed the water-boiled 
starches (225 + 52, 256 + 86, and 121 + 46 ACF for w-CS, w-HA, and w-SAC, 
respectively) (Fig. 2, panel A).  
 
In both rats fed the water-boiled and the bread-baked starches, a small but 
significant elevation of ACF multiplicity was seen in the rats fed SAC compared with rats 
fed CS or HA diets. In the water-boiled treatment groups ACF multiplicity significantly 
increased from the CS < HA < SAC groups (Fig. 2, panel B). 
 
In rats fed water-boiled starches, a significant reduction of MDF was seen in the 
rats fed w-SAC compared with rats fed w-CS or w-HA diets. In the groups fed the bread-
baked starches, rats fed b-SAC diet had fewer MDF than rats fed b-CS or b-HA diets. 
There was a trend of higher MDF number in the rats fed the water-boiled starches (10.7 + 
4.1, 8.7 + 3.5, and 2.1 + 1.5 MDF for w-CS, w-HA, and w-SAC, respectively) than in the 
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bread-baked starches (6.1 + 2.6, 4.9 + 3.0, and 1.9 + 1.4 MDF for w-CS, w-HA, and w-
SAC, respectively) (Fig. 2, panel C). 
 
Total ACF number, ACF multiplicity, and total MDF number were assessed 
throughout two segments of the collected colon tissue: the proximal colon and distal 
colon. A very similar result was observed in the significance or the trends between dietary 
groups compared with what we observed in the entire distal 75 mm colon tissue (Fig.3 
and 4). 
 
The numbers of large ACF (crypts/foci >= 4) were also counted and compared in 
the whole collected colon tissue or in the proximal and distal segments of the colon tissue. 
A similar trend was observed as was seen in the total ACF numbers. Large ACF numbers 
were significantly lower in the rats fed w-SAC compared with w-CS or w-HA either in 
the whole collected colon tissue or in the distal or proximal part of the collected colon in 
the rats fed the water-boiled starch. In the rats fed the bread-baked starch, Large ACF 
numbers were significantly reduced in the rats fed b-SAC compared with b-CS in distal, 
proximal or total assessed colon. Comparing the two starch cooking method groups, large 
ACF numbers were higher in the rats fed the water-boiled starches than those fed the 
bread-baked starches (Fig. 5). 
 
3.5. SCFA 
SCFA amount in the cecum (µmol/cecum), calculated as cecum weight times 
cecal SCFA concentration, were similar in animals fed the same starch diets regardless of 
the preparation method (bread-baked or water-boiled) and carcinogen treatment (AOM or 
saline) (Table 4). Total amounts of acetate and the sum of SCFA in the cecum were 
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significantly greater in animals fed b-HA and b-SAC compared with b-CS, or w-HA and 
w-SAC compared with w-CS. Total amount of butyrate or propionate in cecum were 
higher in rats fed HA or SAC diets compared with CS diet groups. No differences were 
observed in the cecal SCFA amount between 8 groups fed HA or SAC. For µmol per g 
cecal contents, acetate and total SCFA tended to be lower in rats fed water-boiled starch 
diets compared with those fed bread-baked starch diets. 
 
No differences were observed in colon SCFA µmol/g concentrations between the 
diets when comparing amongst rats fed either bread-baked diets or water-boiled diets.  
 
In fecal samples, no significant difference was seen in rats fed water-boiled diets 
in total SCFA or acetate. In the bread-baked diet group, a significant increase of total 
SCFA or acetate was observed in rats treated with AOM and fed b-HA compared with 
rats fed b-CS. Fecal butyrate did not differ among treatments. 
 
Interestingly, minor SCFA, including isobutyrate, isovalerate and valerate, were 
only detected in animals fed control starch diets. There were no significant differences in 
isovalerate and valerate among groups in cecal, colonic and fecal samples (data not 
shown). Isobutyrate concentrations in the cecum were significantly greater in the rats fed 
w-CS and treated with saline (0.88 ± 0.26 µmol/g wet weight) or AOM (0.94 ± 0.30,) 
than in rats fed b-CS (0.35 ± 0.15 in saline group and 0.39 ± 0.28 in AOM group). There 
was no such difference in colonic and fecal samples.  
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3.6 Global Gene Differential Expression 
In the microarray analysis which compared colon mucosa samples collected from 
rats fed w-CS and injected AOM or saline, mRNA expression showed that a total of 6404 
genes were expressed differentially with fold changes 1.2 times or more and FDR less 
than 0.05. Of these 6404 genes, 3368 genes were up-regulated and 3060 genes were 
down-regulated, with 7% of the selected genes showing more than 2 fold change. Other 
selected genes had 1.2- 2 fold change (Table 5). 
 
In the microarray analysis which compared gene expression changes of the AOM-
treated rats after they were fed w-SAC compared with those fed w-CS, 1403 genes were 
identified to be differentially expressed with FDR < 0.05 and fold change > 1.2, among 
which 544 genes were up-regulated and 859 genes were down-regulated (Table 5). The 
majority of the selected genes (96%) showed moderate alteration in expression of fold 
change between 1.2 – 1.9.  Twenty genes showed a fold change between 2 - 4.9 with up-
regulated expression and 33 genes in this fold change range had down-regulated 
expression. 
 
Of the differentially expressed genes, 152 genes were differentially expressed in 
both the Microarray Analysis for AOM treatment and diet treatment with FDR < 0.05 and 
FC > 1.2 (Figure 6, 7). Among these common genes, 83% had a down-regulated 
expression in the diet study (AOM w-SAC compared against AOM w-CS, p-value < 
0.05) and an up-regulated expression in the AOM study (AOM w-CS compared with 
saline w-CS, p-value < 0.1). These genes were picked out as potential target genes related 
to the inhibitory effect of SAC on AOM induced preneoplastic lesions. Some of the target 
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genes that have reported connection to colorectal cancer were HSPD1, HSPH1, MCM6, 
Rac1, Cd55 and TFRC (Table 6A).  
 
 
3.7 Confirmation of Differential Gene Expression 
Semi-quantitative real-time PCR (qRT-PCR) analysis was conducted of 
expression levels of genes differentially expressed in the microarray experiment in rat 
colon with AOM or saline injections; and with w-CS or w-SAC diet feeding (Table 7). 
The expression levels of 3 genes (CACYBP, RhoA, and MAPK1) were confirmed from 
the microarray results that the expression levels of these genes were significantly 
increased in the AOM injected rats compared with saline injected rats when both groups 
were fed w-CS diet (P-value < 0.05). TOPBP1 was confirmed to have a decreased 
expression in the AOM treated w-SAC fed rats compared with rats fed w-CS (P-value < 
0.05). HSPH1, MCM6, and HSPD1 were confirmed to have both a decreased expression 
in the diet study (AOM w-SAC compared against AOM w-CS, P-value < 0.05) and an 
increased expression in the AOM study (AOM w-CS compared with saline w-CS, P-
value < 0.1). APC did not show significant expression changes.  
 
 
4. Discussion 
SAC is an amylose-lipid complex which is a newly developed type of resistant 
starch – RS5 (Hasjim et al., 2010). It is hypothesized that the lipid in the complex forms a 
single helical complex with linear molecules of amylose and keeps the starch granules in 
a more intact form and more resistant to enzyme hydrolysis. With each cooking method, 
SAC diets suppressed both the total ACF number and the total MDF number compared 
with HA or CS diet. The same conclusion was revealed by either proximal or distal total 
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ACF number or MDF number data. The results of total, proximal and distal large ACF 
numbers (crypts >= 4), suggested to have a greater potential to the cancer progress than 
small ACF, were consistent with the total ACF or MDF numbers. ACF multiplicity 
increased slightly but significantly in SAC compared with CS in either the whole 75 mm 
of colon observed, or either the proximal or distal portion of this colon segment. 
Interestingly, when we compared the two cooking methods, rats fed starches prepared by 
the bread-baking method had fewer total ACF, total MDF, or large ACF in all parts of the 
colon compared with rats fed starches prepared by the water-boiling method.  
 
In one of our previous studies, we compared water-boiled starch diets with 
uncooked starch diets. The resistant starch contents of the uncooked diets did not show 
any difference between the SAC and HA diets (12.2 + 0.7% in uncooked SAC compared 
with 13.2 + 0.8% in uncooked HA), and the water-boiling method obviously increased 
the differences between these two diets (25.8 + 5.0% in w-SAC against 14.3 + 3.0% in w-
HA) (Zhao et al., 2011). The resistant starch content values from this study also suggested 
that cooking is an important procedure for increasing the resistant starch content (32.7 + 
0.8% in b-SAC against 24.5 + 0.2% in b-HA), and this increasing trend might correlate 
with the enhanced inhibitory effect of SAC on colorectal carcinogenesis in F344 rats.  
 
The influence of the two cooking methods on the resistant starch contents might 
come from the properties of starch gelatinization procedure. Cooking starch is a starch 
gelatinization process requiring sufficient amounts of water and appropriate temperature 
when heating starch granules, which causes an irreversible change of a starch from semi-
crystalline structure to amorphous structure (Tester and Karkalas, 1996; Tufvesson et al., 
2003). In our water-boiled cooking process, water was sufficiently added to the starch 
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(water: starch >= 2.5:1, w/w), and the starch paste gained a water-boiled temperature of 
95°C. With the bread-baking cooking method, bread contained an insufficient percentage 
of water (34.2%) in the total weight. On the other hand, the bread baking temperature was 
204°C on the surface of the bread, while the internal temperature of the bread was around 
82 - 93°C. It is likely that a less complete starch gelatinization was gained in the bread 
than in the water-boiled paste. Starch gelatinization temperatures of SAC and HA were 
measured by Hasjim. SAC displayed a thermal transition from 78.9°C (TO) to 125.3°C 
(Tc), while HA showed a thermal transition from 70.4°C (TO) to 125.3°C (Tc) (Hasjim et 
al., 2009). For both SAC and HA, although the crust temperature of bread exceeded the 
starch gelatinization temperature, both the internal bread temperature and the water-
boiled paste temperature were lower than Tc, and the internal temperature of bread was 
not as high as the temperature of the water-boiled paste. Importantly, when the starch is 
heated with a limited amount of water, as was the case with the bread-baking procedure, 
the gelatinization temperature would be expected to increase. Research suggested that the 
less water content the starch retains, the higher temperature of the endotherm was 
required when purified potato starch granules were heated, and this shift to higher 
temperature was believed to be due to the decreased melting point of starch crystallites by 
solvent water (Donovan, 1979). Based on the fact that the bread-baking process contained 
an insufficient amount of water and increased gelatinization temperature, we believe the 
bread-baking method led to less adequate starch gelatinization so that less amylose-SA 
complex was dissociated than with water-boiled starches. Consequently, resistant starch 
content was higher in starch cooked by the bread-baking method than in the water-boiled 
starch for SAC or HA. In our study, rats fed bread-baked SAC or HA showed a dramatic 
reduction of either MDF number, or total ACF number and large ACF number compared 
with the rats fed water-boiled RS. Connecting the higher resistant starch content in bread-
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baked SAC and HA with their elevated inhibitory ability on colonic preneoplastic lesions 
compared with the water-boiled SAC and HA, respectively, it may imply that bread-
baked RS can gain a better carcinogenesis inhibitory effect than the water-boiled RS 
through obtaining a higher starch resistance by this cooking method. There was no 
significant difference in the resistant starch content of CS because the gelatinization 
temperature for CS is between 45°C and 75°C (Buckow et al., 2007). CS was expected to 
be completely gelatinized in either of the cooking methods.  
 
Other than the differences in the resistant starch content, differences also exited 
between water-boiled and bread-baked diet when comparing other ingredients. Water-
boiled diet reflected a modified AIN-93M maintenance purified diet, and the primary 
change was replacing cellulose with corn starch as was discussed in our previous study 
(Zhao et al., 2011). In the bread-baked diet, vitamins and minerals were included at lower 
levels (56% and 61% of what was present in the water boiled diets). It has not been 
reported if the reduced amount of vitamins and minerals will impact the colon 
preneoplastic lesions in a short time study. The present reports were focused on the effect 
of vitamin and mineral deficiency to the colon cancer occurrence in a long term 
observation. Of all the vitamins, Vitamin D deficiency has been widely associated with 
the incidence of colon cancer. In an animal study, the growth of MC-26 colon cancer 
xenografts in Balb/c mice was enhanced after these mice were fed Vitamin D deficient 
diet for 3 months (Tangpricha et al., 2005). Vitamin B-12-deficient diet was also 
observed to created aberrations in both base substitution and methylation of colonic DNA 
in weanling male Sprague-Dawley rats, which might increase susceptibility to 
carcinogenesis (Choi et al., 2004).Notably, none of the reports presented the effects on 
the low levels of multiple nutrition components or multiple deficiencies to the rat colon 
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carcinogenesis. Notably, in the studies mentioned above, the deficiency of the respective 
vitamin means none supplement of that vitamin in the diet at all. E.g. in the study by 
Tangpricha et al., a vitamin D–sufficient diet contained cholecalciferol of 500,000 IU/kg 
food, whilea vitamin D–deficient diet was identical except that it contained no 
cholecalciferol. In the study by Choi et al., vitamin B-12 (as cyanocobalamin) sufficient 
diet maintained 50 ug vitamin B-12/kg diet, while the deficient diet had the exact same 
diet without cyanocobalamin. In our study, no obvious signs of weight change, 
deficiency, sickness or abnormal activity of rats fed bread-baked diets were observed 
during the process of the study. Furthermore, bread-baked diet seemed to have a more 
significant inhibition of ACF and MDF than the water-boiled diet. This might be because 
the vitamin and mineral insufficiency was not severe, or the negative effect of the lower 
intakes did not appear because it was in a short-term study of 10 weeks. 
  
In our study, an increased apparent cecal fermentation (lower cecum pH and 
higher cecal content weight) of SAC comparing with HA or CS was observed within each 
cooking method. An increased SCFAs or individual major SCFA (butyrate, acetate, and 
propionate) were found in some SAC groups compared with CS groups. Although no 
reports have been found discussing the function of SCFAs in the cooked resistant 
starches, some previous studies showed the change in cecum fermentation and SCFAs in 
rats after they were fed heat-moisture treatment (HMT)-treated resistant starch. HMT is 
defined as a physical modification that involves treatment of starch granules. Three 
conditions are required for the treatment: 1) moisture < 35% moisture w/w, 2) 
temperature at 84 – 120 C, 3) treatment time at 15 min – 16h. Novelose 330 is a 
retrograded RS3 with RS content of 40.4%. A hydrothermal treatment was conducted 
with Novelose 330 to increase the RS content up to 75%. The fermentation of 
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hydrothermal-treated Novelose 330 produced higher concentrations of short chain fatty 
acids and butyrate than untreated Novelose 330. Furthermore, the fermentation of 
hydrothermal-treated Novelose 330 was shown to occur beyond the caecum and 
throughout the colon, yet the fermentation of untreated Novelose 330 occurred in the 
caecum and proximal colon. Total bile acid concentration increase was strongly inhibited 
in hydrothermal-treated Novelose 330, which in turn was related to the low pH and high 
concentrations of butyrate. Since bile acid, especially some secondary bile acids like 
deoxycholic acid (DCA) and lithocholic acid (LCA), has been reported to be implicated 
in the promotion of colon tumorigenesis in animals and man, the low pH and high 
butyrate concentration may indicate a protection of the mucosa of the distal colon from 
toxic and inflammatory damage (Jacobasch et al., 2006). 
   
Putative targets of w-SAC that may be involved in the reduction of prenoeplasia 
were identified as genes that were up-regulated by AOM induction (compared with 
saline) and down-regulated by w-SAC intake (compared with w-CS), such as HSPH1, 
MCM6, Rac1, CD55, TFRC and HSPD1. Of these genes, Rac1 is a key gene in several 
pathways, such as Rac1/PAK1 and ILK/IQGAP1/Rac1 signaling transduction pathway, 
and enhances colon cancer cell migration and invasion (Zhu et al., 2011; Tang et al., 
2011; Wang et al., 2010). CD55 is a decay accelerating factor and considered a colon 
cancer marker (Bjørge and Jensen, 1996; Koretz et al., 1992). Tfrc is a target gene of Wnt 
pathway, which regulates development, cell growth and proliferation (Röhrs et al., 2009). 
MCM6 has been reported as a biomarker of cell proliferation and its expression has been 
observed to relate to cutaneous melanoma, Merkel cell carcinoma, and lung cancer (Nioi 
et al., 2008; Gammbichler et al., 2009; Kadara et al., 2009). MCM6 also played a critical 
role in regulating the initiation of DNA replication and cell cycle in the butyrate induced 
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cell cycle arrest in bovine cells (Li and Li, 2008). HSPD1 is an apoptosis-related gene and 
has been reported to be overexpressed in human colon cancer tissues, human gastric 
carcinoma cell line, and human ovarian cancer cell line (Jung et al., 2011; Nagahama et 
al., 2008; Li et al., 2010). HSPH1 was also reported to be overexpressed in squamous cell 
carcinoma (Muchemwa et al., 2006). Meanwhile, a few other genes, i.e. CD48, were 
down-regulated by AOM induction and up-regulated by w-SAC intake. CD48 is an 
immune response gene and a member of NF-kappa B gene family (Ramos et al., 2011). 
CD48 can increase the immunogenicity on some poorly immunogenic tumors in mice 
when combined to B7-1 (Li et al., 1996). 
 
Our study indicated for the first time that the preneoplastic lesions (ACF and 
MDF) were inhibited by SAC diet prepared by either of the two cooking methods, water-
boiling and bread-baking, at the promotion stage in male Fisher 344 rats. This is the first 
report in the literature where different cooking methods were compared for their 
inhibitory effects on the preneoplastic lesions. A genome-wide microarray expression 
analysis was also conducted, and promising genes for inhibiting colon carcinogenesis by 
SAC intake were identified. Further studies are needed to explain the impact of different 
starch cooking methods on colon tumorigenesis and the application of the promising 
genes in the prevention of colon cancer, so that humans can benefit from improved 
dietary strategies for colon cancer prevention. 
 
Abbreviations  
ACF, Aberrant Crypt Foci 
AOM, Azoxymethane 
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CS, Control cornstarch diet 
FC, Fold Change 
FDR, False Discovery Rate 
HA, High amylose cornstarch diet 
MDF, Mucin Depleted Foci 
RS, Resistant starch 
SAC, Stearic acid complexed high-amylose cornstarch diet 
SCFAs, Short chain fatty acids 
w-, Water-boiled  
b-, Bread-baking  
 
Safety 
Azoxymethane is a potent carcinogen to induce colon cancer in rats and mice. It might 
cause harm to humans if swallowed, inhaled or absorbed through skin.  
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Figure Captions 
 
Fig. 1.  Cecal weight and pH measured when rats were killed  
(9 weeks after the first AOM injection; n = 5 for saline-injected rats in each diet group, n 
= 10 for AOM-injected rats in each diet group ):   
A. Cecal tissue weight (g); B. cecal content weight (g); C. cecal content pH. 
Values are means +SD. 
a,b,c,d,e,f.
 bars with different letters in each panel are significantly 
different at P-value < 0.05. One sample was collected from each rat. Five samples were 
collected from saline-injected rats and 10 from AOM-injected rats in each diet group.
 
Fig. 2.  Colon lesion numbers and multiplicities in rats fed water-boiled or bread-
baked starch diets killed 9 weeks after the first AOM injection (n = 5 for saline-
injected rats in each diet group, n = 10 for AOM-injected rats in each diet group):   
A. total ACF number; B. ACF multiplicity; C. total MDF number. The ACF and MDF 
were measured in the distal 75mm of the colon from anus. 
ACF were only seen in AOM-treated rats. Values are means +SD. 
a,b,c,d.
 bars with 
different letters in each panel are significantly different at P-value < 0.05. One sample 
was collected from each rat. Five samples were collected from saline-injected rats and 10 
from AOM-injected rats in each diet group. 
Fig. 3  Proximal colon lesion numbers and multiplicities in rats fed water-boiled or 
bread-baked starch diets killed 9 weeks after the first AOM injection (n = 5 for 
saline-injected rats in each diet group, n = 10 for AOM-injected rats in each diet group):   
A. proximal total ACF number; B. proximal ACF multiplicity; C. proximal total MDF 
number.  
ACF were only seen in AOM-treated rats. Values are means +SD. 
a,b,c,d.
 bars with 
different letters in each panel are significantly different at P-value < 0.05. One sample 
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was collected from each rat. Five samples were collected from saline-injected rats and 10 
from AOM-injected rats in each diet group. 
 
Fig. 4.  Distal colon lesion numbers and multiplicities in rats fed water-boiled or 
bread-baked starch diets killed 9 weeks after the first AOM injection  
(n = 5 for saline-injected rats in each diet group, n = 10 for AOM-injected rats in each 
diet group):   
A. distal total ACF number; B. distal ACF multiplicity; C.distal total MDF number.  
ACF were only seen in AOM-treated rats. Values are means +SD. 
a,b,c,d.
 bars with 
different letters in each panel are significantly different at P-value < 0.05. One sample 
was collected from each rat. Five samples were collected from saline-injected rats and 10 
from AOM-injected rats in each diet group. 
 
Fig. 5.  Large ACF numbers and multiplicities in rats fed water-boiled or bread-
baked starch diets killed 9 weeks after the first AOM injection (n = 5 for saline-
injected rats in each diet group, n = 10 for AOM-injected rats in each diet group):   
A. proximal large ACF number; B. distal large ACF number; C. total large ACF number. 
The ACF was measured in the distal 75mm of the colon from anus. 
ACF were only seen in AOM-treated rats. Values are means +SD. 
a,b,c.
 bars with different 
letters in each panel are significantly different at P-value < 0.05. One sample was 
collected from each rat. Five samples were collected from saline-injected rats and 10 from 
AOM-injected rats in each diet group.  
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Fig. 6. Numbers of common genes that were differentially expressed under each 
respective treatment group when compared to respective control. N = 10 in either 
AOM w-SAC rat group or AOM w-CS rat group for the comparison of gene expression 
level impacted by the diet treatment (n = 6 from one experiment; n = 4 from another 
experiment; Colon tissues were collected from distal session of the colons from each 
experiment). For the analysis of gene expression change caused by AOM induction, n = 
10 in AOM w-CS rat group (n = 6 from distal colon tissue; n = 4 from adjacent colon 
tissue), and n = 9 in saline w-CS rat group (n = 6 from distal colon tissue; n = 3 from 
adjacent colon tissue). 
 
Fig. 7. Heat map showing the differential expression of the genes impacted by the 
AOM treatment (AOM vs. saline) and the diet treatment (w-SAC vs. w-CS) with 
FDR < 0.01 and FC > 1.5 for each of the treatment groups. 
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Fig. 2 
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Tables 
Table 1A: Ingredients for the Water-boiled Starch Diet and Bread-baked Starch 
Diet
1
. 
 
Diet Ingredient 
water-boiled 
starch diet 
bread-baked 
starch diet 
starch 55.00% 55.00% 
Bread flour - 22.06% 
wheat Gluten - 10.98% 
Shortening - 3.63% 
Yeast - 0.74% 
Salt - 0.56% 
casein 20.00% - 
Dextrose 15.00% - 
mineral mix (AIN-93) 3.50% 2.00% 
choline 0.20% 0.14% 
methionine 0.30% 0.16% 
vitamin mix (AIN-93) 1.00% 0.55% 
L-lysine - 0.43% 
DL-trypthophan - 0.05% 
L-histidine - 0.20% 
DL-threonine - 0.20% 
corn oil 5.00% 3.30% 
 
1
Starches were purchased from Cargill Inc., Minneapolis, MN and processed and/or 
cooked as described in the text. All non-starch diet ingredients in both experiments were 
purchased from Harland Teklad (Madison, WI) or Sigma-Aldrich (St. Louis, MO). 
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Table 1B. Nutrient Compositions of the Water-boiled Diet or Bread-baked Diet 
Ingredient
1 
 
Nutrient Constituent 
water-boiled 
diet (%) 
bread-baked 
diet (%) 
Protein 20.3 12.51 
starch 55 55.00 
salt - 0.56 
mineral(AIN-93) 3.5 2.13 
choline bitartrate 0.2 0.14 
vitamin mix  (AIN-93) 1 0.56 
Total lipid (fat) 5 7.56 
other carbohydrate 15 20.43 
other Fiber, total dietary - 0.79 
Sugars, total - 0.07 
Ash - 0.26 
 
Table 1C. Amino Acid Composition of Water-boiled Diet and Bread-baked Diet 
Ingredient
1,2
 
Amino Acid Constituent 
water-boiled diet 
bread-baked 
diet 
AIN-93M Ingredient 
amino acid 
composition 
(%) (%) (%) 
Alanine 0.56 0.32 0.39 
Arginine 0.70 0.58 0.49 
Aspartic acid 1.29 0.51 0.9 
Cystine 0.33 0.25 0.23 
Glutamic acid 4.09 4.54 2.86 
Glycine 0.39 0.46 0.27 
Histidine 0.51 0.49 0.36 
*Isoleucine 0.96 0.57 0.67 
*Leucine 1.73 0.96 1.21 
*Lysine 1.46 1.12 1.02 
*Methionine 0.51 0.40 0.36 
*Phenylalanine 0.96 0.68 0.67 
Proline 2.36 1.60 1.65 
Serine 1.10 0.61 0.77 
*Threonine 0.77 0.55 0.54 
*Tryptophan 0.21 0.19 0.15 
Tyrosine 1.01 0.39 0.71 
Valine 1.14 0.60 0.80 
 
* Essential amino acids 
1The nutrient compositions of the bread-baked diet ingredient was caculated based on the USDA National Nutrient 
Database for Standard Reference. 
2The amino acid composition of wheat gluten was cacluated based on the publication of Wookey N (Wookey, 1979). 
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Table 2. Primer Sequences for Differentially Expressed Genes Confirmed by 
Quantitative Real Time PCR 
 
gene 
 
Primer Sequence 
APC Forward 5’- GTCCCCCGTGTACTTTTTCA -3’ 
 
Reverse 5’- GAGCACTGTGGGGATATGGT -3’ 
   
CACYBP Forward 5’- AGAAGAGGTCAAAGTGCTGCTGGA -3’ 
 
Reverse 5’- ACCCTGTTGTAAGAGGAGCAACCA -3’ 
   
Rhoa Forward 5’- TGCCCATCATCCTAGTTGGGAACA-3’ 
 
Reverse 5’- AGCGCCAATCCTGTTTGCCATATC -3’ 
   
MAPK1 Forward 5’- GCGCTACACCAACCTCTCGT -3’ 
 
Reverse 5’- CACGGTGCAGAACGTTAGCTG -3’ 
   
MCM6 Forward 5’-AAGTAT TCCCCGGAGTTTAGA GG-3’ 
 
Reverse 5’-GACACCGCGTTT TACTTCATCATT-3’ 
   
HSPD1 Forward 5'-TCACCGGAAGCCCTTGGTCATAAT-3' 
 
Reverse 5'-ACCCTGGAGCTTTGACTGCTACAA-3' 
   
TOPBP1 Forward 5'-TCATGTCAGCAACCTCCATCGTGA-3' 
 
Reverse 5'-TTCATTCTGGGAGGGCTCTGTGTT-3' 
   
HSPH1 Forward 5'-TTAGCGTGGAGCAGATAACAGCCA-3' 
 
Reverse 5'-GTCATTCATGAGCCGCAAGCAGTT-3' 
   
GAPDH Forward 5’-GGGTGGTGCCAAAAGGGTC-3’ 
 
Reverse 5’-GGAGTTGCTGTTGAAGTCACA-3’ 
   
The primers used to confirm differentially expressed genes were designed using the 
software PrimerQuest (Integrated DNA Technologies, Inc., Coralville, IA). 
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Table 3. Resistant Starch Contents and Water Content of the Three Diets Prepared 
by Two Methods. 
Starch 
Groups 
Resistant Starch Content on Dry Diet 
Basis 
(% + sd) 
Moisture Content of the 
Diets 
(% + sd) 
b-CS 2.6 + 0.1
e
 52% + 2%
b
 
b-HA 24.5 + 0.2
c
 50% + 0
b
 
b-SAC 32.7 + 0.8
a
 49% + 1%
b
 
 
w-CS 2.9 + 0.2
e
 60% + 1%
a
 
w-HA 16.4 + 1.2
d
 53% + 2%
b
 
w-SAC 27.2 + 0.1
b
 49% + 1%
b
 
 
  
Data are expressed as mean + SD (n = 3). Resistant starch contents of diets were 
measured by AOAC method 991.43.  
a,b,c,d,e Indicates values in each column with different letters are significantly different 
at P-value < 0.05. 
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Table 5. The Distribution for Fold Change of Gene Expression. 
  
Fold Change 
 
  
1.2-1.5 1.5-2 2-5 
5-
10 
total 
AOM w-CS vs. saline 
w-CS (FDR < 0.05) 
up-regulated genes 2036 949 379 4 3368 
down-regulated 
genes 
2468 510 82 0 3060 
AOM w-SAC vs. 
AOM w-CS (FDR < 
0.05) 
up-regulated genes 435 89 20 0 544 
down-regulated 
genes 
708 118 33 0 859 
 
 
 
Table 6A.  Some Genes Differentialy Expressed Caused by Both AOM Treatment and 
w-SAC Diet Feeding. Fold Changes (FC) are More Than 1.2 for Either Up- or Down-
regulations for All the Genes.  
Gene Title 
Gene 
Symbol 
AOM treatment diet treatment 
FC P.Value 
q. 
value 
FC P.Value 
q. 
value 
heat shock protein 1 
(chaperonin) 
Hspd1 1.91 0.009 0.045 0.83 0.000 0.007 
heat shock 105kDa/110kDa 
protein 1 
Hsph1 1.84 0.000 0.003 0.56 0.000 0.014 
minichromosome maintenance 
deficient 6 (MIS5 homolog, S. 
pombe) (S. cerevisiae) 
Mcm6 1.85 0.002 0.019 0.59 0.000 0.003 
ras-related C3 botulinum toxin 
substrate 1 
Rac1 1.25 0.012 0.028 0.81 0.172 0.236 
CD55 antigen Cd55 6.16 0.000 0.000 0.81 0.193 0.251 
transferrin receptor Tfrc 3.35 0.000 0.000 0.57 0.000 0.008 
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Table 6B. Some Genes Differentialy Expressed Caused by AOM or Diet Treatment. 
Fold Changes are More Than 1.2 for Either Up- or Down-regulations for All the 
Genes.   
Gene Title Gene Symbol 
AOM treatment 
FC P.Value q 
calcyclin binding protein Cacybp 3.10 0.000 0.000 
ras homolog gene family, member A Rhoa 2.13 0.000 0.000 
mitogen activated protein kinase 1 Mapk1 2.15 0.000 0.000 
adenomatosis polyposis coli Apc 1.66 0.000 0.000 
Janus kinase 1 Jak1 3.33 0.000 0.000 
Janus kinase 2 Jak2 2.13 0.000 0.000 
signal transducer and activator of 
transcription 1 
Stat1 2.26 0.000 0.000 
v-raf murine sarcoma 3611 viral oncogene 
homolog 
Araf 1.37 0.019 0.038 
eukaryotic translation initiation factor 4, 
gamma 2 (predicted) 
Eif4g2_predicted 4.04 0.000 0.000 
phosphatidylinositol 3-kinase, catalytic, 
beta polypeptide 
Pik3cb 1.66 0.000 0.000 
v-Ki-ras2 Kirsten rat sarcoma viral 
oncogene homolog 
Kras 1.36 0.028 0.050 
CD9 antigen Cd9 2.37 0.003 0.012 
CD38 antigen Cd38 2.36 0.001 0.006 
CD59 antigen Cd59 2.92 0.000 0.000 
CD55 antigen Cd55 6.16 0.000 0.000 
CD48 antigen Cd48 0.81 0.415 0.283 
caspase 8 Casp8 2.41 0.000 0.000 
caspase 3, apoptosis related cysteine 
protease 
Casp3 3.40 0.000 0.000 
interleukin 1 alpha Il1a 2.23 0.001 0.007 
transferrin receptor TFRC 3.35 0.000 0.000 
     
Gene Title Gene Symbol 
Diet treatment 
FC P.Value q 
topoisomerase (DNA) II beta binding 
protein 
Topbp1 0.76 0.045 0.050 
FC stands for Fold Change 
    Fold change of AOM treatment reflects the multiple on gene expression level of AOM 
w-CS compared with that of saline w-CS. Fold change of diet treatment reflects the 
multiple on gene expression level of AOM w-SAC compared with that of AOM w-CS.  
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Table 7. Quantitative Real-time PCR Analysis of the Expression Levels of Genes 
Affected by AOM or Diet to Confirm Microarray Results (Data represent means + 
standard deviation) 
 
Gene 
Effect 
Compared 
real-time 
PCR 
analysis 
p-
value 
Gene 
Expression 
Level 
Confirmed 
Microarray 
Results 
gene differential 
express by 
AOM treatment 
(n = 10) 
CACYBP 
AOM w-CS vs. 
saline w-CS 
-3.45 + 
2.27 
0.0150 increase Yes 
RhoA 
AOM w-CS vs. 
saline w-CS 
-2.84 + 
2.52 
0.0411 increase Yes 
MAPK1 
AOM w-CS vs. 
saline w-CS 
-3.36 + 
2.46 
0.0243 increase Yes 
APC 
AOM w-CS vs. 
saline w-CS 
-2.26 + 
2.96 
0.4379 no change No 
gene differential 
express by w-
SAC treatment 
(n = 9) 
TOPBP1 
AOM w-SAC 
vs. AOM w-CS 
1.50 + 
1.34 
0.0031 decrease Yes 
gene differential 
express by both 
AOM and w-
SAC treatments 
(n = 10) 
HSPH1 
AOM w-SAC 
vs. AOM w-CS 
1.56 + 
1.29 
0.0015 decrease Yes 
AOM w-CS vs. 
saline w-CS 
-1.27 + 
1.30 
0.0073 increase Yes 
MCM6 
AOM w-SAC 
vs. AOM w-CS 
1.64 + 
1.68 
0.0347 decrease Yes 
AOM w-CS vs. 
saline w-CS 
-1.37 + 
1.59 
0.074 increase Yes 
HSPD1 
AOM w-SAC 
vs. AOM w-CS 
0.91 + 
1.28 
0.0503 decrease Yes 
AOM w-CS vs. 
saline w-CS 
-0.81 + 
1.27 
0.0767 increase Yes 
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Supplement 
 
Pathways that were significantly enriched by either AOM/saline treatments or 
different diet treatments were picked out by DAVID 7. Up-regulated signaling pathways, 
such as Jak-STAT signaling pathway, Cancer related pathways, Apoptosis, Natural killer 
cell mediated cytotoxicity, Focal adhesion, RIG-I-like receptor signaling pathway, 
Alzheimer's disease pathway, may be important pathways for the induction of 
preneoplasia by AOM (Table supplement 1). 
 
Pathways were also clustered by genes affected by feeding w-SAC against w-CS in 
AOM-induced rats. DNA replication, ABC transporters, cell cycle and RNA degradation 
pathways were discovered from the down-regulated genes all with a p-value less than 
0.05. The up-regulated genes in the diet effect genes were clustered mainly as lipid or 
carbohydrate metabolism pathways. Some other pathways involved in cell cycle (oocyte 
meiosis pathway, p-value < 0.03) or immune activity (graft-versus-host disease pathway, 
p-value < 0.1) were also clustered (Table supplement 1).   
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Abstract 
 
Guat209 (Guat) and AR16035 (AR) are two corn lines both from Latin American 
exotic populations. These two corn lines were crossed to form a new line ARXGuat. Guat 
is a resistant starch (RS) with 34.5% of resistant starch content, while AR and ARXGuat 
hold low resistant starch content of 1.2% and 1.9%, respectively. The prevention abilities 
of both water-boiled Guat and ARXGuat on preneoplastic lesions in the colons of 
azoxymethane (AOM)-treated Fisher344 rats were compared with water-boiled AR. Each 
starch composed 55% of the diet and was fed to the AOM-induced rats for 8 weeks. Our 
study showed a notable increase in the weights of the cecal content and cecal tissue, and a 
decreased cecum pH in the Guat-fed rats compared with those in the AR- or ARXGuat-
fed rats.  A slight increase of crypts/foci was observed in the AOM-injected rats fed Guat 
compared with those fed the other two diets. No differences in aberrant crypt foci (ACF) 
and mucin depleted foci (MDF) numbers, as well as aberrant crypt (AC) numbers were 
seen among the groups.  This study suggested no inhibitory effect of cooked starches 
from either the inbred corn line Guat or hybrid corn line ARXGuat on AOM induced 
colorectal preneoplastic lesions induced in Fisher 344 rats.  
 
 
Introductions 
 
Colorectal cancer (CRC) is one of the most prevalent cancers in western countries 
and is rapidly increasing in developing countries. CRC is the third most common cancer 
in both men and women In the United States (American Cancer Society, 2010). It has 
been commonly believed that the incidence of CRC is greatly affected by food intake. 
Diets with RS have been reported to reduce CRC. Several studies have observed 
suppression of colon cancer or precancerous biomarkers by dietary resistant starch or 
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other dietary fibers in rat models (Le Leu et al., 2007a; Le Leu et al., 2007b; Clarke et al., 
2008; Jacobsen et al., 2006; Caderni et al., 1994; Thorup et al., 1995). In other studies, 
indirect evidence was shown for the protective role of RS on CRC incidence both in rat 
studies and in human trials. In AOM-injected Sprague–Dawley rats fed high amylose 
cornstarch, increased fecal and cecal fermentation and concentrations of short chain fatty 
acids (SCFA), as well as a decreased cell proliferation in the colonic epithelium, were 
observed, which might indicate a correlation between the inhibitory effects of RS on CRC 
and the cecal physiological changes after RS intake (Le Leu et al., 2003). Studies of bile 
acids and secondary bile acids, two CRC promoting agents, were also among some of the 
indirect evidence. The concentration of bile acids and secondary bile acids were 
significantly reduced in colonic adenoma(s) removed patients after the intake of 45 g 
native amylomaize starch (resistant starch content of the starch was 62%) for 4 weeks, 
compared with control starch intake (45 g of maltodextrin) (Grubben et al., 2001). The 
impact of resistant starch intake on colon cancer, however, remains controversial because 
some studies did not find protective effects of these carbohydrates against colon 
carcinogenesis (Caderni et al., 1991; Sakamoto et al., 1996; Young et al., 1996).   
Resistant starch is a dietary starch that is not digested and absorbed in the small 
intestine, but fermented in the large intestine instead.  Resistant starch can be classified 
into four main types: RS1 to 4. The RS5 classification was newly introduced (Hasjim et 
al., 2010). Resistant starch1 is physically entrapped starch such as coarsely milled grain. 
RS2 comprises starches highly resistant to α-amylases digestion by their nature. High 
amylose corn starch is rich in RS2. RS3 includes starches retrograded by a cook-and-cool 
process. RS4 are chemically modified starches, and RS5 are a complex of amylose and 
lipid. 
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AR and Guat are derivatives of the Argentine and Guatemala corn landrace and were 
inbred respectively (work conducted in the Department of Food Science and Human 
Nutrition, Iowa State University and Agricultural Research Service, U.S. Department of 
Agriculture).  Guat is an exotic population with the amylose content up to 70% and is 
considered RS, but this cornline is not high in yield. AR was derived from a high-yielding 
Latin American exotic population and is known as digestive starch. Crosses were made 
between AR and Guat corn lines, and a new corn line, ARXGuat, was formed.  This 
hybrid, ARXGuat, was hoped to retain both the high-yield from AR and the high resistant 
starch content from Guat. One important gene that may hold the high RS trait of Guat is 
the mutant of branching enzyme 1 gene (Sbe1). Corn starch with sbe1a mutant was 
reported to alter molecular structures resulting in a better resistance to pancreatic α-
amylase, β-amylase, and isoamylase than wt starch (Xia et al., 2011). This mutant of Sbe1 
was expected to be inherited from Guat to ARXGuat so that the hybrid starch can retain 
the high RS property from Guat. In our test of resistant starch content, Guat contained 
34.5% of resistant starch, yet AR and ARXGuat were low in resistant starch content 
(1.2% and 1.9% respectively). The research reported here tested the hypothesis that both 
the inbred corn line Guat and the hybrid ARXGuat could inhibit colon preneoplastic 
lesions, ACF and MDF, in the colon of carcinogen-induced rats. All three starches were 
cooked by a water-boiling procedure in this study based on our previous observation that 
the cooking procedure could improve the impact of resistant starch against colon 
carcinogenesis, and starchy food are commonly served to humans cooked (Zhao et al., 
2011). 
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Materials and Methods 
 
Diets. AR, Guat, and ARXGuat were cooked by a water-boiling method and then mixed 
with other components into diets. The diet formulation was based on the standard diet 
recommended by the American Society for Nutritional Sciences for mature rats (AIN-
93M) (Reeves, 1997), but the 5% cellulose in the AIN-93M was not included and the 
starch content was increased by this amount. Thus the proportion of the starch reached 
55% (Table 1). The boiling procedure was described in a previous study (Zhao et al., 
2011). Diets were made and fed fresh to the rats every two days. The resistant starch 
contents of the starches and diets were measured fresh by AOAC method 991.43 
(Horwitz, 2003). The -water content of these samples was determined by a Sartorius 
moisture analyzer MA30 (Bohemia, NY). The resistant starch contents and water contents 
were listed in Table 2.  
 
Animals and Housing.Forty-five five-week-old male Fischer 344 (F344) rats were 
obtained from Charles River laboratory (Wilmington, MA). Each rat was housed 
individually in a plastic cage with stainless-steel, wire-mesh top, and a stainless-steel wire 
floor was placed on the bottom of each cage to prevent the rats from eating their own 
feces. The temperature of the animal room was 22+1
o
C and relative humidity at 
60%+5%, and fluorescent lights were on from 6 AM to 6 PM. Diet and water were 
provided ad libitum. The animal studies were performed in compliance with the 
guidelines of The Institutional Animal Care and Use Committee of Iowa State University. 
 
Carcinogen Treatment. AOM was purchased from Midwest Research Institute (Kansas 
City, MO) and injected at the dosage of 20 mg AOM/Kg rat body weight (n=30 rats). The 
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rats were injected intraperitoneally one week after they arrived. A second injection was 
followed 1 week later. The remaining rats were injected with physiological saline as 
negative controls (n = 15). 
 
Diet Treatment. AR was fed to all the rats from the day they arrived until 3 days after 
the second AOM injection. Then the rats were divided randomly into 3 diet groups with 
15 rats in each diet group (10 AOM-injected rats and 5 saline-injected rats) and fed the 
respective diets for 8 weeks. Body weight was measured weekly. Food disappearance was 
measured by calculating the difference between the amount that was fed to the rats and 
the amount that remained at the end of each feeding time. The rats were then euthanized 
by CO2. 
 
Cecal Weight and pH. Right after the rat died, its cecum was collected and weighed as 
cecal weight with contents. The cecum was then cut open and cecal contents were scraped 
off from the cecal tissue to measure the cecal pH. Then the cecum tissue was rinsed in 
phosphate buffered saline, quickly dried with a paper towel and weighed as the cecal 
tissue weight. The difference of the cecal weight with content and cecal tissue weight was 
calculated as cecal content weight.  The liver was also removed and weighed.  
 
Aberrant Crypt Foci and Mucin Depleted Foci. The rinsed colons were cut open 
longitudinally, laid flat, and flushed with saline. The distal 50 mm were trimmed and 
fixed in 10% formalin for 24 hours before they were made into specimens. Colons were 
stained with 1% alcian blue in acetic acid (pH 2.5), then counterstained with 1% neutral 
red to view ACF and MDF using a light microscope.  
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Statistical Analysis. Body weight, food disappearance, liver weight, cecal endpoints, 
ACF and MDF number, as well as average crypts/foci were analyzed using Two-way 
AVONA performed through GLM Procedure in SAS (SAS Institute, 2010). One-sided t-
tests were then applied to test the significant differences between groups. All values were 
reported as mean + standard deviation and P-value < 0.05 was considered significant.  
 
Results 
Resistant Starch Content of the Experimental Diets.Resistant starch content of the AR, 
Guat, and ARXGuat were 5.4 + 0.5%, 18.6 + 0.9%, and 8.6 + 0.6% on the dry diet weight 
of the diets, respectively. The water contents of the 3 diets were 20.0 + 0.9%, 14.1 + 0.9% 
and 13.0 + 1.0%, respectively. For the starches, the resistant starch contents are 1.2 + 
0.1%, 34.5 + 2.0% and 1.9 + 0.1% for AR, Guat, and ARXGuat, respectively. Three 
samples were randomly selected and measured for each diet group (Table 2).  
 
Body Weight, food Disappearance and Liver Weight. No significant differences were 
seen in the body weight gain or food disappearance over the period of 8 weeks. An 
average body weight gain was 175 + 6 g, and the average daily food disappearance of rats 
was 15.2+1.4 g/day. No effects of diet or AOM were observed on rat liver weight. 
 
Cecum Weight and Ph. Results of total cecal weight with content, cecal tissue weight 
and cecal content weight were consistent in that rats fed Guat always had significantly 
elevated weights compared with the rats fed AR or ARXGuat within either AOM-treated 
groups or saline-treated groups.  Significantly higher cecal tissue weight was also seen in 
AOM-injected rats fed ARXGuat compared with those fed AR. Other than these, no 
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differences of cecal weight were observed between AR and ARXGuat fed rats (Figure 
1B, C and D).  
Cecal content pH was significantly decreased in the cecum of rats fed Guat compared 
with the rats fed the other 2 diets whether AOM or saline were injected. Azoxymethane-
treated rats fed ARXGuat had a statistically significant decreased cecal content pH 
compared with  those fed AR, but the same trend of decreased cecal content pH in the 
ARXGuat fed rats compared with the AR fed rats was not seen in the saline-injected 
groups  (Figure 1A).      
 
Aberrant Crypt Foci and Mucin Depleted Foci. ACF and MDF were only seen in the 
colons of AOM-treated rats. Rats fed Guat showed a small but statistically significant 
increase in average crypts/foci in their colon samples compared with those fed the other 2 
diets (Figure 2B). A 37% decrease of ACF number was observed in the colon sample 
from AOM-treated Guat rat group when compared to the AR-fed rats, and a 26% of 
decrease trend was also seen in the ARXGuat group compared to the AR group, yet 
neither of these decreases were significant (Figure 2A and 2B). The total AC number, 
which is a multiple of ACF number and average crypts/foci, did not show significant 
differences between the rats fed 3 diets,  although the total AC number in the AR group 
was 30-40% higher than in the ARXGuat or Guat group (Figure 2D). No differences in 
the MDF number were observed (Figure C). 
 
Discussion  
The results of this study showed that feeding rats with ARXGuat did not 
significantly alter the yield of ACF or MDF numbers, and only the average number of 
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crypts/foci was somewhat elevated in the Guat-fed rat colon. Since there was actually a 
reduced trend of ACF number in the Guat group compared with the other two diet groups, 
the total AC number was not elevated in the Guat group against AR or ARXGuat groups.  
On the other hand, MDF was considered a subgroup of ACF that may predict tumor 
outcome better than ACF (Caderni et al., 2003; Femia et al., 2003). In our study, although 
a decreased trend of the numbers of ACF, MDF and AC was seen with the increased 
resistant starch content in the diets, no significant differences were observed, suggesting 
that the preneoplastic lesion rate was not altered by Guat or ARXGuat starch in AOM-
induced Fisher 344 rats compared with the normal control cornstarch AR. Meanwhile, 
Crypts/foci is a measurement of the ACF size, which was considered more related to the 
malignant potential of CRC than ACF number (Osawa et al., 2002; Pierre et al., 2003). A 
study of the predictable feature of ACF size on polyp histopathology was conducted on 
patients undergoing routine colorectal cancer screening over a 31-month period (20 
crypts/ACF as small ACF; 20-100 crypts/ACF as medium; >100 crypts/ACF as large). 
The study showed that small flat ACFs correlated with the occurrence of distal adenomas, 
and large raised ACFs were more of a precursor of hyperplastic polyps (Kim et al., 2008). 
In our study, although the ACF size slightly elevated in the Guat-fed rat group after AOM 
treatment, ACF sizes assessed from the rats fed all of the 3 diets fell in the range of small 
ACFs. We thus believe ACF size in rats fed either Guat or the other two diets prone to 
present the potential of these preneoplastic lesions to form distal adenomas.  
Rats fed Guat starch diet had increased cecal tissue and content weight, and decreased 
cecal content pH compared with those fed AR or ARXGuat starch diets. The increased 
cecal weight and decreased cecal pH were previously reported as a result of the 
fermentation of RS and production of SCFAs in the rat colon by gut bacteria. In a 
previous study, a diet containing 16.7% potato starch (RS 1) or 66.7% modified potato 
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starch (RS 2) to male Wistar rats increased rat cecal and fecal SCFA, and stimiulated the 
growth of bifidobacteria compared with basel diet (60% waxy maize). A significant 
increase in total culturable bacteria, lactobacilli, streptococci, and enterobacteria was also 
observed in RS2 treated animals (Kleessen et al., 1997). Cecal weight gain was also 
observed in Sprague-Dawley rats after they were fed high amylose resistant cornstarch 
(Keenan et al., 2006).  In our study, Guat maintains statistically higher resistant starch 
content than the other two starches, thus a stronger fermentation may occur in the Guat-
fed rats and caused a decreased cecal pH and increased cecal weights.  This high 
fermentation may relate to increased SCFAs. Meanwhile, SCFA, especially butyrate, was 
reported as an inhibitor of CRC through the regulation of proliferative, differentiation and 
apoptosis (Inagaki and Sakata, 2005; Kruh, 1982; Smith, 1986), but this link between the 
increased SCFA accumulation and reduced preneoplastic lesions was not seen in our 
study. It might be because the resistant starch content is not high enough to produce 
sufficient SCFA that can inhibit carcinogenesis, but is this assumption correct, or what is 
a ‘sufficient’ amount of resistant starch content or SCFA content is not known yet. In our 
study, the resistant starch content of water-boiled Guat diet was 18.6 + 0.9%, which was 
similar to the resistant starch content of water-boiled HA diet in the last study (see 
Chapter 3) where the resistant starch content of the w-HA was 16.4 + 1.2%. Comparing 
with their respective normal starch diet controls, rats fed either diet had an increased cecal 
weight, but neither of the groups of rats fed these diets experienced a decrease in the 
ACF/MDF numbers. This provided some evidence for our assumption that diets much 
contain a certain amount of resistant starch in order to inhibit colon carcinogenesis. 
In conclusion, Guat did not show inhibitory abilities on ACF and MDF, the two 
colorectal preneoplastic lesions, although Guat contains significantly higher resistant 
starch content than either ARXGuat or AR starch. Not surprisingly, rats fed ARXGuat did 
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not show any inhibition of preneoplastic lesions against rats fed AR, which might be 
related to the fact that the hybrid cornline ARXGuat did not increase the resistant starch 
content compared with either of its parent cornlines, either as raw starch or after cooked 
and made into diets. Guat diet feeding to the rats resulted in a decreased cecal content pH 
and increased cecal weights (cecal tissue weight, cecal weigh with content and cecal 
content weight), suggesting a fermentation process undergoing by gut microflora. This 
feature of Guat gives us a hint that Guat might be able to bring benefits to human by 
fighting disease such as diabetes and obesity. In a human study, dietary fibre was found to 
produce a SCFA profile that could have anti-inflammatory effects in the body (Roelofsen 
et al., 2010). In another human study with 23 hypertriglyceridemic subjects who were 
overweight mostly because of abdominal adiposity, subjects fed a high-amylose starch 
diet showed a lower fecal pH and increased short-chain fatty acid concentrations in fecal 
water. A significant reduction in the overall postprandial plasma insulin concentration 
relative to the low-amylose diet was also observed (Noakes et al., 1996). Long-term 
consumption of high-amylose starch on insulin and glucose response were investigated in 
aother human study. Chronic consumption of high-amylose foods normalized the insulin 
response of hyperinsulinemic subjects. All these evidences led to a potential benefit of 
high resistant starch for diabetic subjects (Behall and Howe, 1995). There are also reports 
showing that RS can effectively control obesity in rats mediated by the high resistant 
starch content of the starch (Shimotoyodome et al., 2009; Aziz et al., 2009). 
 
Abbreviations 
ACF, Aberrant Crypt Foci 
AOM, Azoxymethane 
146
  
AR, AR cornstarch diet 
ARXGuat, Hybrid resistant starch diet came from the parental lines AR and Guat 
CRC, Colorectal cancer 
Guat, Guat cornstarch diet 
MDF, Mucin Depleted Foci 
 
Safety 
Azoxymethane is a potent carcinogen to induce colon cancer in rats and mice. It 
might cause harm to human if swallowed, inhaled or absorbed through skin.  
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Figure Captions 
Figure 1.  Cecal endpoints collected after rats were fed water-boiled AR, Guat or 
ARXGuat diet and killed (9 weeks after the first AOM injection):  (A) cecal content pH; 
(B) Cecal weight with content (g); (C) Cecal tissue weight (g); (D) Cecal content weight 
(g). 
Values are means +SD. 
a,b,c.
 bars with different letters in each panel are significantly 
different P-value < 0.05. Each diet was fed to 15 rats (10 rats were injected AOM, and the 
other 5 were injected saline).
 
Figure 2.  Lesions observed in rat fed water-boiled AR, Guat or ARXGuat diet (rats 
were killed 9 weeks after the first AOM injection): (A) average ACF number; (B) average 
crypts/foci in ACF; (C) average MDF number; (D) average AC number. The ACF and 
MDF were measured in the distal 75mm of the colon. 
ACF were only seen in AOM-treated rats. Values are means +SD. 
a,b.
 bars with different 
letters in each panel are significantly different P-value < 0.05. Each diet was fed to 15 rats 
(10 rats were injected AOM, and the other 5 were injected saline). 
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Figures 
Fig. 1 
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Fig. 2 
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Tables 
Table 1: Diet Ingredients
1. 
 
 
Diet Ingredient 
water-boiled 
starch diet 
starch 55.0% 
casein 20.0% 
Dextrose 15.0% 
cellulose (insoluble fiber) 0.0% 
mineral mix (AIN-93) 3.5% 
choline 0.2% 
methionine 0.3% 
vitamin mix (AIN-93) 1.0% 
corn oil 5.0% 
 
 
1.
Starches were cooked as described in the text.  All non-starch diet 
ingredients were purchased from Harland Teklad (Madison, WI) or 
Spectrum (Gardena, CA). 
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Table 2: Resistant starch contents (RC) of the three starches and three diets, 
and water content (WC) of the three diets. 
Starch Groups 
Resistant Starch Content of the 
Diets on Dry Diet Basis (n=3) 
Water 
Content of 
the Diets 
(n=3) 
Resistant Starch Content 
of the Starches on Dry 
Diet Basis (n=2) 
(% + sd) (% + sd) (% + sd) 
AR 5.41+0.53% 20.01+0.92% 1.2 ± 0.1 
GUAT 18.58+0.90% 14.12+0.89% 34.5 ± 2.0 
AR  X GUAT 8.57+0.59% 12.99+0.98% 1.9 ± 0.1 
 
    Data are expressed as mean + SD. Resistant starch contents of diets were measured 
by AOAC method 991.43.  
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CHAPTER 5: GENERAL CONCLUSIONS 
General Discussion 
Resistant starches are natural food ingredients obtained from many plants. In western 
countries, the intake of high RS diet is on average poor, impeding humans from the 
benefits in intestinal/colonic health. Studies showed that 28 grams of resistant starch per 
day was well tolerated in healthy humans, which is 6 times more than the average daily 
intake in a western diet (Van Munster et al., 1994).  
In our studies, two types of RS were tested for their inhibition of colorectal 
preneoplastic lesions: RS obtained from a combination of amylose and lipid (SAC), and 
RS from inbred or hybrid of corn lines (Guat and ARXCuat). We measured the incidence 
and multiplicity of ACF and the incidence of MDF in male Fisher 344 rats 8 weeks after 
AOM injections.  We provided clear evidence that consumption of a diet rich in cooked 
SAC suppressed AOM-induced colon carcinogenesis, but water-boiled Guat and 
ARXGuat did not show ability as colon preneoplastic lesion suppressors. The results have 
important implications for humans because starchy food is usually consumed by humans 
in a cooked form. I believe our research on the inhibitory effect of cooked SAC is the first 
to study the impact of RS on colorectal carcinogenesis when the RS was cooked by 
different methods. There has been a single report of the impact of cooking dietary beans 
and peas fed to Wistar rats after these diets were cooked in a microwave (Krupa-Kozak et 
al., 2009). A reduction of glucose and total cholesterol concentration in rat blood serum 
and induced SCFA in the cecal digesta was observed, but no effect on CRC incidence was 
tested.  
Our data showed decreased ACF or MDF numbers and increased ACF multiplicity in 
the distal colon section of rats fed SAC when compared to their respective controls. The 
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distal colon section was collected and observed because reports have shown greater CRC 
occurrence in the distal colon than in the proximal colon in men and in women (Distler 
and Holt, 1997). The incidences of ACF were also reported to be higher in the middle and 
distal colon than in the proximal colon in Wistar rats treated with AOM and fed RS diet 
(Liu and Xu, 2008).  In our study testing the inhibitory effect of SAC, a global gene 
expression analysis was conducted on the colon mucosa samples collected from the distal 
colon or the adjacent colon. The genetic analysis was focused on the more distal part of 
the colon because the genetic changes occurring in our carcinogen-induced sporadic CRC 
were expected to be more frequent in the distal section of the colon as was reported by 
other studies. Furthermore, a bioinformatics analysis of a large amount of published 
papers revealed that proximal and distal colons may reflect different colonic neoplastic 
transformations. Genetic alteration in the proximal tumors appear to be more stable and 
may relate more to the inherited nonpolyposis colon cancer, while distal tumors showed 
greater genetic instability and were more similar to the polyposis-associated colorectal 
cancer syndromes (Bufill, 1990).  
It is notable that in our study, the rats were injected AOM twice before their 8-week 
feeding of RS. This order of RS diet administration after AOM exposure can be pivotal 
for the inhibition of carcinogenesis. Actually, the differences in the order of treatments 
indicated the impact of RS in the different tumorigenesis stages. Carcinogenesis occurs in 
three different stages: initiation, promotion, and progression. Initiation is caused by an 
irreversible damage to DNA by viral, chemical or physical agents and promotion occurs 
when the initiated cells are transformed into a population of preneoplastic cells 
(Thangapazham et al., 2006).  In our study on cooked SAC, RS obviously showed its 
effect in the promotion stage. In fact, inhibitory effects of RS on CRC or on its pre-
cancerous lesions in the promotion stage and an opposite impact in the pre-initiation stage 
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were shown in some previous researches. Liu and Xu reported that feeding male Wistar 
rats with dietary RS after they were treated with AOM significantly suppressed ACF and 
total AC formation, yet an increased ACF number was observed when the RS diet was 
fed prior to AOM exposure (Liu and Xu, 2008).  One of the explanations for the opposite 
impacts of RS in the different carcinogenesis stages is that RS enhances carcinogen 
absorption during the initiation stage, thus promoting the formation of preneoplastic 
lesions and increasing the incidence of CRC. On the other hand, the RS may dilute 
potential toxins and carcinogens and shorten their contact time with the colonic 
epithelium by increasing fecal bulk and reducing transit time at the promotion stage. The 
main increase in the fecal bulk comes from the SCFA induction during the fermentation 
of prebiotic RS by gut bacteria. The RS impact on the carcinogen uptake and disposition 
in a pre-initiation stage was revealed in a study on female Wistar rats (Kestell et al., 
2004). The rats were first fed 35% maize starch (negative control), 35% hi-maize, or 35% 
potato starch, and then gavaged with [2-14C] 2-amino-3- methylimidazo [4,5-f]quinoline 
(IQ). Both plasma and urinary metabolites were tested. Plasma contained markedly higher 
level of intact IQ and lower level of major IQ metabolites in rats fed 35% hi-maize or 
35% potato starch than those fed negative control. A significantly slower metabolite 
excretion in urine was also revealed in rats fed these two diets. A similar study by the 
same group of scientists also revealed that RS enhanced carcinogen bioavailability in both 
colonic mucosa and bloodstream in the pre-initiation stage (Ferguson et al., 2003).  
Meanwhile, the suppression effect of RS in the promotion stage was reported on rats fed 
potato starch, high-amylose maize starch, or an alpha-amylase-treated high-amylose 
maize starch, where increased fecal and cecal weight and a slightly shortened transit time 
were observed (Ferguson et al., 2000). These increased fecal bulk and reduced transit 
time may imply a cause for CRC inhibition when RS was administrated in the promotion 
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stage. Previously there was controversy regarding the relationships between dietary RS 
and CRC. Studies on the impact of RS at the different carcinogenesis stages obviously 
helped to clear up the arguments, and our study provided powerful evidence that cooked 
RS had an inhibitive role in the promotion stage. 
Aberrant crypt foci were one of the first observed biomarkers for CRC (Bird, 1987; 
McLellan and Bird, 1988), but some more recent studies suggested that MDF predicts 
tumor outcome better than ACF in rodent models (Femia et al., 2003; Caderni et al., 
2003; Pierre et al., 2010). In our first study to assess the inhibitory effect of water-boiled 
resistant starch or raw resistant starch in AOM treated rats, no effect of either raw or 
water-boiled SAC diet on the total number of ACF at 8 weeks after initiation with AOM 
was detected compared with their respective controls, yet a reduction in the total number 
of MDF were seen in the rats fed water-boiled SAC compared with rats fed water-boiled 
CS. It was also suggested that ACF with multiple crypts are better predictors of tumor 
incidence since they were considered more prone to progress into cancer (Magnuson, 
1993; McLellan and Bird, 1991). In my study assessing the impact of SAC preparedby 
different cooking methods, large ACF numbers decreased dramatically with the increase 
of resistant starch content in the diets, and this trend was consistent with what we 
observed in the total ACF number.    
Our data demonstrated increased cecal weights and decreased cecal content pH with 
the increase of resistant starch content in both the SAC starch studies and the Guat and 
ARXGuat starch study. Reports suggested these changes are due to an increased 
fermentation by colonic bacteria using RS as substrate to produce SCFA (Gibson, 1996). 
This assumption was consistent with our findings in the cooked SAC studies that the total 
amount of SCFA, as well as the amount of butyrate and acetate, increased significantly 
with the increase of the resistant starch content of the diets. Resistant starch was 
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considered to achieve its anti-carcinogenic effect through increased SCFA from the 
anaerobic fermentation of RS in the colonic lumen. It was assumed that rapidly fermented 
fibers leave no substrate for fermentation in the distal colon since they can be completely 
broken down, while less well fermented fibers produce butyrate all along the large bowel 
(Scharlau et al., 2009; McIntyre et al., 1993). Butyrate was thought to be the main 
component in SCFA to promote colonic health and protect against CRC by inhibiting cell 
proliferation, inducing differentiation, and enhancing apoptosis of CRC cells (Sengupta et 
al., 2006; Scheppach et al., 1995; Whitehead et al., 1986). Markedly, the role of butyrate 
on the prevention of CRC incidence is still not clear since variable results have been 
discovered. Although some negative correlation of butyrate concentration and tumor mass 
were reported, some opposite observations were also revealed. Rats treated with 1,2-
dimethylhydrazine and given 1% or 2% sodium butyrate in drinking water actually 
experienced enhanced development of colonic neoplasia with increased fecal butyric acid 
concentrations (Freeman, 1986). Another rat study showed no inhibitive effect of resistant 
starch against colon carcinogenesis although the butyrate concentration was increased in 
the large intestine of the rats (Sakamoto et al., 1996). 
 In the cooked Guat and ARXGuat maize starch study, the rats fed Guat starch 
obtained reduced cecal pH and enhanced cecal weights, but did not show any suppression 
of the pre-cancerous lesion incidence. One of the explanations is that a sufficient amount 
of resistant starch content is required to show the inhibitory impact of a starch on colon 
lesions. As was reported, the suppressive effect of dietary RS on AOM-induced ACF 
formation was dose-dependent (Liu and Xu, 2008). It was also reported that the positive 
correlation between higher cecal pH and more ACF numbers was dose-dependent 
(Verghese et al., 2002).  In our studies, SAC diet contained 32.7% and 27.2% of resistant 
starch content in the bread-baked and water-boiled starch diets respectively, while the 
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resistant starch content of water-boiled Guat diet was only 18.6%.  It is possible that the 
Guat starch diet did not have enough resistant starch content to prevent the colon lesion 
formation, although this amount was already enough to show obvious fermentation 
differences in the rat large bowel. On the other hand, although resistant starch content is 
frequently used to measure the potential of RS to promote intestinal fermentation and 
suppress colon lesions, it is not the only indicator since other factors, such as starch type, 
efficiency of starch absorption, and differences of SCFA metabolism, can also impact the 
results. For example, different starches may have different fermentation efficiencies and 
impact SCFA metabolism in different ways even when they have the same resistant starch 
content. In a study feeding high amylose maize starch or hydrothermal treated high 
amylose maize starch to young Large White crossbred pigs, although both starches 
contained 85% amylose and both were mixed in the diet by 50%, profoundly more 
resistance to small intestinal digestion was shown in hydrothermal treated high amylose 
maize starch. Consequently, hydrothermal treated high amylose maize starch promoted 
more fermentation in the distal colon (Bird et al., 2007). In this study by Bird et al., 
hydrothermal treated high amylose maize starch was observed to deliver more 
fermentable carbohydrate to the large bowel than high amylose maize starch although 
both diets had the same amylose content and the higher amount of fermentable 
carbohydrate in hydrothermal treated high amylose maize starch might connect to the 
more active fermentation of hydrothermal treated high amylose maize starch. In our 
study, we assessed the resistant starch content of each diet, but the amount of fermentable 
carbohydrate in the large bowel or differences of SCFA metabolism by each starch diet 
were not measured, which might also be determinant factors on the inhibitory effect of 
different RS to the intestinal fermentation and ACF or MDF formation. Meanwhile, 
resistant starch content or the fermentation ability of a RS are not the only factors 
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impacting the formation of preneoplastic lesions. In a study on 1 ,2-dimethylhydrazine-
treated  Sprague-Dawley rats, a less fermentable fiber, wheat bran was found to result in 
significantly higher fecal butyrate concentration and fewer malignant tumors than those 
fed highly fermentable fibers, guar and oat bran (McIntyre et al., 1993). In this study, 
although wheat bran was less fermentable than Guar gum and oat bran, fermentation of 
wheat bran continued in the distal colon, while fermentation of the other two fibers did 
not.  
In our studies, a short feeding period with cooked RS of 8 weeks was conducted with 
AOM-induced rats. Although a reduced number of AOM-induced ACF and MDF were 
observed, these studies need to be followed up in a long-term tumor experiment to 
provide a more complete measurement of the anti-carcinogenesis potential of the RS.  
Previously, a long-term study feeding high amylose starch to male Sprague‑Dawley rats 
revealed a significant reduction in the incidence and multiplicity of adenocarcinomas in 
the rat colon compared with the control normal starch diet (Le Leu et al., 2007). A long-
term intake of raw potato starch also showed an improved colonic mucosal integrity and 
reduced gut apoptosis and blood immune cells in pigs compared with those in normal 
corn starch fed pigs (Nofrarias et al., 2007).  But none of the publications we found have 
done the long-term assessment of tumorigenesis by cooked starches, nor did any studies 
show this long-term relationship in humans.  
Our studies used a rodent model where Fisher 344 rats were injected with AOM twice 
with an interval of one week, and then RS or control diets were fed to them for 8 weeks 
before the preneoplastic lesion assessment. Effective as this rodent model is to induce the 
sporadic form of rat large bowl lesions in the distal colons and to associate with human 
sporadic colorectal cancer (Shamsuddin and Trump, 1981; Druckery, 1972; Papanikolaou 
et al., 1998), there are limitations of this experimental system for studying the molecular 
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and pathological changes of human CRC.  First of all, this animal model is not associated 
with the inherited forms of human CRC such as human FAP and HNPCC since the 
process of carcinogenesis and gene alteration in FAP or HNPCC are comparatively 
different from the ones in sporadic CRC. Secondly, marked differences are considered 
between rodent and human sporadic CRC at the cellular and molecular levels. Not a lot of 
studies have been reported on the differences in tumorigenesis between Fisher 344 rat and 
human, but the differences have been reported on many other rodent models. Generally, 
the basal metabolic rate is 7 times higher in mice than in humans, which may lead to a 
higher level of endogenous oxidants causing DNA damage by oxidizing the bases (Ames 
et al., 1993; Adelma et al., 1988). At the genetic level, fewer genetic changes were 
required in a mouse model than in human CRC tumorigenesis. CRC is known as a 
stepwise accumulation of genetic changes in humans including key gene mutations such 
as APC, K-ras, p53, SMAD4, and DCC. In AOM-treated rodents, APC mutations or p53 
allelic loss were rarely seen in their invasive colonic carcinomas (Okamoto et al., 1993).  
A comparison of 4 rat models (Apc
Min/+ 
mice model, AOM carcinogen model, Tgfb1
-/-
 
Rag2
-/-
 mice model, Smad3
-/-
 mice model) and 100 human CRC samples revealed that 
human CRC adenocarcinomas lost additional suppressor modules (IGFBP4, MAP4K1, 
PDGFRA, STAB1 and WNT4), and gained expression of modules associated with 
advanced malignancy (ABCC1, FOXO3A, LIF, PIK3R1, PRNP, TNC, TIMP3 and 
VEGF) compared with the rodent models (Kaiser et al., 2007). Furthermore, arguments 
exist in that laboratory rodents are exposed to high levels of dietary carcinogens or 
toxicants that are usually rare in humans. All these reports indicated a gap between a 
rodent model and a human application, thus human studies will be necessary after the 
results are gained and concluded from rodent experiments.  
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In our study, the global view of gene expression during the early phase of colonic 
carcinogenesis revealed for the first time the genetic alterations by cooked resistant 
starches in the SAC starch studies. Microarray technique provided powerful analysis of a 
large number of different mRNAs, identified genes and gene families whose expressions 
were altered by diet in previous studies (Kato et al., 2004; Park et al., 2008). Most cancer 
related signalling pathways in the process of AOM-induced gene expression focused on 
the up-regulated pathways including Jak-STAT signalling pathway, apoptosis pathway, 
Alzheimer’s disease related pathway, natural killer cell mediated cytotoxicity pathway, 
focal adhesion pathway, cancer-related pathway, and so on. Genes such as JAK1, STAT1, 
CASP3, CASP8, CD9, CD38, CD48, MAPK1, IL1a, Kras, Braf, and RAF1 were shared 
by these signalling pathways and up-regulated in rats treated AOM compared to saline 
treated control rats. These genes and pathways have been reported to involve in immune 
function, cell growth, cell apoptosis, proliferation, migration, tumorigenesis in the colon 
cancer cell lines, rodent models or human CRC patients, and crosstalk with pathways 
such as TGF-β-signaling pathway, ERK1/2/NF-κB signal transduction pathway, 
TF/FVIIa/PAR2 pathway, RAF/MEK/ERK pathway (Slattery et al., 2011; Zugowski et 
al., 2011; Sreevalsan et al., 2011; Lin et al., 2011; Li et al., 2011; Kim and Hong, 2011; 
Guo et al., 2011; Slattery et al., 2010; Behl et al., 2011; Wilhelm et al., 2004; Benvenuti 
et al., 2007). When comparing the gene expression of SAC or control diet treatment, four 
down-regulated pathways, DNA replication, cell cycle, RNA degradation, and ABC 
transporters were most connected with colon cancer incidence. Of these pathways, DNA 
replication stress relates to some oncogene-induced precancerous DNA lesions 
(Petermann and Helleday, 2007; Ichijima et al., 2010). Abnormal cell cycle reduces 
sensitivity of signals to adhere, differentiate, or apoptosis thus causes inappropriate 
proliferation and is associated with cancer (Hartwell and Kastan, 1994). Improper 
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regulation of RNA degradation can lead to cancer and other diseases (Ross et al., 2001). 
ABC transporters are one of the largest transportome in the human genome and are 
overexpressed in several cancers (Fojo et al., 1987).  Common genes, like CD55, RAC1, 
TFRC, HSPD1, HSPH1, and MCM6, were up-regulated by AOM induction and down-
regulated by SAC feeding. These genes have been reported to regulate cell development, 
growth and proliferation, or enhance cancer cell migration and invasion (Zhu et al., 2011; 
Li et al., 2008; Bjørge et al., 1996; Nioi et al., 2008; Jung et al., 2011; Muchemwa et al., 
2006). The up-regulated by AOM induction and down-regulated by SAC feeding of these 
genes indicated an inhibitory effect of SAC on AOM induced carcinogenesis in the 
genetic level. CD48, an immune response gene in the NF-kappa B gene family was found 
to be down-regulated by AOM treatment and up-regulated by SAC feeding. The 
differentially expressed genes, both induced by AOM and reduced by SAC, can be used 
as potential target genes for the intervention of CRC. 
In conclusion, our studies suggest that the cooked resistant starch SAC, an amylose-
lipid complex, inhibited preneoplastic lesions in the AOM-induced rat. The cooked Guat 
or ARXGuat starches did not show these inhibitory effects in a same rat model. Different 
cooking methods were also compared in the SAC study, and bread-baked method gained 
a more effective inhibitory impact than the water-boiled method by a dramatic reduction 
of ACF and MDF.  It was the first time cooking procedures were involved and compared 
in the consideration of inhibition on preneoplastic colonic lesions by novel RS gained 
from different methods. Our studies suggested that enhanced intake of high content RS 
with appropriate cooking method will help to provide health benefits of RS to the 
maximum extent. The differentially expressed genes selected by the genome-wide gene 
expression screening on the water-boiled rat colon samples are potentially target genes for 
the prevention of CRC. 
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